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“Toutes les sciences ont leur chimère, après laquelle elles
courent, sans la pouvoir attraper ; mais elles attrapent en che-
min d’autres connaissances fort utiles.”
Bernard le Bovier de Fontenelle

Abstract
Atrial fibrillation is the most common cardiac rhythm disorder encountered in clini-
cal practice, often leading to severe complications such as heart failure and stroke. This
arrhythmia, increasing in prevalence with age, already affects several millions of people
in the United States, with a rising occurrence of the disease during the past two decades.
In spite of these warning signals, atrial fibrillation is still difficult to treat, because ba-
sic mechanisms of the arrhythmia remain poorly understood and current treatments are
therefore based on empirical considerations.
The future of therapeutic solutions for the treatment of complex diseases such as
atrial fibrillation relies on a strong collaboration between medicine, biology and engi-
neering. Only through such synergies will efficient monitoring, diagnostic and therapeu-
tic devices be created. The goal of the present thesis was to adopt this multidisciplinary
approach, and develop new strategies for atrial fibrillation therapy using both computer
modeling and advanced signal processing methods.
Biophysical modeling is a practical and ethically interesting approach to develop
innovative therapies, since physiological phenomena of interest are reproduced nume-
rically and the resulting framework is then used with full repeatability to explore me-
chanisms and test treatments. A model of the human atria, that was developed in our
group, was used to simulate atrial fibrillation and perform mechanistic and therapeutic
investigations. In a first study, computer simulations were used to observe spontaneous
terminations of two models of atrial fibrillation corresponding to different developmental
stages of the arrhythmia. Dynamical parameters were observed during several seconds
prior to termination in order to describe the underlying mechanisms of this natural phe-
nomenon, showing that different levels of fibrillation complexity led to different termi-
nation patterns. The mechanisms highlighted by the study were successfully compared
to those described in the existing literature and could suggest interesting guidelines to
better investigate spontaneous terminations of atrial fibrillation in experimental and cli-
nical settings. Moreover, a more precise understanding of the natural extinction of atrial
fibrillation will certainly be crucial for future therapy developments.
The potential of rapid low-energy pacing for artificially terminating atrial fibrillation
was also thoroughly investigated. First, the possibility to entrain and thereby control
fibrillating atrial activity by rapid pacing was studied in a systematic manner. Results
showed that optimized pacing parameters provided sustained entrainment of electrical
activity, although total extinction of atrial fibrillation was never observed. The ability
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to control atrial activity by pacing was also shown to depend on specific properties of
the atrial tissue, showing that patients with atrial fibrillation may not all respond in the
same way to pacing treatments. Finally, this study suggested different guidelines for the
development of pace-termination algorithms for atrial fibrillation. Based on these results,
a new pacing sequence for the automatic termination of atrial fibrillation was designed,
implemented and tested in the biophysical model. The pacing protocol comprised two
distinct phases involving a succession of rapid and slow pacing stimulations. The results
of the tests suggest that this pacing scheme could represent an alternative to current
treatments of atrial fibrillation, and could easily be implemented in patients who already
have an indication for pacing.
Advanced signal processing techniques were also used in this thesis to analyze real
cardiac signals and develop new diagnosis tools. Multivariate spectral analysis and com-
plexity measures were combined to develop an automatic method able to describe subtle
changes in atrial fibrillation organization as measured by non-invasive ECG recordings.
Accurate discrimination between persistent and permanent AF was shown possible, and
potential applications in clinical settings to optimize patient management were demons-
trated.
Collectively, the results of this thesis show that major public health issues such as
atrial fibrillation can strongly benefit from the contribution of biomedical engineering.
The modeling and signal processing approaches used in the present dissertation proved
effective and promising, and synergies between clinicians and scientists will definitely
be at the basis of future therapies.
Keywords : Atrial fibrillation, Biophysical modeling, Computer Simulations, Low-
energy pacing, Surface electrocardiogram, Spectral analysis, Complexity measures.
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Résumé
La fibrillation auriculaire est le trouble du rythme cardiaque le plus commun rencon-
tré en clinique, menant bien souvent à de sévères complications telles que défaillances
cardiaques et accidents vasculaires cérébraux. Cette arythmie, dont la prévalence aug-
mente avec l’âge, affecte par exemple plusieurs millions de personnes aux États-Unis,
et a vu sa présence se renforcer de manière notoire durant les deux dernières décennies.
Bien que ces faits appellent à des développements cliniques importants, la fibrillation au-
riculaire reste difficile à traiter, car les mécanismes fondamentaux de cette arythmie sont
encore mal compris et les traitements actuels sont dès lors basés sur des considérations
empiriques.
Les futures solutions thérapeutiques dédiées aux maladies complexes telles que la
fibrillation auriculaire reposent sur une forte collaboration entre les univers de la mé-
decine, de la biologie, et de l’ingéniérie. Ce n’est que par de telles synergies que des
systèmes efficaces de surveillance, de diagnostic assisté et de thérapie pourront voir le
jour. Le but de cette thèse est d’adopter cette approche multidisciplinaire et de dévelop-
per de nouvelles stratégies thérapeutiques pour le traitement de la fibrillation auriculaire
au moyen de méthodes ayant recours à la modélisation informatique ainsi qu’à des tech-
niques avancées de traitement de signal.
La modélisation biophysique est une approche pratique et intéressante du point de
vue éthique pour le développement de nouvelles thérapies, puisque les phénomènes phy-
siologiques observés sont reproduits numériquement et que le cadre résultant se prête à
l’exploration des mécanismes et aux tests de thérapies avec une répétabilité illimitée.
Un modèle d’oreillettes humaines développé dans notre équipe de recherche a été utilisé
pour simuler la fibrillation auriculaire et entreprendre une analyse des mécanismes et une
recherche de thérapies potentielles. Durant une première étude, des simulations informa-
tiques furent utilisées afin d’observer des terminaisons spontanées dans deux modèles de
fibrillation auriculaire correspondant à différents stades développementaux de la mala-
die. Les paramètres dynamiques d’intérêt furent observés pendant plusieurs secondes
avant terminaison afin de décrire les mécanismes sous-jacents de ce phénomène natu-
rel, démontrant que des fibrillations de différents niveaux de complexité présentent des
scénarios de terminaison différents. Les mécanismes mis en valeur par l’étude furent
comparés avec succès à ceux décrits par la littérature existante et purent ainsi suggérer
des lignes de recherche intéressantes visant à examiner de manière plus détaillée les ter-
minaisons spontanées de fibrillation auriculaire en laboratoire et en clinique. De plus,
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une compréhension plus précise du phénomène d’extinction naturelle de la fibrillation
auriculaire sera certainement cruciale pour le développement de futures thérapies.
Le potentiel des méthodes de stimulation rapide à basse intensité dédiées à la ter-
minaison artificielle de la fibrillation auriculaire a également été investigué en détail.
Tout d’abord, la possibilité d’entraîner, et par-là même de contrôler l’activité auriculaire
au moyen d’une stimulation rapide, a été étudiée de manière systématique. Les résultats
obtenus montrent que des paramètres de stimulation optimisés peuvent fournir un entraî-
nement soutenu de l’activité électrique, bien qu’aucune extinction totale de fibrillation
auriculaire n’ait pu être observée. Il a aussi été démontré que l’aptitude à contrôler l’ac-
tivité auriculaire par stimulation dépend de propriétés spécifiques du tissu des oreillettes,
ce qui tend à prouver que des patients en fibrillation auriculaire pourraient ne pas tous
réagir à ce traitement de la même manière. Finalement, l’étude a permis de formuler des
suggestions pour le développement des futures solutions de stimulation thérapeutique.
Grâce à ces résultats, une nouvelle procédure de stimulation menant à la terminaison au-
tomatique de la fibrillation auriculaire a été conceptualisée, implémentée et testée dans
le modèle biophysique. Le protocole de stimulation proposé comprend deux phases dis-
tinctes mettant en oeuvre des stimulations électriques rapides puis lentes. Les résultats
des tests suggèrent que cette procédure de stimulation pourrait représenter une alter-
native aux traitements courants de la fibrillation auriculaire, et pourrait être facilement
implémenté chez des patients ayant déjà une indication pour un pacemaker.
Des méthodes avancées de traitement de signal ont aussi été utilisées durant cette
thèse pour analyser des signaux cardiaques réels et développer de nouveaux outils de
diagnostic. Une combinaison d’analyse spectrale multivariée et de mesures de com-
plexité permirent le développement d’une méthode automatique permettant de quantifier
finement des changements d’organisation de l’activité fibrillatoire des oreillettes dans
des signaux d’ECG de surface. Une distinction précise entre signaux de fibrillations
auriculaires persistentes et permanentes a été proposée, et de potentielles applications
cliniques visant à optimiser la prise en charge du patient ont été démontrées.
Pris collectivement, les résultats de cette thèse montrent que des problèmes de santé
publique majeurs comme la fibrillation auriculaire peuvent clairement bénéficier de la
contribution du domaine de l’ingéniérie biomédicale. Les approches par la modélisation
et le traitement de signal utilisées dans ce travail de thèse se sont montrées efficaces
et prometteuses, et des synergies entre médecins et scientifiques seront assurément à
l’origine du développement des thérapies du futur.
Mots-clés : Fibrillation auriculaire, Modélisation biophysique, Simulations informa-
tiques, Stimulation électrique à basse intensité, Électrocardiogramme de surface, Ana-
lyse spectrale, Mesures de compléxité.
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Introduction 1
1.1 Motivation and Problem Statement
Atrial Fibrillation
Atrial Fibrillation (AF) is the most common cardiac rhythm disorder (arrhythmia),
increasing in prevalence with age. During an episode of AF, the upper chambers of the
heart (the atria) do not beat in a normal way, the so-called sinus rhythm, but present rapid
and uncoordinated activations. A general consensus classifies this arrhythmia according
to its degree of recurrences [1, 2, 3]: when AF lasts less than seven days and returns
spontaneously to sinus rhythm, it is called paroxysmal AF. When the AF episode lasts
more than seven days, and may require a clinical intervention (called cardioversion) to
restore normal rhythm, it is called persistent AF. Long-standing persistent AF has lasted
for more than one year when it is decided to adopt a rhythm control strategy. Finally,
when cardioversion fails to suppress AF on a long-term run, the arrhythmia is described
as permanent AF.
This abnormal tachyarrhythmia results in an impaired atrial mechanical activity, ir-
regular ventricular response, rapid heart rate, and decreased cardiac output [1, 3], which
in turn can cause symptoms such as severe palpitations, dizziness, angina, dyspnea, de-
creased exercise tolerance, and more generally decreased quality of life [4, 5]. Although
not directly life-threatening, AF was shown to potentially lead to severe complications,
such as a tendency to precipitate or worsen heart failure; besides, the loss of atrial con-
tractility promotes the formation of blood clots, resulting in increased risks for stroke
and thromboembolic events. Therefore, AF was associated with substantial morbidity
and mortality [6].
Recently, it has been estimated that more than 2.2 millions of people in the United
States are affected by AF [1], and a rising occurence of the disease was observed during
the past two decades, so that projective studies estimated that 15.9 millions of people will
be affected by 2050 if present trends continue [7]. As a consequence, the financial costs
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of AF, which constitute already a substantial part of health expenditures, will become a
crucial issue in the following years [8]. Therefore, the need for efficient therapies for the
treatment of AF is now obvious.
Therapy of Atrial Fibrillation: a Challenging Future
Several guidelines for the management of AF have been proposed, and provide a
practical basis for the treatment of the arrhythmia in clinical settings [1, 3, 9]. Nowadays,
possible treatments of AF include:
• pharmacological solutions using anti-arrhythmic drugs (AAD) to slow down the
pathologic rapid heart rate or switch it back to normal sinus rhythm by modulating
pharmacologically the ionic properties of the cardiac tissue,
• electrical cardioversion, where an electric shock resets the atrial activity towards
normal rhythm,
• ablation procedures, where portions of the atrial tissue are ablated either surgically
(surgical ablation) or with high-frequency electrical impulses (catheter-based ab-
lation) for artificially restraining the pathway of AF electrical propagation and
therefore suppressing the fibrillatory activity,
• low-energy pacing solutions by means of implanted atrial pacemakers, where the
atrial rhythm is regulated by electrical stimulations of low intensity in order to
prevent or terminate AF.
Thus far, none of the above solutions has proven to be fully satisfactory, and presently
available treatment options are suboptimal. The current guidelines for the treatment of
AF recommend the use of AAD such as flecainide, dofetilide, propafenone, ibutilide,
amiodarone and dronedarone for pharmacological conversion [1, 2]. However, the long-
term efficacy of pharmacological cardioversion as well as the problem of its related car-
diac and extracardiac side effects (frequent intolerance, organ toxicity, pulmonary fibro-
sis, photosensitivity and neurological disorders) are still a matter of debate [10, 11, 12].
Moreover, pharmacological treatments may increase mortality by causing proarrhythmia
[10, 11, 13, 14, 15]. Although electrical cardioversion by means of electric shocks ap-
plied either internally or externally shows high success rates for restoring sinus rhythm,
it was also shown to have a rather high rate of AF recurrence and a weak maintenance
of sinus rhythm [1, 11]. It was also suggested that the procedure has a substantial risk of
proarrhythmic effects, in that the shock could subsequently trigger ventricular arrhyth-
mia. Another risk related to electrical cardioversion is the creation of thromboembolic
events, when a newly formed blood clot is ejected by the shock out of the atria. Finally,
an acute pain is perceived by patients during electrical cardioversion [16], and the sys-
tematic need for conscious sedation or anesthesia makes the procedure unsuitable for
regular use. Ablation procedures are promising approaches to treat AF but are still fac-
ing major issues before becoming first-line treatments. On one hand, surgical ablation
requires open-heart surgery, and linear lesions are placed during cardiac arrest, which
contributes to a risk of complications [17]. Therefore, surgical ablations are restricted
to patients undergoing concomitant heart surgery for other purposes or to patients with
contraindications to other treatments of AF. On the other hand, catheter-based ablation
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is often considered as a serious alternative to AAD treatments [12]. Nevertheless, this
technique still raises several questions [18]. First, it was shown that AF catheter ablation
often results in the occurrence of an atrial tachyarrhythmia (AT), which can be seen from
the patient point of view like an adverse event more than a success [19]. Moreover, the
late-phase AF recurrence in patients initially defined as successfully ablated is reported
to occur at a rate of approximately 5% per year [20], probably because the technique
is less efficient with persistent AF than with paroxysmal AF [21]. Another drawback is
that, as for any invasive procedure, catheter ablation does not allow trial-and-error ther-
apy, and its success rate and the occurrence of complications are dependent on the skills
of the operator. Moreover, the technique has not been standardized and differs across
institutions and operators, which leaves open the search for a specific sequence of ab-
lations leading to optimal AF termination rates. Finally, the field of low-energy pacing
still lacks a reliable solution for the specific treatment of AF. Although many atrial anti-
tachycardia pacing (ATP) algorithms have been developed either to prevent or terminate
AF [22, 23], recent long-term clinical surveys tend to confirm that current ATP strategies
fail to provide long-term benefits in AF patients with implanted pacemakers [24, 25].
Taken together, these results suggest that the quest for an optimal treatment of AF
still remains an opened question, and future directions for the developments of new
therapeutic strategies remain to be proposed. Regarding the diversity of suboptimal
treatments available, it would be of strong interest to develop automatic diagnostic tools
that could determine, based on the analysis of the AF dynamics of a specific patient,
which treatment would have the most chance to succeed. Treatments themselves can
also be optimized. Of course, the development of new AADs is ongoing [11, 26, 27],
but the biggest surprise could also come from the field on non-pharmacological thera-
pies. Indeed, the field of catheter-based ablation benefits from the development of new
energy sources and technical equipments ensuring single and highly effective procedures
[17, 28], so that ablation could slowly become a potential candidate for routine treatment
of AF [29]. In this perspective, it would be of crucial interest to develop optimized se-
quences of ablation lines, as well as automated algorithms able to describe and track
changes in the organization of AF dynamics during the ablation procedure. Eventually,
the final goal would be to have a dedicated monitoring system providing patient-specific
solutions for optimal ablation procedures. In the same direction, implanted pacemakers
could provide a minimally invasive solution to treat AF without adverse effects. The ma-
jor challenge for future research will be to design new ATP algorithms for specifically
terminating AF, and thus reducing AF burden for patients with paroxysmal as well as
chronic AF. On one hand, systematic studies of the response of AF dynamics to various
pacing protocols still remain to be done, in order to better understand the strengths and
weaknesses of current ATP algorithms and design new AF-specific protocols with better
therapeutic properties. On the other hand, targeted research on the dynamical proper-
ties of spontaneous AF termination could bring fruitful information about the way AF
naturally disappears; such insights may give rise to a new generation of efficient pacing
algorithms. Ultimately, it would be of crucial importance to create an automatic algo-
rithm embedded in current implantable devices, able to continuously monitor atrial ac-
tivity, quickly detect and terminate AF if necessary, and therefore maintain sinus rhythm
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without the need of drugs.
Collectively, the non-pharmacological approaches of ablation or low-energy pacing,
as well as possible combinations of these methods with drugs (so-called hybrid solu-
tions) show great promise in the field of AF therapy, and will surely require extensive
engineering developments in the next decade before a reliable and efficient therapeutic
solution to AF will be proposed.
Biophysical Modeling of Atrial Electrophysiology
Computer modeling of biophysical phenomena has gained increasing importance
in the field of physiology and biology research, particularly because improvements in
computational speed now allow the simulation and analysis of very detailed and realistic
biological models. Indeed, computer models for the analysis of biological systems lead
to the precise description of the underlying phenomena under controlled conditions, be-
cause all the variables of interest can be observed at any temporal or spatial scales.
Compared to experimental research, biophysical modeling also benefits from a perfect
reproducibility of any experiment at any time.
The field of cardiac electrophysiology strongly benefits from the coupling and com-
parison of findings coming from clinical and experimental research on one hand, and
from biophysical modeling on the other hand [30]. Specifically, computer models of AF
in realistic atrial geometries can be implemented to better understand the functional and
dynamical features of the arrhythmia under fully controlled conditions [31, 32, 33, 34,
35, 36]. Such models can thus be an ideal framework for the development of therapeutic
strategies for AF treatment, and have already proven to be fruitful, for instance in the
field of catheter-based ablation of AF [37].
Objectives
The present dissertation has to be considered in the continuation of a series of re-
search projects made by former PhD students of the Lausanne Heart Group 1. During
these previous contributions, a biophysical model of AF was created [38] and devel-
oped [39, 40]. Especially, a realistic geometry of the human atria derived from magnetic
resonance images was developed together with models of atrial cells with relevant ex-
citability, propagation and restitution properties [35]. Optimized numerical schemes
made the use of this model possible for in silico simulations of cardiac arrhythmias with
reasonable computational load. Subsequently, the dynamics of simulated AF could be
analyzed [40, 41], and strategies of AF ablation could be explored [41].
Within this framework, the major goal of the present dissertation is to further develop
therapeutic strategies for AF using both the aforementioned biophysical model and real
clinical signals. The main objectives are:
• to investigate the dynamical processes underlying the phenomenon of AF sponta-
neous termination in the biophysical model,
1. http://lausanneheart.epfl.ch/
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• to provide a detailed analysis of the effect of rapid pacing on simulated AF dy-
namics, and determine its ability to control atrial activity,
• to propose innovative pacing schemes dedicated to the automatic termination of
AF, and assess their performance in the biophysical model,
• to develop new signal processing methods measuring the level of organization
of AF electrical activity, in order to provide potential diagnostic tools that could
better discriminate between different types of AF and subsequently propose ap-
propriate treatments.
This work has been realized in the framework of a collaboration between Medtronic Eu-
rope and the Applied Signal Processing Group 2 of the Swiss Federal Institute of Tech-
nology. This collaboration between industry and academic research, supported by the
Commission for Innovative Technology and the Theo-Rossi-Di-Montelera Foundation,
is an ideal opportunity for fruitful interactions between complementary entities. The
ultimate goal of this thesis is to provide concrete diagnostic schemes and therapeutic
tools, promoting industrial implementation for future clinical use. Hopefully, such con-
tribution could help bridge gaps between academic research, biomedical industry and
clinics.
1.2 Organization of the Dissertation
The dissertation is divided into two parts:
I. Modeling of Atrial Fibrillation Dynamics: the first part is devoted to the presen-
tation of a biophysical model of human atria, and its applications to the simulation
of cardiac arrhythmias. In chapter 2, the electrophysiological and numerical prop-
erties of the biophysical model used throughout this work are reviewed. In chap-
ter 3, the ability of the model to simulate atrial fibrillation is described. Using this
framework, a model-based study of the phenomenon of spontaneous termination
of AF is presented in chapter 4.
II. Therapeutic Strategies for Atrial Fibrillation: in the second part, low-energy
pacing approaches to treat AF are analyzed and improved, and diagnostic tools are
proposed. In chapter 5, a detailed study of the properties of rapid pacing during
AF is presented. In particular, the effect of both pacing parameters and atrial
tissue properties on the ability to control electrical activity through rapid pacing is
studied. Based on these results, a novel pacing protocol for the termination of AF
is presented and tested in the biophysical model (chapter 6). In chapter 7, measures
of AF organization based on multivariate spectral analysis are presented and used
as a diagnostic tool to automatically characterize the type of a newly discovered
AF, and thereby improve patient management and therapeutic decisions.
Finally, a summary of the whole project as well as possible future directions of
research are given as conclusion in chapter 8.
2. http://aspg.epfl.ch/
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1.3 Original Contributions
The main contributions 1 of this work are:
• Advances in fundamental research and therapeutic testing for atrial fibrillation
using a biophysical model of human atria.
– A dynamical study of the phenomenon of AF spontaneous termination com-
paring different models of AF dynamics, and relating mechanisms to existing
literature.
– A systematic study of the effect of pacing parameters and atrial tissue properties
on AF capture during rapid pacing.
– The development and testing of a multi-stage pacing scheme dedicated to the
automatic termination of AF.
• Advances in signal processing techniques for the non-invasive analysis of atrial
fibrillation.
– Development of organization measures based on multivariate spectral analysis
to assess the spatiotemporal organization of AF based on the spectral informa-
tion of multiple surface ECG electrodes.
– Automatic classification of persistent and permanent AF signals to improve cur-
rent patient management.
1. See also the list of patents and publications at the end of the text.
Part I
Biophysical Modeling of Atrial
Fibrillation Dynamics
The first part of the dissertation is devoted to the presentation of the
modeling approach used to study the dynamical properties of atrial
fibrillation. In chapter 2, a brief review of the biophysical model of
human atria used in this project is proposed, including basic concepts
and mathematical formulations. The third chapter shows the ability of
the model to simulate realistic atrial fibrillation dynamics. As an ap-
plication, a study of the dynamics of spontaneous termination in atrial
fibrillation is presented in chapter 4.

Biophysical Modeling
of the Human Atria 2
2.1 Introduction
The mechanisms underlying cardiac arrhythmias are highly complex, and far from
being understood. Since a more precise description of these mechanisms is needed to
target efficient therapeutic solutions, physicians and researchers have made extensive ef-
forts to tackle this problem with different approaches. On one hand, animal models have
been largely used in a successful way to uncover various electrophysiological mecha-
nisms of cardiac arrhythmias. However, the results obtained using these models can not
be directly translated to human patients, since it is not sure that the nature of the arrhyth-
mias under study are similar in animals and in humans. Moreover, repeatability issues
as well as ethical concerns make the use of animal experiments sometimes relatively
difficult. In parallel, complementary approaches based on the biophysical modeling of
cardiac activity was developped as early as in the 1960’s to offer new insights into car-
diac processes [42]. The dramatic increase of computer power over the last decade as
well as fruitful collaborations between physicians and engineers accelerated the develop-
ment of such approaches in an exponential way, leading to precise computerized models
of cardiac activity, in turn opening the way to in silico experiments for investigating
pathophysiological processes under controlled conditions.
A model of cardiac electrophysiology is usually performed following a bottom-up
approach. First, channel gating kinetics must be modeled at the molecular level. Then,
ionic currents, pumps, and ion exchangers can be integrated in a model of cell mem-
brane. The sum of the contributions of each ionic current and its effect on ionic concen-
tration provide a model of the cardiac cell. Furthermore, cells can be coupled to form
a tissue, and eventually a model of the whole organ through the reproduction of the de-
sired anatomy. Finally, measurement of stimulation devices such as electrodes are also
simulated, in order to give clinicians the opportunity to observe and analyze the pro-
cesses produced by the model in a realistic way. Today’s computer models incorporate
all these features, and allow the simulation of realistic cardiac arrhythmias as well as the
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evaluation of potential therapies. Among them, several models have been developed to
specifically describe the atrial myocardial cell. The first models of atria were based on
measurements in rabbit [43, 44], but models extended to describe the human atrial cell
were proposed later [31, 32, 33, 34, 45]. Specific configurations of the Courtemanche
model described in [45] were then proposed in order to account for structural or elec-
trical remodeling [46, 47], offering the framework needed to investigate the underlying
mechanisms of atrial arrhythmias and their corresponding potential therapies [48].
In this chapter, the biophysical model of human atria that was created and developed
in the Lausanne Heart Group [35, 38, 39, 40, 41] is briefly reviewed, following the
bottom-up approach that was used to create it. First, the cellular properties of the model
are presented in the light of some general physiological concepts. Then, the integration
of this cellular description into a tissue model is exposed. Finally, the construction of a
realistic geometry of human atria is presented. Further details on the spatial and temporal
discretization schemes that were used to implement the model numerically can be found
in previous works [39, 40].
2.2 Modeling the cardiac cell
2.2.1 Properties of the cardiac cell
The cardiac tissue can be thought of as a dense array of cells arranged into bun-
dles. Each cardiac cell is typically 30-100 µm long and 8-20 µm wide [49], with a
plasma membrane defining its boundary, and maintaining the characteristic differences
between the intracellular and extracellular environments. The cell membrane is a thin
film of lipid and protein molecules held together by non-covalent interactions [50]. The
lipid molecules are arranged as a continuous double layer about 5 nm thick. Protein
molecules embedded in this lipid bilayer form channels allowing specific ions to cross
the membrane either through passive or active transport 1. The transmembrane poten-
tial Vm is defined by the difference in voltage between the interior and exterior of a cell
(Vinterior − Vexterior). In cardiac cells, the major ions contributing to the net value of Vm
are the Na+, K+ and Ca2+ ions. At steady-state equilibrium, the transmembrane potential
Vm is approximately maintained at −80 mV.
Cardiac cells have the property to be excitable. As long as the transmembrane po-
tential stays under a critical value called the threshold potential, no specific response
of the cell membrane is elicited (subthreshold response). But when the transmembrane
potential reaches the threshold potential, for instance due to a sufficiently strong external
stimulation, an action potential is automatically triggered by voltage-gated cation chan-
nels. During such superthreshold stimulation, the typical time-course of the induced
action potential is shown in Figure 2.1, and consists of 5 phases [51, 52]. In a first step
(phase 0), a rapid depolarization (action potential upstroke) due to a large inward Na+
1. During passive transport, specific ions diffuse rapidly down their electrochemical gradients across
the lipid bilayer, whereas during active transport, carrier proteins actively pump ions across the membrane
against their electrochemical gradient.
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Figure 2.1: Electrical response of a cardiac cell simulated with a Luo-Rudy membrane kinetics
model. (A) Subthreshold stimulation. (B) Superthreshold stimulation. The different phases of the
action potential are numbered from 0 to 4 and are explained in the text.
current (INa) shifts the cell potential from its resting value to about +40-50 mV within
a fraction of a millisecond. Then, an early repolarization takes place (phase 1), where
transient outward K+ currents (Ito) cause the cell to briefly repolarize. During phase 2,
the cell repolarizes slowly, giving rise to a relatively flat portion of the action potential,
called the plateau, and maintained by an inward Ca2+ current (Isi). Finally, during the
late repolarization phase (phase 3), a series of K+ currents (IK) called delayed rectifiers
(IKur, IKr, IKs, IK1) lead to cellular repolarization, and thus bring the potential back to the
resting value (phase 4).
A characteristic feature of excitable cells is that once they get depolarized, they
cannot generate supplementary action potentials during an interval of time called the
effective refractory period (ERP). This intrinsic parameter of cardiac tissue is crucial for
the occurrence of arrhythmia [52]. Estimation of ERP requires sequences of repeated
stimulations of the cell tissue with various timings until the excitability threshold can be
found. This protocol is not well adapted to computer simulation settings, so a measure of
the action potential duration (APD) is used instead [53, 54]. As shown in Figure 2.2(A),
the APD is usually measured between the onset of the action potential upstroke and the
point at which the cell repolarizes to a certain fraction of the maximum reached [49].
For instance, a commonly used measurement is the APD90 representing the APD at 90%
repolarization. By definition, the APD depends on the preceding diastolic interval (DI),
defined as the time interval between the end of the last action potential and the onset
of the next one. The dependent behavior of APD values for various DI is described by
the corresponding restitution curve (Figure 2.2(B)). This curve has been shown to be
a crucial indicator of the susceptibility of the cardiac tissue to initiate and perpetuate
arrhythmias [55, 56]. Similarly, the conduction velocity (CV) of wavefronts and the
ERP are modulated by the preceding DI, and possess their respective restitution curves.
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Finally, the cycle length (CL) is the sum of APD and DI, which is the total time elapsed
between two successive action potential upstrokes.
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Figure 2.2: Definition of action potential parameters and restitution properties for the Luo-Rudy
membrane kinetics model. (A) Action potential duration (APD), diastolic interval (DI) and cycle
length (CL). (B) Restitution curve computed on a 1D cable.
2.2.2 Modeling the cardiac cell membrane
Most of the available models of cardiac cell membrane were derived based on the
mathematical formulation first introduced by Hodgkin and Huxley [57] for neuronal
cells and then applied to cardiac ventricular cells [58, 59, 60, 61]. In this mathematical
description, the cell membrane, consisting of a dielectric lipid bilayer, acts as a trans-
membrane capacitor denoted by Cm, and the membrane potential Vm varies according to
the following evolution equation:
Im = Cm
dVm
dt
+ Iion − Istim (2.1)
Vm = Φi − Φe (2.2)
where Im is the total transmembrane current, Iion is the sum of the ion currents, Istim is
an external stimulation current possibly used to trigger an action potential, and Φi and
Φe are the intracellular and extracellular potentials, respectively. Each of the individual
currents Ik contributing to the total ionic current Iion can be put in the following form:
Ik = gk y(Vm − Ek). (2.3)
Ik represents the current associated with the ion of type k, gk is the maximum conduc-
tance of the related ion channels, and y is a gating variable (0 ≤ y ≤ 1) indicating the
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state (open when y = 0 and closed when y = 1) of the ionic channels. Ek stands for the
potential of the Nernst equation [50] of an ion of type k given by:
Ek =
RT
zF
· ln
(
[k]e
[k]i
)
(2.4)
where R is the universal gas constant, T is the absolute temperature, z is the valence of
ion k, F is the Faraday constant, and [k]i and [k]e are the intracellular and extracellular
ion concentrations, respectively. Thus, each individual ionic current Ik in (2.3) has its
own gating kinetics, which describes the transition of the gate y between the open (O)
and the closed (C) state. Let αy (resp. βy) be the forward (resp. backward) rate of
the reaction C 
 O. The fraction y(t) of open gates at time t is then governed by the
equation
dy
dt
= αy(1 − y) − βyy. (2.5)
In the next subsections, two membrane kinetics models that were widely used throughout
the presented research projects are described more specifically.
The Luo-Rudy Membrane Kinetics Model
The Luo-Rudy membrane kinetics model was originally dedicated to the modeling
of cardiac ventricular cells [60, 61]. In its first version [60], called the Luo-Rudy I (LRI)
model, the total ionic current Iion is the sum of six individual currents involving six
gating variables and the intracellular calcium concentration (see also Figure 2.3):
Iion = INa + Isi + IK + IK1 + IKp + Ib. (2.6)
Each individual ionic current is characterized by its own gating kinetics equation of the
form (2.5). In Table 2.1, the main charateristics of each current are documented. The
LRI model is a passive model, because the ion concentration inside the cell remains
unchanged; a dynamic version called LRII model was later proposed, which included a
dynamic regulation of the intracellular ionic balance for sodium and potassium [61].
In this work, the LR1 model was largely used to simulate atrial arrhythmias for sev-
eral reasons. First, this model has a reduced set of variables, making the computational
load more tractable, especially when a large number of simulations is needed for system-
atic test studies. In addition, the original LR1 model could be modified in order to mimic
atrial membranes by adjusting some ionic conductance properties [55, 62]. This "atrial-
ized" LR1 model was further developed to mimic electrical remodeling as observed in
permanent AF, such as shortening of action potential duration (APD) [56].
The Courtemanche-Ramirez-Nattel Membrane Kinetics Model
The Courtemanche et al. membrane kinetics model (CRN) can be considered as
a refinement of the LRII model, and was derived using specific formulations of ionic
currents based on direct measurements in human atrial myocytes [45]. It is therefore
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Symbol Current Direction
Sodium channel
INa fast inward Na+ current E → I
Calcium channel
Isi slow inward current E → I
Potassium channels
IK time-dependent outward K+ current I → E
IKp time-independent outward plateau K+ current I → E
Ib time-independent outward background K+ current I → E
IK1 time-independent outward K+ current I → E
Table 2.1: Ionic currents of the Luo-Rudy membrane kinetics model. In the column "‘Direction"’,
E stands for extracellular space and I for intracellular space.
one of the first model of the human atrial cell. The model includes the dynamics of
intracellular currents of the sarcoplasmic reticulum 1 (SR). According to the CRN model,
the total current Iion of the modeled cell membrane is the sum of 12 individual ionic
currents as follows (see also Figure 2.4):
Iion = INa + INa,b + ICa,L + ICa,b + Ip,Ca + Ito + IKur + IKr + IKs + IK1 + INa/K + INa/Ca. (2.7)
Table 2.2 summarizes the main properties of the membrane currents of the model, in-
cluding those involved in the dynamics of intracellular currents. More details about the
functions of each individual current can be found in [45]. The underlying gate kinet-
ics of each ionic current is governed by differential equations of the form (2.5). The
Courtemanche et al. model became very popular for the simulation of cardiac arrhyth-
mias, because several studies proposed specific modifications of parameters to reproduce
1. The sarcoplasmic reticulum is a network of tubules and sacs in skeletal muscle fibers. It plays an
important role in muscle contraction and relaxation by releasing and storing calcium ions.
IK IK1 IKp Ib INaIsi
Figure 2.3: Schematic representation of the Luo-Rudy membrane kinetics model. The Luo-Rudy
model includes six membrane currents listed in Table 2.1.
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structural or electrical remodeling, which are crucial substrate alterations in order to be
able to simulate arrhythmias [46, 47].
Ito IKur IKr IKs INa INa,bIK1 INa/K
INa/Ca
ICa,b
ICa,L
Ip,Ca
Itr
NSR JSR
Ileak IrelIup
Figure 2.4: Schematic representation of the Courtemanche et al. human atrial model. The different
membrane currents of the model are listed in Table 2.2. In addition, the model includes a model
of sarcoplasmic reticulum (SR) subdivided into the network SR (NSR) and the junctional SR (JSR).
Circles represent active pumps and exchangers.
2.3 Modeling cardiac tissue
At the tissue level, equations of electrical propagations have to be derived in order to
model the propagation of electrical impulses on a piece of cardiac tissue. In this section,
both bidomain and monodomain approaches are presented.
2.3.1 The Bidomain Model
In the bidomain theory [49, 63], the propagation equations are expressed in a contin-
uous model of excitable tissue composed of an intracellular and an extracellular medium.
The evolution equations are derived from the law of conservation of charge. Moreoever,
one has to take into account boundary conditions. The complete system of a bidomain
model is represented by the following reaction-diffusion equations:
S −1v ∇ · σi∇φi = Cm
∂Vm
∂t
+ Iion (2.8)
∇ · (σi∇φi + σe∇φe) = 0 (2.9)
where Vm = Φi − Φe, with Φi and Φe the intracellular and extracellular potentials, S v
is the cell surface-to-volume ratio, and σi and σe are the intracellular and extracellu-
lar conductivity tensors summarizing gap junction resistivities, and reflecting electrical
properties that are spatially averaged over several cardiac cells. It is assumed that there is
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Symbol Current Direction
Sodium channels
INa fast inward Na+ current E → I
INa,b background Na+ current E → I
Calcium channel
ICa,L L-type inward Ca2+ current E → I
ICa,b background Ca2+ current E → I
Potassium channels
Ito transient outward K+ current I → E
IKur ultrarapid delayed rectifier K+ current I → E
IKr rapid delayed rectifier K+ current I → E
IKs slow delayed rectifier K+ current I → E
IK1 inward rectifier K+ current E → I
Pumps
INa/K Na+-K+ pump current I → E
Ip,Ca sarcolemmal Ca2+ pump current I → E
Ion exchanger
INa/Ca Na+-Ca2+ exchanger current E → I
Sarcoplasmic reticulum fluxes
Ileak Ca2+ leak current NSR → I
Iup Ca2+ uptake current I → NSR
Irel Ca2+ transfer current NSR → JSR
Itr Ca2+ release current JSR → I
Table 2.2: Ionic currents of the Courtemanche et al. model. In the column "Direction", E stands
for extracellular space, I for intracellular space, NSR for network sarcoplasmic reticulum and JSR for
junctional sarcoplasmic reticulum.
no current flow between the intracellular and extracellular domain through gap junctions.
This can be expressed as the following von Neumann boundary conditions:
n> · σi∇φi = 0 (2.10)
where n is a unit vector perpendicular to the tissue interface. On the exterior boundary of
the surrounding bath, which could for instance correspond to the body surface, a no-flux
boundary condition is also assumed:
n> · σe∇φe = 0 (2.11)
Moreover, the extracellular domain, in the absence of any source current, is governed by
the following equation:
∇ · σe∇φe = 0 (2.12)
It has to be noted that other boundary conditions may be imposed [49, 64], depending
on the targeted application. For instance, during defibrillation modeling, the electrodes
used for the defibrillation must be considered.
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2.3.2 The Monodomain Model
The monodomain approximation consists in a simplification of the bidomain prob-
lem, in that only one medium is considered for the resolution of the propagation equation
[49]. While the numerical resolution of the bidomain equations involve complex com-
putations [65, 66], the monodomain approach provides a significant reduction of com-
putational load. A monodomain model can be built in several ways. A first approach
consist in starting from the following assumptions [39]:
• the tissue is thin and lies in an extensive bath,
• the extracellular potential variations are sufficiently small, so that the intracellu-
lar potential variations are approximately equal to the transmembrane potential
variations,
• the effect of the extracellular potential on the transmembrane current sources is
small, so the bidomain equations can be decoupled.
Under these assumptions, a cardiac tissue can be modeled by the monodomain propaga-
tion equation below:
S −1v ∇ · σ∇Vm = Cm
∂Vm
∂t
+ Iion − Istim (2.13)
where the conductivity tensor σ is equal to σi. The related boundary condition reads:
n> · σ∇Vm = 0. (2.14)
Another way to conceive a monodomain model is to consider that the anisotropy
ratios of the intracellular and extracellular domain are equal, σe(x) = κσi(x), where κ is
a constant [67]. Under this assumption, the bidomain equations (2.8) and (2.9) can be
decoupled, so that only one medium has to be considered [49], and equations (2.13) and
(2.14) still hold, with σ−1 = σ−1i + σ
−1
e . A particular case is to consider an isotropic
homogeneous conductivity tensor
σ = ρ−1 I (2.15)
where I is the identity matrix and ρ is the scalar resistivity. In this case, the passive
resistivity can be used to determine the CV, according to the approximate power law
ρ ∝ CV−2 [68]. In a more general framework, anisotropic conduction can be simulated
by modifying the conductivity tensor σ [40].
2.3.3 Simulated Electrograms
In clinical settings, transmembrane potentials are only rarely accessible for the prac-
titioners, and cardiologists are rather used to deal with less invasive cardiac signal record-
ings, such as electrogram signals 1 (EGM) or electrocardiogram signals 2 (ECG). As a
1. A cardiac electrogram is a recording of the heart’s activity as measured directly on the surface of the
myocardium.
2. An electrocardiogram is a graphic signal representing the global electrical activity of the heart as
measured by skin electrodes placed on the thorax.
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consequence, it is necessary to include simulated EGMs and ECGs as measured by vir-
tual electrodes in any model aiming at providing valuable information to clinicians.
A virtual unipolar electrode can be modeled as a point measurement of the (extracel-
lular) electric potential. Such virtual electrodes are ideal, since they do not alter the tissue
or the geometry of the model. As a convention, the reference electrode (zero potential)
is located at infinity. The distance of the electrode to the tissue surface determines the
spatial extent of the area of cardiac tissue the electrode considers for averaging. Unipolar
EGMs are simulated through the computation of the extracellular potential Φe, which can
be obtained using a current source approximation for a large volume conductor [35, 69]:
Φe(x, t) =
1
4piσ
∫
Ωepi
dy δ
S vIm(y, t)
‖x − y‖ , (2.16)
where Ωepi is the epicardial surface, dy is an infinitesimal surface element, δ is the thick-
ness of the tissue, σ is the surrounding bath conductivity, Im is the current source per unit
area of membrane surface, and S v is the cell surface-to-volume ratio. As a supplemen-
tary step, this formula can be extended to take into account the finite size of the torso
as well as its inhomogeneity (lung, blood cavity) in order to provide simulated ECGs
[70, 71].
2.4 Atrial Geometry
The propagation equations presented in the previous section have to be defined on a
specified tissue geometry. In this section, we briefly present the monolayer 3D surface
atrial geometry that was used in this work. It should be mentioned that multilayer ver-
sions of the presented atrial geometry were also developed, as well as geometries with
additional anatomical details [40]. Although these geometries are slightly more realistic
than the one presented below, they were not appropriate for the studies conducted in
this thesis, in which massive amounts of simulations were performed to systematically
test potential AF therapies. Thus, for obvious computational reasons, the monolayer 3D
surface geometry was used exclusively and is described below.
2.4.1 Monolayer 3D Surface
Nowadays, the majority of the biophysical models are based on real medical imag-
ing, such as magnetic resonance imaging (MRI). Below, the different processing steps
that were needed to create the biophysical model of human atria used in the Lausanne
Heart Group are enumerated:
• Data acquisition: An MRI acquisition was first performed on a normal human
subject 1.
1. The raw data was kindly provided by Ryan Lahm, Dr. Josée Morisette and Dr. Arthur Stillman
(Medtronic Inc.). The segmentation was also done by the same group.
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• Segmentation: The epicardial surface of the atria was semi-automatically seg-
mented slice-by-slice, so that a 3D reconstruction of the atrial structure could be
performed, resulting in a coarse triangular mesh. At this point, the original mesh
could not be directly used for partial differential equation solving, because of im-
portant geometrical problems [38]. Indeed, appendages as well as several valves
were poorly segmented, and the definition of the septal wall was unclear.
• Surface design: In order to solve these problems, the surface was smoothed and
parametrized using 3D splines by means of the software Ideas R© (SRDC Inc.). The
sizes of the appendages, veins and valves were corrected to better correspond to
published values [72]. Finally, a septal wall was created [38].
• Meshing: From this parametrized surface, several triangular meshes with dif-
ferent spatial resolutions were generated [40]. Among them, two meshes were
extensively used in the present work: the first mesh contains 50’000 nodes for a
spatial resolution of ∆x = 0.6 mm, and the second contains 100’000 nodes for a
spatial resolution of ∆x = 0.4 mm.
The resulting geometry is a monolayer 3D-surface shown in Figure 2.5 that includes
most of the important anatomical features of the human atria: mitral valve (MV), tricus-
pid valve (TV), left/right superior pulmonary vein (LSPV/RSPV), left/right inferior pul-
monary vein (LIPV/RIPV), inferior/superior vena cava (IVC/SVC) and coronary sinus
(CS). Indeed, the geometry comprises both atrial chambers, and openings corresponding
to the location of veins and valves. The septum wall has a non-conducting hole repre-
senting the fossa ovalis. The total excitable area of the right atrium (resp. left atrium) is
84 cm2 (resp. 72 cm2). The dimensions of the other anatomical features of the geometry
are detailed in Table 2.3.
Right atrium total RA SVC IVC TV CS
84.20 2.84 3.14 4.29 0.54
Left atrium total LA LSPV RSPV LIPV RIPV MV
72.10 1.07 1.02 0.89 1.08 4.57
Septum total septum
4.36
Table 2.3: Dimensions of the atrial geometry. RA/LA stand for right atrium / left atrium. Values are
indicated in cm2.
2.5 Conclusion
In this chapter, the biophysical model of human atria that was developed in the Lau-
sanne Heart Group over almost two decades has been briefly reviewed. The bottom-up
approach used to create the model was followed step by step, starting from the molecular
level with the presentation of cell membrane kinetics, to the organ level and the creation
of a realistic anatomy of human atria. Throughout this dissertation, the 3D monolayer
surface version of the model was preferred to a multilayer one. This choice is inherent to
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LAA
MV LSPV
RSPV
RAA
Septum
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Figure 2.5: Geometry of a model of human atria based on MR images: anterior view (on the left)
and posterior view (on the right). The left/right atrium appendages are indicated by LAA/RAA. The
major anatomical obstacles are also indicated: mitral valve (MV), tricuspid valve (TV), left/right su-
perior pulmonary vein (LSPV/RSPV), left/right inferior pulmonary vein (LIPV/RIPV), inferior/superior
vena cava (IVC/SVC) and coronary sinus (CS). A cut of the septum is also shown with its fossa ovalis
(FO). The location of the sino-atrial node (SAN) is represented as a red dot.
the trade-off between model accuracy and computational load needed to perform large
scale evaluations such as the ones presented in the next chapters.
Two different membrane kinetics models (the Luo-Rudy I and the Courtemanche et
al. models) were successively described, because both are used in the studies presented
in the next chapters. The interest of using these models is that they present very different
simulated AF dynamics: while the Courtemanche et al. model gives rise to a fibrillating
activity of relatively low complexity, the Luo-Rudy model can generate highly complex
simulated AF patterns. These variations in AF complexity was also observed in clinical
and experimental settings [73, 74], and comparisons could be made between different
AF dynamics by using both models (see chapter 3 and 4).
Simulating Atrial
Fibrillation 3
3.1 Introduction
The quality of a biophysical model is mostly determined by its ability to reproduce a
physiological phenomenon with satisfying reliability and to suggest innovative hypothe-
ses based on its output. Although models can be made very complex to exactly mimic
reality, the real challenge is to create a simple model with the lowest possible number
of parameters, and still be able to conduct relevant analyzes and make predictions about
the underlying phenomena [75]. Thus, the real strength of a biophysical model lies in
its simplicity, and not in its complexity. With this philosophy in mind, the biophysical
model of the Lausanne Heart Group was designed in such a way that realistic AF could
be simulated with a small number of parameters and a relatively simple anatomy. Thanks
to this simplicity, the model could be used to run systematic analyzes involving a very
large number of simulations in a reasonable time.
The major goal of this dissertation is to use computer modeling and signal analysis
for the study of AF and its related therapies. In order to achieve such investigations, sim-
ulated AF (SAF) must be first artificially induced in the model, so that the modeled atria
keep fibrillating in a stable and realistic way. Once this situation is reached, subsequent
analyses and therapeutic testing can be performed. In this chapter, the ability of the bio-
physical model used in this dissertation to simulate cardiac arrhythmias is demonstrated.
First, the model is used to simulate normal sinus rhythm. Then, the simulation of dif-
ferent dynamics of SAF are presented using two different membrane kinetics models. It
should be mentioned that the simulation of atrial flutter 1 (AFL) is not presented here,
since it was not the object of the studies presented in this dissertation. Nevertheless,
atrial flutter was also successfully simulated by the model in a previous study [41].
1. Atrial flutter is an abnormality of the heart rhythm, resulting in a rapid and sometimes irregular
heartbeat. It often degenerates into atrial fibrillation.
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3.2 Simulating Sinus Rhythm
The normal sinus rhythm originates from the sinoatrial node (SAN), which is a clus-
ter of pacemaker cells located in the posterior right atrium that fire spontaneously ap-
proximately every second [76]. Each depolarization wave triggered by the SAN spreads
uniformely from the right to the left atrium down to the atrio-ventricular node (AVN)
via the interatrial septum area, and then triggers ventricular contraction. In Figure 3.1,
the typical pattern of activation time for normal sinus rhythm as simulated by the atrial
model is displayed, together with its corresponding isochrones. The total duration of a
normal sinus propagation is about 110 ms. Atrial activation propagates from the right to
the left side and terminates in the left lateral wall, where wavefronts coming from both
sides of the left atrium converge. It is worth mentioning that this activation pattern is
comparable to experimental findings [77] or to other anatomical models [32], although
several anatomical structures such as Bachman’s bundle or crista terminalis have not
been included in the geometry.
Activation time [ms]
0 20 40 60 80 100
SAN
Figure 3.1: Activation map and isochrones during normal sinus rhythm initiated from the sinoatrial
node (SAN). Isochrones are indicated every 10 ms. (Reprinted with permission from Dr. V. Jacquemet)
3.3 Simulating Atrial Fibrillation
3.3.1 The Polymorphic Beast
Atrial fibrillation was first described specifically at the end of the 19th century [78],
although many observations of the phenomenon were made before without clear un-
derstanding of the underlying disease [79, 80]. In 1906, the first electrocardiographic
recordings of AF were performed [81], and led quickly to a definitive identification of
the arrhythmia and its self-sustained nature [82]. Quickly, discussions about the mech-
anistic nature of atrial fibrillation became a subject of intense debate. Very early, two
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opposed hypotheses were proposed to describe the basic mechanism accounting for AF
perpetutation [80]. On one hand, AF was thought to be created and maintained by the
rapid spiking of a single focus [83]. Another theory called "circus movement" stated that
multiple rotating electrical waves could perpetuate atrial fibrillation in a self-sustained
manner [84]. The latter theory progressively prevailed as the dominant explanation of
the mechanism of AF, and was further supported by pioneering computer studies [42].
In this modeling work, the so-called "multiple wavelet" model was first introduced, with
multiple independent wavelets maintaining fibrillation. Moreover, electrophysiological
experiments demonstrated the crucial role of the wavelength of rotating waves for this
multiple reentry model [85, 86].
This classical view of AF mechanisms was soon challenged in the beginning of the
21st century by new theories built on experimental findings [52]. Indeed, mapping stud-
ies suggested that AF could either be created and sustained by the automatic discharge of
ectopic foci in specific areas of the atria [87], or alternatively by one or a small number
of stable and self-sustained high frequency rotors [88]. Which of these three theories is
the most probable description of AF mechanisms remains a matter of debate [89]; it is
often suggested that different stages of the disease could be better represented by one
or another of the above theories. In this context, it is of major importance to be able
to generate different types of AF dynamics with a biophysical model in order to take
into account all the proposed dynamical frameworks mentioned in this section. For this
reason, several models of AF have been developed by the Lausanne Heart Group. In this
dissertation, two models presented below are used, namely a model of recent chronic AF
that could be linked to the multiple wavelet model, and a model of paroxysmal AF based
on meandering wavelets. Nevertheless, it should be noted that other AF types were also
implemented in the model for specific studies, such as a model of ectopic foci [90] or
models of cholinergic AF as well as AF with refractoriness heterogeneity [91].
3.3.2 Initiation and Perpetuation of Atrial Fibrillation
In order to study AF dynamics in the biophysical model, SAF must be first induced
in the model by means of a direct intervention aiming at creating a substrate for arrhyth-
mogenesis. In animal models, this procedure can be achieved by the application of a
drug or chronic pacing. Several clinical pacing protocols known to lead to AF induction
can be mentioned:
• Burst-pacing protocol [92]: during this protocol, a single atrial site is paced at a
periodic fixed frequency of 20-50 Hz during a few seconds until atrial fibrillation
is induced.
• Ramp protocol [93]: during ramp pacing, a sequence of stimuli is delivered with
a progressively decrementing time interval between two subsequent pulses. The
ramp is designed such that AF is triggered by the successive pulses at a given
point.
• Programmed stimulation protocol (S 1 - S 2 - S 3) [94, 95]: these pacing schemes
are a little bit more complex, and involve three different pacing sites. Each site
is stimulated with a different timing that must be specified, and the interactions
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between the created wavefronts trigger the arrhythmia.
In this dissertation, initiation of SAF was performed either by means of a 20 Hz burst-
pacing protocol applied during 3 seconds on the sinoatrial node for the recent chronic
AF model, or by a ramp pacing protocol for the initiation of the paroxysmal SAF. These
simple pacing protocols were preferred because no complex time adjustment is required
between stimuli, and SAF could be reliably induced.
Once SAF has been initiated, its ability to be sustained must be considered, espe-
cially in the context of therapy testing. Indeed, in order to assess reliably the success
rate of a therapy in the model, it must be assured that a termination of SAF observed
in the simulations is directly caused by the therapeutic intervention, and is not due to
spontaneous termination of an unsustained SAF. According to the multiple wavelet hy-
pothesis, the number of fibrillating waves evolving on the atrial tissue at a given time is a
critical parameter for AF maintenance [42, 96]. It was indeed observed that a high num-
ber of fibrillating wavelets increase overall AF complexity and ensure AF perpetuation,
and that AF can not be maintained reliably when this number of wavelets falls below a
critical value [97, 98]. More generally, different alterations of the atrial substrate were
shown to promote AF perpetuation [99]:
• Electrical remodeling: it has been shown that rapid atrial pacing provokes a
shortening in atrial refractoriness through electrical remodeling, which increases
susceptibility to AF [92]. This progressive remodeling in atrial ionic properties
causes the remodeled cells to present shorter APDs as well as a loss of rate adap-
tation [46] and a flattening of the restitution dependence. These factors largely
contribute to AF maintenance. Conversely, steep restitution curves lead to spon-
taneous wavebreaks [100, 101].
• Structural remodeling: the presence of structural heterogeneities such as fibrosis,
heterogeneities in specific ionic concentrations or gradients in APD is also a po-
tential contributor to AF perpetuation. It was shown in human and animal studies
as well as in modeling studies that these structural changes were associated with
AF inducibility and sustainability [102, 103, 104, 105]. From a mechanistic point
of view, these structural alterations can be thought to cause spatial dissociation of
wavelets and therefore promote AF maintenance.
• Inflammation: Finally, it has been recently suggested that inflammation could play
a role in the progressive development of AF. C-reactive proteins (CRP), which
are acute-phase proteins of the innate immune system, were shown to be corre-
lated with the level of chronicity of AF [106]. Moreover, the level of specific
proinflammatory cytokines was also positively correlated with the duration of AF
episodes, indicating a potential role of inflammation in the process of atrial re-
modeling [107].
Both electrical and structural remodeling were implemented in the presented biophysi-
cal model, leading to sustained SAF dynamics useful for subsequent analyses [40, 91].
However, in the different studies presented in this dissertation, only models including
electrical remodeling were used.
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3.3.3 A Model of Recent Chronic Atrial Fibrillation
The first model of AF proposed is based on the multiple wavelet hypothesis, which
states that several independent fibrillating waves evolve randomly on the atrial tissue
and maintain AF by their self-sustained interactions [42, 96]. Such SAF dynamics was
reproduced using the Luo-Rudy I (LRI) membrane kinetics model presented in section
2.2.2 [60]. Although this model was first derived for ventricular cells, some modifica-
tions of its ionic properties were performed to shorten the resulting APD and therefore
better approximate the specific ionic properties of atrial cells [108]. Thus, the channel
conductance Gsi was set to 0.085 mS/cm2, GK was set to 0.423 mS/cm2, and GNa was
reduced to 16 mS/cm2, as was proposed in [109]. Each channel conductance mentioned
can be easily linked to its corresponding ionic current as depicted in Table 2.1 for further
details. As a result, the APD was in the range of reported values for atrial refractory
periods in humans [77]. In addition, an isotropic homogeneous tissue with resistivity
ρ = 200 Ωcm was selected, providing an average conduction velocity during sinoatrial
propagation of 70 cm/s. This "atrialized" baseline version of the LRI model can be
considered as a model of healthy atrial cell, and will be called baseline modified LRI
model in the remaining of the dissertation. In Figure 3.2, the action potential shape as
well as the corresponding restitution curve of this baseline model are illustrated (contin-
uous line). Interestingly, the maximal slope of the restitution curve is greater than one,
meaning that SAF can be easily initiated in this model [101]. However, as was shown in
previous studies, the baseline version of this AF model could not give rise to sustained
SAF, since all episodes terminated after 4-5 seconds, either through mutual annihilations
of wavefronts, or through interactions with refractory tissue [40]. This dynamical behav-
ior of the baseline modified LRI model is typical of normal human atria, in which AF
episodes usually terminate after a few seconds [110]. In order to mimic electrical remod-
eling as observed in permanent AF, the channel conductance Gsi was further reduced to
0.055 mS/cm2. The main effect of this modification was a shortening of the APD and a
flattening of the restitution curve, as displayed in Figure 3.2 (dashed line). Under these
conditions, SAF could be maintained in a stable manner, with wavebreaks continuously
occuring and ensuring AF perpetuation. Consequently, this model of fibrillating atria
was called remodeled modified LRI model.
In order to initiate SAF in the biophysical model, it was therefore necessary to use
a combination of the baseline model and the remodeled model in a sequential way, as
illustrated in Figure 3.3. In a first step, the baseline atrial model was stimulated at the
sinoatrial node by a 20 Hz rapid pacing protocol during 3 seconds. Each stimulating
pulse was modeled by the injection of intracellular current (Istim = 80 µA/cm2) during
2 ms (square pulse). After the first induced pulse, the atrial surface was entirely depo-
larized and stayed for several hundreds of milliseconds in a refractory state. However,
as mentioned above, the steep restitution characteristics of the baseline version provides
an ideal framework for wavebreak occurrence [101], and the first SAF wavelet was cre-
ated after 500 milliseconds, as illustrated on the color maps of Figure 3.3. From this
point, wavebreaks occured continuously under the influence of the pacing, and fibril-
lating waves could progressively spread to the left atrium. After 3 seconds, the pacing
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Figure 3.2: Action potential shape and restitution curve of the modified Luo-Rudy membrane
kinetics model. (A) Transmembrane potential. (B) Restitution curves. Two configurations of the model
are presented: the baseline model with Gsi = 0.085 mS/cm2 (continuous line), and the remodeled
version with Gsi = 0.055 mS/cm2 (dashed lines).
sequence had created a sufficient number of fibrillating wavefronts circulating over both
atria; pacing was stopped and a switch towards the remodeled tissue and its flattened
restitution could be performed to ensure AF perpetuation (red bar on the EGM traces,
panel (A) of Figure 3.3). The resulting fibrillating activity could be maintained during
more than 10 minutes, which is to our knowledge one of the longest simulations ever
performed in a biophysical model of AF.
In Figure 3.4, an example of SAF as simulated by the modified LRI model is pre-
sented together with its related physiological parameters. In panel (A), a sequence of
instantaneous transmembrane potential maps equally spaced by 15 ms increments is
shown, illustrating the dynamical behavior of this model during a short period of time
(135 ms). Clearly, the dynamics observed in these space plots is a multiple wavelet AF,
including numerous wavebreaks and spiral formations. In this example, a typical pattern
of this type of dynamics can be observed in the right lateral wall, where a spiral wave
(pointed by the red arrow in the first space plot) progressively rotates, until it hits its own
refractory tail and gives rise to a wavelet that will in turn create several spiral waves.
A 10 seconds time segment of this self-sustained SAF can be observed in panel (B),
together with examples of simulated unipolar electrograms and membrane potentials, as
well as dynamical parameters such as the number of wavelets present on the atria or
the percentage of excited atrial tissue. These curves illustrate well the chaotic nature
of the simulated fibrillating activity. In Figure 3.5, the histograms of AF cycle length
(AFCL) and of the number of fibrillating wavelets detected on the tissue were computed
over the whole 10 minutes episode of SAF. In panel (A), local measures of AFCL were
performed, with two sites in the left atrium and two in the right atrium. Mean AFCL val-
ues were slightly different from one site to another, demonstrating the influence of atrial
anatomy on the fibrillating activity. Interestingly, the AFCL computed in the pulmonary
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Figure 3.3: SAF initiation by 20 Hz burst pacing in the modified Luo-Rudy membrane kinetics
model. (A) Simulated unipolar electrogram as measured on the sinoatrial node. The modified LR1
model was switched from the baseline to the remodeled version after the three seconds of 20 Hz burst
pacing (red line) and was then let to evolve freely during 10 minutes. (B) Space plots of membrane
potentials during SAF initiation and perpetuation.
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Figure 3.4: Dynamics of sustained SAF using the remodeled modified Luo-Rudy membrane kinetics
model. (A) Space plots of membrane potentials during SAF showing self-sustained multiple wavelet
dynamics with wavefront fusions and wavebreaks. (B) Dynamical analysis of a 10 seconds segment
of SAF: (i) Simulated unipolar electrogram as measured in the right anterior wall. (ii) Simulated
transmembrane potential as measured in the right anterior wall. (iii) Number of fibrillating wavelets
present on the total atrial surface. (iv) Percentage of excited tissue.
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Figure 3.5: Local and global dynamical properties of a 10 minutes episode of sustained SAF
using the remodeled modified Luo-Rudy membrane kinetics model. All histograms were based on
the total SAF of 10 minutes duration. For all plots, mean values, standard deviations, medians and
median absolute deviations are indicated in shaded blue. (A) AF cycle length (AFCL) in local atrial
sites: AFCL was measured in two sites of the left atrium and two sites of the right atrium. (B)
Global measures of AFCL and of the number of wavelets present on the tissue. The global AFCL was
computed by grouping the four sites of the upper panel.
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veins was the lowest, meaning that this area tends to fibrillate faster than the others.
This behavior was also observed during experimental studies on sheep [111]. In panel
(B), the AFCL measures of each site were grouped to give a global measure of AFCL,
and the number of wavelets was also documented. It should be noted that the average
AFCL observed with the modified LRI model is slightly lower than the values usually
reported in humans, since AFCL under 100 ms are only rarely measured. Nevertheless,
other parameters such as APD or CV are in the range of reported values. The number of
wavelets present in the tissue varied between 1 and 14, with an average of 4. In terms
of complexity, this SAF dynamics can be defined as a type II-III AF, as described by
Konings et al. [74].
The numerical implementation of this AF model was done as follows. Propagation
of atrial electrical activity was computed on the atrial geometry discretized using triangu-
lar elements. A finite volume approach was used to solve the monodomain propagation
equations [35, 39]. This approach considers the atrial tissue as a network of resistors
[112]. The actual values of the resistors depends on the geometry of the neighboring
triangles (edge length and angles) as described in Zozor and colleagues [39]. The dis-
cretized surface of 50, 000 nodes resulting in a spatial resolution of 0.6 mm was retained.
This coarse discretization was motivated by the need to simulate thousands of runs of
AF in the studies presented throughout next chapters. It represents a trade-off between
accuracy and computational load that has been used before to reproduce clinical obser-
vations [113, 114]. Moreover, the whole procedure was also tested with a finer mesh
(100, 000 nodes, ∆x = 0.4 mm) in previous studies, and no major difference was ob-
served between the two configurations [41]. The resulting error in conduction velocity
(CV) was about 20% compared to a very fine mesh, but tissue resistivity was adjusted to
compensate for this effect [39]. Operator splitting and adaptive time steps were used for
time integration [35]. The time steps varied between 12.5 µs for depolarization and 50
µs for repolarization.
Overall, the remodeled modified LRI model simulates the existence of a long-lasting
and sustained AF affected by electrical remodeling, but without structural remodeling or
ectopic activity. Therefore, this model is proposed as a model of recent chronic AF,
in which fibrillation has already altered the ionic properties of the atria, but structural
damages are not yet visible. Interestingly, this AF model is characterized by a complex
dynamics, and its resulting fibrillatory activity is not likely to terminate spontaneously
without any external intervention. As a consequence, this model was appropriate for the
testing of simulated therapeutic interventions such as ablation procedures or low-energy
pacing protocols, since it was sure that any observed termination could be attributed to
the therapy under investigation and not to a spontaneous termination. Moreover, this
model was preferentially used compared to other highly complex models because of its
reduced computational load, and its overall simplicity in reproducing recent chronic AF
dynamics. Moreover, past studies demonstrated that results obtained during AF ablation
simulations using this model were not significantly different from clinical findings in
humans [113]. For all these reasons, the modified LRI membrane kinetics model was
largely used in this dissertation, and is at the core of the following studies:
• A study of the phenomenon of spontaneous termination of complex SAF dynamics
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(chapter 4). For this particular study, some ionic properties of the model were
slightly modified in order to make spontaneous terminations more frequent.
• A detailed investigation of AF rapid pacing as observed in the biophysical model,
in order to better understand the effect of rapid pacing on atrial tissue and on AF
electrical activity (chapter 5).
• The presentation and testing of a novel therapeutic solution for AF suppression
based on low-energy pacing (chapter 6).
3.3.4 A Model of Paroxysmal Atrial Fibrillation
The second type of AF that was simulated and studied in this dissertation is charac-
terized by a much simpler dynamics, and can be viewed as a type I-II AF according to
Koning’s classification [74]. For this purpose, the Courtemanche et al. model was used
[45]. In its original configuration of healthy atrial cell, the Courtemanche model could
not provide sustained SAF episodes of more than one second due to long spatial wave-
lengths [115]. To permit self-sustained SAF, electrical remodeling was simulated with
the modification of specific parameters of the membrane model, as proposed in [46], in
order to better match restitution properties measured experimentally in humans during
AF [56]. Therefore, the currents Ito, ICaL, and IKur were reduced by 80%, 30% and
90% respectively, and IKr was increased by 50%, so that APDs were significantly short-
ened as shown in Figure 3.6 (panel A), and the flattened APD restitution curve shown
in panel B of Figure 3.6 was relatively similar to the experimental findings of Kim and
colleagues [56]. This model will be referred to the modified Courtemanche model from
now on. However, the refractory period of the modified Courtemanche model is 230 ms
at rest and 120 ms for the shortest diastolic interval, which is still slightly too long to
ensure SAF perpetuation. In order to shorten the spatial wavelength and thus maximize
the maintenance of SAF after initiation, the resistivity parameter ρ was set to 500 Ωcm,
resulting in a CV of 40 cm/s. Structural remodeling was not implemented in this spe-
cific model, but other types of SAF based on the same biophysical model and including
heterogeneities in vagal action or in APD were also proposed elsewhere [91].
SAF was initiated in the modified Courtemanche model by applying a ramp pac-
ing protocol in the sinoatrial node. Based on previous studies [40], the ramp pacing
sequence was set to start with a cycle length of 280 ms. The pacing cycle length was
then decremented by 1 ms at each beat. Such pacing protocol was extensively used in
clinical studies to induce AF or atrial flutter [93]. The ramp pacing was applied during
11 seconds and then stopped to let AF evolve freely on the atrial surface. In Figure 3.7,
the simulated unipolar electrogram as measured on the sinoatrial node as well as space
plots of membrane potentials during SAF initiation are presented. A progressive change
of atrial activity towards fibrillatory conduction can be observed. After 5 seconds of
pacing, patterns of alternans appeared as the stimulation cycle length decreased. After
approximately 9.3 seconds (35th stimulating pulse), the first fibrillating patterns could be
observed (Figure 3.7, panel B). From that point on, fibrillating wavelets started meander-
ing on the tissue in a self-sustained manner. Interestingly, clinical studies in patients also
found that large APD oscillations were triggered just before AF inititiation [116]. After
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Figure 3.6: Action potential shape and restitution curve of the Courtemanche model. (A) Trans-
membrane potential. (B) Restitution curves. Two configurations of the model are presented: the
baseline model (continuous line), and the remodeled version (dashed lines).
11 seconds, pacing was stopped and SAF was maintained for more than 28 seconds.
In Figure 3.8, a typical sequence of SAF using the modified Courtemanche model is
presented together with its dynamical properties. In panel (A), a sequence of membrane
potential maps equally spaced by 60 ms increments is shown, while panel (B) presents
the analysis of a 10 seconds time segment, where simulated unipolar electrograms, trans-
membrane potentials, the number of wavelets evolving on the tissue and the percentage
of excited tissue are documented. Clearly, the dynamics of this SAF is very different
from the one provided by the modified Luo-Rudy membrane model. Here, fibrillating
electrical activity is characterized by very simple dynamical patterns. Wavebreaks and
spiral formation are not frequent, so the resulting electrical activity only involves a few
spirals drifting randomly on the atrial surface at the same time. For this reason, this
type of SAF is considered as a model of meandering AF. This regularity in dynamics
can also be observed in the curves displayed in Figure 3.8 (panel(B)). In particular, the
number of wavelets present in the tissue is only rarely higher than two. In Figure 3.9, the
histograms of AFCL in different atrial sites and of the number of fibrillating wavelets
detected on the tissue were computed over an AF episode of 30 seconds to provide more
global statistics. The shapes of the AFCL histograms in the Figure are very similar to
the AFCL distribution corresponding to a type I AF in Konings et al. [74]. In addition,
the small number of wavelets detected in average on the atrial surface also suggest that
the SAF presented in this section is of type I.
Although the modified Courtemanche model is specific of human atrial cells and is
well accepted as a detailed and realistic description of atrial cellular activity, it remains
very difficult to make it fibrillate in a sustained manner. In most cases, the SAF provided
by the model tends to terminate spontaneously after a few seconds. Even when using
the modified ionic properties proposed in this section, the duration of SAF episodes sim-
ulated and analyzed throughout this dissertation ranged between 1.8 seconds and 45.3
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Figure 3.7: SAF initiation by ramp pacing in the modified Courtemanche model. (A) Simulated
unipolar electrogram as measured on the sinoatrial node. The model was electrically remodeled, and
ramp pacing was abruptly stopped after 11 seconds (red line). In this example, the SAF episodes
lasted 28.1 seconds. (B) Space plots of membrane potentials during SAF initiation and perpetuation.
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Figure 3.8: Dynamics of sustained SAF using the modified Courtemanche model. (A) Space plots
of membrane potentials during SAF showing self-sustained SAF with meandering wavelets. (B) Dy-
namical analysis of a 10 seconds segment of SAF: (i) Simulated unipolar electrogram as measured
in the right anterior wall. (ii) Simulated transmembrane potential as measured in the right anterior
wall. (iii) Number of fibrillating wavelets present on the total atrial surface. (iv) Percentage of excited
tissue.
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Figure 3.9: Local and global dynamical properties of a 30 seconds episode of sustained SAF
using the modified Courtemanche model. All histograms were based on the total SAF of 30 seconds
duration. For all plots, mean values, standard deviations, medians and median absolute deviations
are indicated in shaded blue. (A) AFCL in local atrial sites: AFCL was measured in two sites of the
left atrium and two sites of the right atrium. (B) Global measures of AFCL and of the number of
wavelets present on the tissue. The global AFCL was computed by grouping the four sites of the upper
panel.
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seconds, with an average value of 8.5±7.1 seconds (see chapter 4 for more details). This
tendency towards spontaneous termination combined with its relatively simple "mean-
dering wavelets" dynamics and the fact that no structural heterogeneities were consid-
ered for this model motivated the decision to propose it as a model of paroxysmal AF.
However, it could be argued that paroxysmal AF often involve ectopic activity stem-
ming from pulmonary veins [87]. Indeed, continuous ectopic activity was not simulated
in the proposed model. Nevertheless, our model can be thought of as simulating ongo-
ing episodes of acute AF that could have been triggered by a transient firing of ectopic
foci. Due to its inherent properties, this model was not adapted to therapy testing, where
sustained SAF is absolutely needed. Indeed, in order to assess therapy efficiency in a
reliable way, it must be certain that an observed SAF termination was provoked by the
therapy, and not by a spontaneous phenomenon. Thus, this model was used exclusively
in chapter 4 to study the mechanisms of spontaneous AF termination.
The advantage of simulating short AF episodes is that the computational load is not
a constraint anymore. Therefore, the numerical implementation of this AF model was
done in a surface mesh of 100, 000 nodes giving a spatial resolution of ∆x = 0.4 mm.
The resulting error in conduction velocity (CV) was smaller than 15% compared to a
very fine mesh, but tissue resistivity was again adjusted to compensate for this effect.
The numerical integration of the numerous differential equations of the Courtemanche
model was performed the same way as for the modified LRI model.
3.4 Conclusion
In this chapter, the biophysical model of human atria presented in chapter 2 was
used to simulate both normal and altered cardiac activity. SAF could be successfully
initiated using two distinct cellular models showing different propensities to be sustained
over time. A detailed documentation of the parameters and integration methods used to
simulate these two AF models was provided, and will be largely used throughout the rest
of this dissertation.
In addition, a complete description of the dynamics of both AF models was pre-
sented, emphasizing the difference in their respective levels of complexity. AF is known
to cover a wide range of complexities depending on its type and its state of progression.
The models used in this dissertation can be considered as representative of either early
stages (paroxysmal AF) or later stages (recent chronic AF) of the arrhythmia. Being
able to simulate AF of different families can be an advantage, as it can be considered
as simulating different sub-populations of patients. For instance, in chapter 4, the phe-
nomenon of spontaneous termination could be studied and compared between early and
later stages of AF, which is not easily feasible in clinical settings. Similarly, the methods
developed in chapters 5 and 6 for AF therapeutic pacing were based on the AF model
of section 3.3.3. Thus, these methods can be considered as targeted to patients with
recently diagnosed chronic AF.
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4.1 Introduction
In this chapter, a modeling study of the dynamics of AF spontaneous termination
is exposed. After a state of the art of this widely observed, but poorly understood phe-
nomenon, a description of the mechanisms of spontaneous termination of two different
types of SAF is presented. This study was at the origin of two publications [117, 118].
Spontaneous Termination: a Poorly Understood Phenomenon
The first case reports of spontaneous termination of long-lasting AF were described
as early as in the 1950’s [119]. Since then, a growing interest in the understanding of this
phenomenon could be observed across the medical and scientific community, as a better
understanding of this process of spontaneous AF termination could lead to a more accu-
rate dynamical description of AF in its last instants, and eventually to the development
of more effective therapies. However, the mechanisms of spontaneous AF termination
are difficult to study in detail due to their transient nature. Nevertheless, several studies
investigated this phenomenon during clinical, electrophysiological or computer-based
experiments, and illustrated the difficulty to precisely describe the time course as well as
the spatial patterns underlying spontaneous AF termination.
Indeed, describing the exact timing of AF spontaneous termination is a major chal-
lenge, sometimes leading to contradictory results. While a study on patients with parox-
ysmal AF reported that changes in the global organization of electrocardiographic sig-
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nals could be detected up to one minute prior to paroxysmal AF termination [120], it
was shown on a similar population of patients that frequency changes in the surface
electrocardiogram are abrupt and occur only during the last 1-2 s of the AF episode
[121]. Moreover, during a mapping study of spontaneous AF termination using a basket
catheter, the earliest detectable event was shown to occur on average 4 s before termina-
tion [122].
Similarly, the spatial patterns of electrical activity underlying AF terminations are
difficult to describe accurately. According to the "multiple wavelet" AF model [96],
AF might terminate either by a simultaneous block of all fibrillating wavelets, or by a
progressive fusion of wavelets into one massive wavefront. Once again, results and con-
clusions were mixed. In a study based on intra-atrial recordings of both drug-induced
and spontaneous termination of AF in humans, observations failed to show any wavelet
linking measured by coherence increase or cycle length increase before spontaneous AF
termination, therefore supporting, but not proving, the hypothesis that AF wavelets are
simultaneously annihilated [123]. The same conclusions were also drawn in a study of
surface ECG recordings [124]. On the other hand, opposite results were obtained in other
electrophysiologic studies, where AFCL was shown to increase several seconds before
spontaneous terminations of AF, suggesting an organization process through wavelet fu-
sion directly preceding AF extinction [120, 122, 125]. This latter hypothesis was further
supported by investigations using signal processing methods dedicated to the quantifi-
cation of organization, such as mutual information or sample entropy [120, 126, 127].
Organization tended to increase progressively several seconds before AF termination, as
fibrillating wavelets progressively fused into a few major waves prior to AF termination
[126]. In terms of spectral parameters, it was observed that AF termination could be
better predicted by a low and stable fibrillatory frequency, which also suggests some
organizing process [121, 128]. Nevertheless, these studies were conducted on different
types of AF encompassing a continuous spectrum of complexity. AF with different dy-
namics can possibly have different termination processes, as will be shown in the next
sections.
Alternatively, several attempts to mechanistic descriptions of the phenomenon were
also published, including both experimental and computer modeling studies [129, 130,
131, 132, 133, 134, 135, 136]. In these studies, the crucial role of wavefront curva-
ture changes during conduction slowing and block was underlined [131, 134, 135],
and mechanisms of termination through spiral wave collisions were largely described
[132, 133]. Especially, two studies based both on computer modeling and animal exper-
iments when considering AF models based on rotors [137] suggested that AF termination
was triggered by a destabilization of spiral rotors evolving on the atrial tissue during AF
through Na+ inhibition [135, 136]. When Na+ decreased, rotors started to increase in
size, which in turn increased their core meander and their wavefront curvature. These
dynamical instabilities promoted rotor extinction either through mutual annihilation with
other rotors, or through collision with anatomic boundaries. Moreover, they were also
observed in another computer modeling study as a critical parameter for AF termination
through wave collision [138]. Finally, it was demonstrated during mapping studies that
spontaneous AF termination was polymorphic with spatially heterogeneous groups of
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unstable rhythms [122]. In particular, different dynamical behaviors between the right
atrium (RA) and the left atrium (LA) were observed.
A Modeling Perspective
Taken together, these results illustrate the complexity of the phenomenon of AF
spontaneous termination. Although several parameters were mentioned as good descrip-
tors of the termination process, more detailed studies are needed to understand the phe-
nomenon in a more systematic way. Such knowledge would be of the utmost impor-
tance, since a precise description of AF spontaneous termination mechanisms could be
used through "reverse engineering" to elaborate more targeted therapies, such as AF-
dedicated pacing alogrithms or ablation patterns.
In this perspective, computer studies are of interest to complement clinical and ex-
perimental findings in the search for a more complete understanding of the underlying
mechanisms of AF spontaneous termination. Indeed, computer simulations can be used
to generate a high number of spontaneously terminated AF episodes in a much easier
way than in clinical settings. Moreover, a refined analysis of the dynamical mechanisms
coming into play can be conducted at different temporal and spatial scales, since all vari-
ables of interest are accessible over time and space, including the number of fibrillating
wavelets as well as their trajectories and mutual interactions.
In the present model-based study, we analyzed simulated episodes of spontaneous
AF termination to assess the temporal and spatial scales of the mechanisms involved.
In order to account for the polymorphic nature of AF, models of either paroxysmal or
recent chronic AF with distinct dynamical properties were investigated, and differences
in SAF dynamics between the RA and the LA were documented.
4.2 Methods
4.2.1 Biophysical Modeling of Atrial Fibrillation
Different computer models of the atria with realistic anatomy and electrophysiology
were developed over the last decade [31, 32, 33, 34, 36, 69]. In order to alleviate the
computational load, simplified versions of these models were derived to make the large-
scale simulation of atrial arrhythmias possible, for instance to investigate therapies, such
as AF ablation [36, 113] or low-energy pacing (see chapter 6 or [139]).
In this study, two biophysical models of AF with an identical anatomical structure
but with different cellular kinetics were successively used to simulate AF dynamics with
distinct levels of complexity: (A) the model of paroxysmal AF presented in section 3.3.4,
depicted as a meandering or type I AF according to the classification of Konings et al.
[74], where only a few reentries wander on the atria, and (B) the model of recent chronic
AF developed in section 3.3.3, i.e. a model of multiple-wavelet AF [96] that could be
classified as a type III AF due to the high number of reentries observed on the tissue.
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The dynamics of spontaneous termination was then analyzed in each of these AF models
in both the temporal and spatial domains.
Atrial Geometry
The atrial geometry used in this work in combination with the cellular models men-
tioned above is the 3-D monolayer surface described in chapter 2. The resulting ge-
ometry includes all major anatomical obstacles to propagation, as shown in Figure 4.1.
Three-dimensional anatomical structures such as Bachmann’s bundle, pectinate muscles
or crista terminalis are not included, so that the effect of the major anatomical features
on the process of spontaneous termination can be specifically investigated.
Figure 4.1: Geometry of the biophysical model of human atria used in this chapter: anterior view
(on the left) and posterior view (on the right), with a cut of the septum in the middle. The major
anatomical obstacles including valves and veins are indicated in red.
Atrial Cell Models
In order to generate SAF dynamics with distinct levels of complexity, two different
cellular models were successively used at each node of the atrial geometry to simulate
atrial electrical activity. First, the modified Courtemanche model introduced in section
3.3.4 was used to simulate a paroxysmal AF based on meandering AF dynamics. The
modifications in the parameters of the membrane accounting for AF tissue properties
shortened the action potential duration to 210 ms, while reproducing the restitution prop-
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erties measured in human atrial cells during chronic AF [56]. The atrial substrate was
kept homogeneous, and conduction anisotropy was not considered. The resistivity ρ was
set to 500 Ωcm, resulting in a conduction velocity of 40 cm/s. With this configuration,
SAF could occasionally be self-sustained for more than 20 seconds, although most of
simulations terminated spontaneously in a shorter period of time.
For the second type of SAF investigated, the remodeled modified LRI model pre-
sented in section 3.3.3 was used, namely a model of recent chronic AF. In its original
configuration, this model tends to keep AF sustained for several minutes of simulation,
which is useful to create the initial database of SAF signals, but is computationally de-
manding when it comes to observing SAF terminations. For this reason, a slight modifi-
cation in the tuning of channel conductance parameters was abruptly made at the begin-
ning of each simulation of spontaneous termination using this model. The K+ channel
conductance was still set to GK = 0.423 mS/cm2, and the Na+ channel conductance to
GNa = 16 mS/cm2, but the L-type Ca2+ channel conductance Gsi was increased to a
value of 0.06 mS/cm2 instead of 0.055 mS/cm2. This abrupt increase in Gsi lengthened
the APD from 195 ms to 210 ms compared to the original model used to generate the
SAF, and subsequently forced spontaneous termination in a shorter time window.
4.2.2 Simulating Atrial Fibrillation Spontaneous Termination
First, SAF had to be triggered properly in each of the configurations depicted above,
in order to be able to observe spontaneous termination mechanisms in a second step.
Each type of SAF, paroxysmal AF model and recent chronic AF model, was initiated
successfully following the protocols of section 3.3.3 and 3.3.4 respectively. Then, a
database of SAF initial conditions was created by selecting 50 instantaneous transmem-
brane potential maps during ongoing SAF, and keeping them as initial conditions (IC)
for the subsequent simulations of spontaneous terminations. An illustration of this pro-
cedure is given for the model of recent chronic AF in the upper panel of Figure 4.2. For
this model, the first IC was taken after 30 seconds of freely evolving SAF (IC1), and
the remaining ones were selected every 5 seconds, IC50 being therefore picked after 4
minutes and 15 seconds of SAF. For the model of paroxysmal AF, the 50 ICs were taken
from 9.6 s to 19.4 s after the beginning of pacing, with 200 ms steps. For this model,
there was a slight difference in the initiation protocol compared to the one presented
in section 3.3.4. Indeed, the ramp pacing protocol was not stopped after 11 s, but was
maintained during 20 s. This small modification ensured that each IC was radically dif-
ferent from the others, and therefore led to distinct termination patterns, since at least
one pacing pulse could be observed between the different time instants when ICs were
taken. Finally, for each of these ICs, SAF simulations were let to evolve freely until
spontaneous termination occurred. Following this protocol, 50 different AF termination
episodes for each model of AF could be simulated, resulting in a total of 100 simulations
of different durations.
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Figure 4.2: Simulation protocol and temporal analysis of SAF spontaneous termination. Upper
panel: Creation of a database of SAF initial conditions by selecting 50 transmembrane potential
maps at regular intervals from simulated sustained AF (Example of the model of recent chronic AF is
shown). Lower panel: Scheme of the temporal analysis of both AFCL and #WF averaged across the
50 initial conditions. AFCL represents the spatial averaged AF cycle length and #WF the number of
wavefronts present in the atria. τAFCL and τ#WF are respectively the times from the onset of the last
AFCL increase or the last #WF decrease prior to AF termination.
4.2.3 Analysis of Spontaneous Terminations
Temporal Analysis
To assess the time scales involved in the SAF termination process, different parame-
ters were measured during the 8 s preceding termination (Figure 4.2, lower panel). First,
the durations of each SAF episode until spontaneous termination were computed. Then,
the temporal evolution of AFCL was documented. AFCL was computed as a spatial
average of the beat-to-beat intervals measured with 64 electrodes uniformly distributed
over the surfaces of both atria (32 on the RA and 32 on the LA). The SAF dynamics was
then characterized by two parameters: the number of wavelets present in the atria and
the number of wavefronts (#WF). A wavelet was defined as a spatial zone of neighbor-
ing atrial cells with a transmembrane potential higher than −60 mV. Wavefronts were
defined as the depolarizing fronts of wavelets, computed as the zones located at the edge
of a wavelet with a positive derivative of the transmembrane potential. Therefore, there
could be more wavefronts than wavelets, as illustrated in Figure 4.3. Finally, the mea-
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sures τAFCL and τ#WF were respectively computed as the time from the onset of the last
AFCL increase and the last #WF decrease prior to SAF termination, as illustrated in the
lower panel of Figure 4.2. These instants were measured because they were presumed
to be triggering mechanisms of termination.
Figure 4.3: Example of SAF wavelet with multiple wavefronts observed on an instantaneous trans-
membrane potential map of freely evolving SAF. The SAF wavelet is shown by a red dashed rectangle.
On the enlarged version of the wavelet, two wavefronts can be observed (white continuous lines),
which shows that a single wavelet can possibly contain more than one wavefront.
Each measure was systematically computed globally in both atria, and separately in
the RA and the LA: statistical comparisons between atria could then be conducted using
Wilcoxon ranksum test with differences considered to be significant at p < 0.001. The
sampling period was 1 ms for AFCL and 5 ms for #WF. In order to observe the temporal
evolution of each measure in a smooth manner, a moving average was performed on the
AFCL and #WF with a sliding window of 1000 ms with 100 ms increments.
Spatial Analysis
The second part of the analysis is aimed at describing systematically the underlying
spatial patterns of SAF spontaneous terminations in the AF models under study. For
each simulation, the location of the extinction sites of the last active reentrant wave-
fronts before SAF termination was documented. In most cases, these last wavefronts
were annihilated by one or several collisions, generating a bigger and more uniform
wavefront that died out in one of the extremities of the geometry a few hundredths of
milliseconds later. Therefore, an extinction site was defined as the site where SAF activ-
ity terminated, but not necessarily where electrical activity was present last in the atrial
tissue. Spatial patterns of spontaneous termination were distinguished according to three
different classes of increasing spatial complexity:
• Spontaneous terminations involving a single extinction site.
• Spontaneous terminations involving multiple extinction sites located in the same
atrium.
• Spontaneous terminations involving multiple extinction sites located in both atria.
A termination pattern was considered to involve a single extinction site whenever the
last reentry observed in the tissue was the only remaining one for a sufficient period of
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time Tsingle before its extinction. Based on preliminary tests, this minimal time interval
Tsingle was defined empirically for each model of AF separately as 0.3 ·AFCLmean, where
AFCLmean is the AFCL averaged across the 50 simulations. This choice was motivated
by the fact that the models of AF compared in this study showed very different dynamical
properties; adjusting Tsingle on the mean AFCL of each model made it independent from
these dynamical discrepancies. Finally, whether unilateral termination patterns occurred
in the RA or the LA was also documented. Thus, all simulations could be classified
within this analysis framework, and binomial tests were run to investigate which spatial
patterns had a statistically significant (0.1% significance level) tendency to occur more
frequently.
Finally, it was attempted, whenever possible, to group simulations according to the
location of their last extinction sites, and to investigate through temporal analysis possi-
bly different termination mechanisms between these groups.
4.3 Results
SAF was consistently observed across the 100 simulations as several fibrillating
wavelets propagating on both atria, but the dynamics observed presented clear differ-
ences depending on the AF model under study. In Table 4.1, average values of AFCL
and #WF computed on a SAF episode of 30 s are given for each AF model. Simu-
lated paroxysmal AF was characterized by a smaller number of fibrillating wavefronts
(6.0 ± 2.8) present on the atrial tissue compared to the recent chronic AF model, for
which an average of 7.8 ± 2.7 wavefronts were detected. Similarly, differences between
the models could be observed in the average AFCL measured on the 30s segment, as
the mean AFCL of the paroxysmal AF model was 275.0 ± 53.0 ms, which is a very
slow AF dynamics, whereas the recent chronic AF model had a very fast dynamics with
an average AFCL of 106.8 ± 39.8 ms. Based on these observations, the variable Tsingle
could be set at 80 ms for the model of paroxysmal AF, and at 30 ms for the model of
recent chronic AF. Finally, in order to relate each SAF dynamics to the well-accepted
classification proposed by Konings et al. [74], an average number of fibrillating wavelets
detected on the RA was computed for each SAF model across the 50 simulations. For the
model of paroxysmal AF, the average number of wavelets in the RA was 1.1 ± 0.4. This
corresponds to type I and type II AF as described in [74], a dynamics of relatively low
complexity. On the other hand, the average number of wavelets in the RA as observed
in the model of recent chronic AF was 2.5 ± 1.3, which represents a more complex AF
dynamics of type II to type III.
All 100 simulations performed in this study had different durations, but ended with
a spontaneous termination. In Figure 4.4, the histograms of the durations of the 50
episodes of SAF for each AF model are presented. For the model of paroxysmal AF,
the mean episode duration was 8.49 ± 7.11 s. However, when looking at the histogram
in panel (A) of Figure 4.4, most episodes terminated in an average time of about 6 s
and only four episodes lasted much longer (up to 45 s). For this reason, the median
and median absolute deviation of the episode duration distribution were also computed,
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resulting in a value of 7.5 ± 3.93 s. For the model of recent chronic AF, the mean and
median values for episode durations were 58.47±56.29 s and 47.10±37.94 s respectively.
The range of possible episode durations was much wider than for the meandering AF
model (Figure 4.4(B)), and some particular simulations could show sustained SAF for
more than 4 minutes.
Paroxysmal AF model
LA RA LA+RA
AFCL 275.2 ± 54.3 ms 274.9 ± 51.7 ms 275.0 ± 53.0 ms
#WF 3.4 ± 2.0 3.8 ± 2.0 6.0 ± 2.8
Recent chronic AF model
LA RA LA+RA
AFCL 106.1 ± 39.5 ms 107.6 ± 40.1 ms 106.8 ± 39.8 ms
#WF 4.6 ± 2.0 4.8 ± 2.1 7.8 ± 2.7
Table 4.1: Dynamical characteristics of each AF model as computed on a 30s segment of ongoing
SAF. Mean values and standard deviations are given for both AFCL and #WF measures.
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Figure 4.4: Histograms of the durations of the 50 episodes of SAF for each AF model. (A) Parox-
ysmal AF model. (B) Recent chronic AF model.
4.3.1 Examples of Simulated Spontaneous Terminations
In this section, two examples of SAF spontaneous terminations are presented, one
for each of the AF models under study. Instantaneous membrane potential maps as well
as dynamical parameters of the eight seconds preceding termination are systematically
shown, in order to illustrate in detail the mechanisms in action during these particular
simulations. For the purpose of clarity, a spontaneous termination episode involving a
single extinction site is shown for each model.
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Termination in a Model of Paroxysmal Atrial Fibrillation
Figure 4.5 presents an example of SAF spontaneous termination as simulated by
the model of paroxysmal AF. In this model characterized by a meandering AF dynam-
ics, SAF showed a low dynamical complexity. Indeed, only 1 to 3 fibrillating wavelets
(translating into approximately 6 wavefronts) could be observed on the tissue, and pe-
riods with more than 2 wavelets (e.g. t = −5470 ms) were generally short. Most of
the time, only 1 or 2 wavelets were observed, and SAF was therefore characterized by
massive wavefronts circulating slowly on the atrial surface. Repolarization alternans
was also observed during SAF evolution on both unipolar electrogram and transmem-
brane potentials (panel (B)-(i)-(ii)). Approximatively 2.5 seconds before termination,
the number of wavelets present in the tissue increased more durably, as can be seen on
space plots (t = −2450 ms), and the percentage of excited tissue started to oscillate a few
hundredths of milliseconds later. From this point, several collisions between wavefronts
progressively decreased the overall complexity of the global activity (t = −1310 ms).
At time t = −790 ms, several wavefronts were still present in both atria, but a series of
blocks provoked by refractory fronts (t = −710 ms, blocks indicated by thick red lines)
occured; as a result, only one reentry still survived in the RA, while the LA was already
free from any fibrillating activity (t = −460 ms). The last reentry spiraled rapidly before
being blocked by its own refractory tail (t = −380 ms). At this point, no more reentries
were present in the tissue, and only a massive uniform wavefront remained (t = −290
ms), propagating from the RA to the LA appendage and finally leaving the tissue free
from any activity (t = −130 ms). Interestingly, repolarization alternans was less present
in the 2 last seconds of this example, which supports the hypothesis that the phenomenon
of repolarization alternans could be related to vulnerability to AF [140].
Termination in a Model of Recent Chronic Atrial Fibrillation
Figure 4.6 shows an example of SAF spontaneous termination from the model of
recent chronic AF. In this model, the number of fibrillating wavelets observed on the
atrial surface could occasionally reach a value of 10, which illustrates the high level of
complexity embedded in the dynamics of this particular SAF. Between 8 and 3 seconds
before termination, SAF was stable and present on the whole atrial surface. Especially,
the number of wavelets was often above five and the percentage of excited tissue re-
mained relatively constant on this time interval, resulting in a globally installed fibrillat-
ing activity. Interestingly, a transient oscillation in the percentage of excited tissue could
be observed 3 seconds before termination (dashed red circle in panel (B)-(iv)), as if the
activity was near termination but somehow found a way to perpetuate itself. This short
phenomenon was due to a collision of wavefronts in the LA momentarily depolarizing
a major portion of the atrium (t = −2820 ms). Nevertheless, fibrillating wavefronts still
present in the RA could rapidly reinitiate SAF in both atria and keep it stable for 2 more
seconds. The termination process could be observed only in the 500 last milliseconds, as
the percentage of excited tissue started to oscillate strongly and the number of wavelets
decreased progressively. This sudden change was provoked by the collisions of multi-
ple wavefronts in the RA (t = −490 ms). As a result, only one wavelet survived (red
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Figure 4.5: Example of spontaneous AF termination for the model of paroxysmal AF. This example
corresponds to the 8 s preceding spontaneous termination for IC35. In this figure, time 0 stands for the
exact instant when no more electrical activation is observed on the atria. (A) Space plots of membrane
potentials during SAF directly preceding spontaneous termination. (B) Dynamical analysis of the 8
s preceding spontaneous termination : (i) Simulated unipolar electrogram as measured in the right
anterior wall. (ii) Simulated transmembrane potential as measured in the right anterior wall. (iii)
Number of fibrillating wavelets present on the total atrial surface. (iv) Percentage of excited tissue.
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arrow) and immediately spread into the whole surface of the RA (t = −390 ms) before
annihilating itself on its refractory tail (t = −370 ms), leaving the RA free from any
reentry. Nevertheless, one or two reentries were still present in the LA (t = −280 ms),
but tended to be rapidly extinguished through refractory blocks. The last reentry present
in the pulmonary veins (t = −230 ms) was finally blocked (t = −210 ms), creating a last
uniform wavefront propagating from LA to RA before total extinction.
4.3.2 Temporal Analysis
The temporal evolution of AFCL and #WF averaged on the 50 AF termination
episodes for the models of paroxysmal AF and recent chronic AF is presented in this
section. On Figures 4.7 and 4.8, dynamical parameters were computed either globally
for both atria (continuous line), or separately for the RA and the LA (dashed and dotted
line respectively). Thus, differences in the timing of termination between the right and
the left atria could be documented.
The mean temporal evolution of the paroxysmal AF model during spontaneous ter-
mination is presented in Figure 4.7 and Table 4.2. In this model, termination was char-
acterized by a progressive increase in AFCL and decrease in the number of fibrillating
wavefronts several seconds before SAF extinction. AFCL started to increase about 3 s
before termination on a global scale, but 800 ms earlier in the LA (τAFCL = 3200 ms)
than in the RA (τAFCL = 2400 ms). During these three last seconds, AFCL became sig-
nificantly higher in the LA than in the RA, meaning that the LA started to fibrillate more
slowly than the RA. In a similar way, #WF started to decrease 1800 ms earlier in the LA
(τ#WF = 3000 ms) than in the RA (τ#WF = 1200 ms). Finally, an AFCL increase in the
LA could be observed between 7 and 6 seconds before termination. During this transient
of 1 s, the LA was shown to fibrillate more slowly than the RA, as if termination was
about to occur. However, during the following second, the number of wavefronts in LA
temporarily increased and became similar to the number of waves in the RA, and AFCL
in LA returned to lower values, ensuring SAF maintenance for 5 more seconds.
Paroxysmal AF model Recent chronic AF model
τAFCL in RA 2400 ms 1600 ms
τAFCL in LA 3200 ms 1600 ms
τ#WF in RA 1200 ms 1600 ms
τ#WF in LA 3000 ms 1600 ms
Table 4.2: Temporal analysis of spontaneous terminations. The average timings of the last AFCL
increase and #WF decrease (τAFCL and τ#WF) are given for each model of AF, separately for the RA
and the LA.
Figure 4.8 and Table 4.2 depict the mean temporal evolution of spontaneous termina-
tion as observed in the recent chronic AF model. Here again, termination was associated
with an increase in AFCL and a sudden decrease in the number of wavefronts circulating
on the atria, but the timings involved and the overall dynamics were different from the
model of paroxysmal AF, as is shown in Table 4.2. Indeed, dynamical changes in AFCL
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Figure 4.6: Example of spontaneous AF termination for the model of recent chronic AF. This ex-
ample corresponds to the 8 s preceding spontaneous termination for IC37. In this figure, time 0 stands
for the exact instant when no more electrical activation is observed on the atria. (A) Space plots of
membrane potentials during SAF directly preceding spontaneous termination. (B) Dynamical anal-
ysis of the 8 s preceding spontaneous termination : (i) Simulated unipolar electrogram as measured
in the right anterior wall. (ii) Simulated transmembrane potential as measured in the right anterior
wall. (iii) Number of fibrillating wavelets present on the total atrial surface. (iv) Percentage of excited
tissue.
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Figure 4.7: Temporal analysis of AF spontaneous termination in the model of paroxysmal AF. (A)
Mean temporal evolution of AFCL in both atria (solid line), in the RA alone (dashed line) and in the
LA alone (dotted line). (B) Same as (A) for the mean temporal evolution of #WF. Instants when a
significant difference (p<0.001) could be observed between the RA and the LA are highlighted in grey.
or #WF triggering termination occurred at the same time in the RA and the LA, and at a
short time scale compared to the model of paroxysmal AF (τAFCL = τ#WF = 1600 ms in
both atria). During this termination process, AFCL was similar in the RA and the LA,
although AFCL had a non-significant tendency to be higher in the RA than in the LA.
In addition, there was most of the time a significantly higher number of wavefronts in
the RA than in the LA. Finally, like with the paroxysmal AF model, a transient sequence
occurring around 6 seconds before termination could be observed; during this short time
period, AFCL was higher in the RA than in the LA, and the number of wavefronts in
each atrium became temporarily similar.
4.3.3 Spatial Analysis
The results of the spatial analysis assessing the localizations of extinction sites for
both AF models are summarized in Table 4.3 and Figure 4.9. As before, observations
differed depending on the AF model under study. In the model of paroxysmal AF, a clear
asymmetry between atria was found in the spatial distribution of extinction sites. First, it
was observed that only five simulations presented termination patterns involving multi-
ple extinctions sites located simultaneously on both atria, which represents a significant
tendency towards unilateral termination patterns compared to bilateral ones (p < 0.001).
Moreover, among the 45 unilateral terminations, significantly more extinction sites were
located in the RA (N = 38) compared to the LA (N = 7). While the extinction sites of
the LA were randomly distributed over the whole atrium, those located in the RA tended
to form clusters around anatomical obstacles (Figure 4.9(2)). This was especially so in
the posterior part of the atrium, where extinction sites were found to create clusters near
the inferior vena cava (IVC) and the superior vena cava (SVC). Finally, no preference for
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Figure 4.8: Temporal analysis of AF spontaneous termination in the model of recent chronic AF.
(A) Mean temporal evolution of AFCL in both atria (solid line), in the RA alone (dashed line) and in
the LA alone (dotted line). (B) Same as (A) for the mean temporal evolution of #WF. Instants when a
significant difference (p<0.001) could be observed between the RA and the LA are highlighted in grey.
termination patterns involving a single extinction site or multiple extinction sites could
be observed across simulations.
The spatial asymmetries in termination dynamics observed in the paroxysmal AF
model were not present as clearly in the model of recent chronic AF. Indeed, although
unilateral terminations were observed significantly more often than bilateral ones, there
were no preferred atrial side for termination to occur, as there were no statistical differ-
ence in the number of extinction sites observed in each atria. Moreover, it can be seen in
Figure 4.9 that extinction sites were regularly distributed over the whole atrial surface,
such that no cluster of extinction sites possibly indicating a specific termination pattern
could be extracted. Finally, there were no statistical preference for single or multiple
simultaneous extinction sites, as for the model of paroxysmal AF.
Paroxysmal AF model Recent chronic AF model
Number of terminations in RA 38 (25/13) 25 (14/16)
Number of terminations in LA 7 (5/2) 17 (11/6)
Bilateral terminations 5 8
Statistics
Termination in LA vs. RA p < 0.001 N.S.
Single vs. Multiple extinction sites N.S. N.S.
Unilateral vs. Bilateral terminations p < 0.001 p < 0.001
Table 4.3: Summary of the spatial analysis of spontaneous terminations. The number of termina-
tions occurring in each atrium and for each AF model is shown. Between brackets, the corresponding
number of terminations through single/multiple extinction site(s) is given. Binomial tests are applied
to assess the properties of termination patterns.
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Figure 4.9: Spatial distribution of extinction sites for: 1. the model of paroxysmal AF 2. the
model of recent chronic AF. Black dots represent spontaneous terminations with a single extinction
site, blue dots stand for multiple extinction sites located on the same atrium, and red dots for multiple
extinction sites located on both atria. For the model of paroxysmal AF, four subgroups of simulations
are distinguished, depending on whether the extinction site(s) are located near the superior vena cava
(SVC group), the inferior vena cava (IVC group), the right anterior wall (RAW group) or the left
atrium (LA group).
4.3.4 Subgroup Analysis in the Model of Paroxysmal Atrial Fibrillation
Since it was observed in the case of a paroxysmal AF model that clusters of extinc-
tion sites located in different areas of the RA could be delineated, it was hypothesized
that these clusters could represent subgroups of distinct termination mechanisms. To
test this hypothesis, the 50 simulations were divided into four groups of termination
episodes, each one corresponding to a specific location of the AF extinction sites (See
Panel 1, Figure 4.9). The IVC group (17 simulations) comprised the simulations involv-
ing extinction sites in the IVC area (including simulations with multiple extinction sites
but at least one in the IVC area). The SVC group (12 simulations) and the right ante-
rior wall (RAW) group (22 simulations) were constructed the same way. Finally, the LA
group (12 simulations) was formed by simulations terminating in LA. Figure 4.10 shows
the temporal evolution of AFCL resulting from the separate analysis of the termination
episodes in the four groups defined in Figure 4.9. The results confirm that, although
there is an increase of global AFCL a few seconds before termination in all groups, the
individual curves differ both in their temporal evolution and in the differences observed
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between the RA and the LA, suggesting distinct termination mechanisms.
In the IVC group, it could be observed on the space plots of membrane potentials
that the termination process was systematically characterized by the installation of an
anchored wave around the IVC approximately three seconds before termination. This
macroreentry progressively took control of the LA before auto-annihilating itself on its
own refractory tail, leaving the tissue free from reentries. Looking at Panel A of Figure
4.10 and 4.11, this process could be described in more detail. Indeed, three seconds
before termination, the AFCL in LA increased suddenly from 275 ms to 295 ms in
one second, and the number of wavefronts in LA decreased abruptly at the same time.
At this point, the macroreentry around the IVC was installed and controlled the LA
by sending periodic waves in its direction. Then, the global AFCL decreased slowly
during the two last seconds, meaning that the macroreentry accelerated progressively,
till the point where it hit its own refractory tail and extinguished itself. Interestingly,
it can be observed on the AFCL evolution that similar patterns could be observed at
−7 s and −5 s, where LA was transiently slower than RA. At the same instants, the
number of wavefronts in LA decreased to lower values. A possible interpretation is that
the installation of the anchored wave around the IVC was done in several steps, during
which the macroreentry tried to control the LA but could not do it successfully, because
the LA was fibrillating too fast and was not entrained. However, after each aborted
attempt, the overall AFCL was increased and the number of wavefronts decreased, so
that eventually a critical value of global AFCL was reached that made it possible for the
macroreentry to push away fibrillating activity in LA and take control of it. According to
the graphs, the critical values of global AFCL and #WF for LA control and subsequent
termination were ∼ 275 ms and ∼ 3.5 wavefronts in the LA.
In the SVC group, the average termination pattern showed large variations in AFCL
during the five last seconds prior to termination. Atrial activity was strongly accelerated
and became homogeneous across atria between −6 s and −4 s, as shown by the sudden
drop in AFCL and the similar value of #WF in this time frame. Then, the global activity
progressively slowed down. At time t = −2.5 s, the LA started to fibrillate more slowly
than the RA (differences in AFCL), although the difference was not significant until the
last second before total AF extinction. Interestingly, at the same time (t = −2.5), the
global AFCL was near 275 ms and #WF decreased below 3.5 in the LA, which are the
same critical values found in the IVC group that triggered termination.
In the RAW group, the AFCL evolution did not show the instabilities of IVC and
SVC group, but remained stable before the first termination mechanisms occurred. Five
seconds before termination, the number of wavefronts in the LA started to be signifi-
cantly lower than in the RA, but remained stable during a couple of seconds. At time
t = −3 s, #WF in the LA started to decrease under the critical value of 3.5, while global
AFCL increased to values just below 275 ms. Less than 0.5 s later, AFCL became sig-
nificantly different between LA and RA, as the LA decelerated strongly while the RA
kept on fibrillating. Again, this dynamical pattern can be interpreted as a progressive en-
trainment of the LA by the fibrillating activity of the RA, which was confirmed by visual
inspection of the membrane potential space plots. This brutal change in LA dynamics
led to termination after two seconds.
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Finally, the LA group was characterized by a much more chaotic behavior. Both
AFCL and #WF variables were continuously changing between eight and three seconds
prior to termination with no predominance of either atrium, making any interpretation of
the phenomenon very difficult. Nonetheless, three seconds before termination, a pattern
typical of the other groups could be observed, as the LA started to fibrillate more slowly
than the RA when the global AFCL crossed the value of 275 ms. However, 1.5 s before
termination, a dramatic change in AFCL evolution could be observed. The fibrillation
in LA suddenly accelerated, simultaneously with an abrupt increase of AFCL in RA,
leading to termination within one second. Thus, consistently with the other groups of
simulations, the atrium where the last reentry was observed had a shorter AFCL imme-
diately before termination.
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Figure 4.10: Mean temporal evolution of AFCL in both atria (solid line), in the RA alone (dashed
line) and in the LA alone (dotted line) for the different subgroups of simulations defined for the model
of paroxysmal AF: (A) IVC group (B) SVC group (C) LA group and (D) RAW group. Instants when a
significant difference (p<0.001) was observed between the RA and the LA are highlighted in grey.
4.4 Discussion
Spontaneous termination of AF is very difficult to observe, and by extension, to study
in detail. First, its occurrence is poorly predictible, and collecting multiple occurrences
of the phenomenon requires long observation times. Such acquisitions can be made
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Figure 4.11: Mean temporal evolution of #WF in both atria (solid line), in the RA alone (dashed
line) and in the LA alone (dotted line) for the different subgroups of simulations defined for the model
of paroxysmal AF: (A) IVC group (B) SVC group (C) LA group and (D) RAW group. Instants when a
significant difference (p<0.001) was observed between the RA and the LA are highlighted in grey.
using Holter recordings, but the resulting quality of the signals acquired in terms of spa-
tial and temporal resolutions is often relatively low. Finer recordings such as mapping
studies can be performed in electrophysiological settings, but with fewer observations.
For this reason, only a few studies tried to describe the underlying mechanisms of AF
spontaneous termination in the past. In this context, modeling studies represent a com-
plementary approach to provide detailed descriptions of a phenomenon under controlled
conditions and with sufficient repeatability, but of course with diminished reliability due
to the simplifying hypotheses embedded in the model. This study presented a detailed
description of SAF spontaneous termination in both temporal and spatial domains, using
two types of AF models with different dynamics. Comparing modeling results and pre-
vious experimental findings can shed light on the putative mechanisms of spontaneous
termination, and explain why past studies on spontaneous terminations of AF have some-
times led to contradictory conclusions.
The two models of AF used in this study were different in many aspects, includ-
ing dynamical parameters such as AFCL or the average number of fibrillating wavelets
present on the tissue. More generally, these models made it possible to study termina-
tion mechanisms in AFs with different embedded complexities: the model of paroxysmal
AF characterized by meandering wavelets could be related to a type I-II AF according
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to Konings classification [74], while the model of recent chronic AF was associated
to a type II-III. Such observations of increasing disorganization of atrial activity dur-
ing chronic AF compared to acute AF were reported during epicardial mapping in dogs
[141]. Moreover, these dynamical differences could also be observed and interpreted in
the results obtained when studying spontaneous termination mechanisms. Indeed, it was
observed that the duration of episodes before spontaneous termination was much longer
in the model of recent chronic AF than in the paroxysmal AF model. This result is in
line with evidence that AF episode durations are longer in persistent and permanent AF
than in paroxysmal AF [1, 2, 3]. Taken together, these observations tend to confirm that
using the modified Courtemanche model presented in section 3.3.4 based on meandering
AF dynamics can be considered as a reasonable model of paroxysmal AF.
4.4.1 Mechanisms of Spontaneous Termination of Atrial Fibrillation
When looking more precisely at the dynamical mechanisms underlying spontaneous
terminations, differences could be found between the AF models used in the present
study. In the model of recent chronic AF, detectable changes before termination only
occurred in the last 1-2 seconds before termination, indicating an abrupt and rapid pro-
cess. In addition, no difference in timings between LA and RA were observed, nor
was it possible to find any recurrent spatial pattern in reentry extinctions. On the other
hand, spontaneous termination mechanisms in the model of paroxysmal AF were char-
acterized by a progressive change to increased organization before termination and clear
differences in timings between the LA and the RA, with termination mechanisms being
triggered earlier in the LA. Moreover, the extinction sites of the last observed fibrilla-
tory activity were also asymmetrically distributed, with a bias towards RA. Therefore,
an asymmetry in dynamics between atria was observed in this model in both temporal
and spatial domains. A temporal decoupling of atria prior to termination was already
reported in clinical observations on human patients with acute or persistent AF, where
the earliest detectable event occurred on average 4 s before termination with a significant
increase of cycle length in the LA first, followed by an increase in the RA only 1 s later
[122]. Similar timings were measured in the present study. The propensity of extinction
sites to be distributed asymmetrically and near anatomical obstacles, however, could not
be demonstrated yet in clinical studies, although evidence of interactions between AF
waves and anatomical boundaries during AF terminations was already demonstrated in
modeling and experimental studies [135, 142]. It would be of interest to extend past
clinical investigations and search for preferential locations of extinction sites in order to
test the additional hypothesis of spatial assymetry that our modeling approach empha-
sized. But current acquisition systems such as high-density mapping electrodes still offer
limited spatial resolution, and observing the exact spatial patterns of fibrillating activity
will represent a major challenge for future studies.
The discrepancies in termination mechanisms between these two models of AF can
be better interpreted in the light of the long-lasting debate about putative mechanisms of
AF termination that can be found in literature. Indeed, whether AF spontaneous termi-
nation is preceded by a progressive fusion of wavelets or involves a simultaneous block
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of all wavelets present in the tissue remains an opened question, and past results were
mixed. Several studies could demonstrate organization processes preceding spontaneous
terminations [120, 122, 125], while other studies could not [123, 124]. Furthermore, no
consensus was found about the appropriate time scale of AF spontaneous termination,
ranging from several minutes [120] to one second [121]. In the present study, it was
shown that for both AF models considered, it was equally likely to observe termina-
tions with single or multiple extinction sites. Therefore, a mechanism of simultaneous
blocks of multiple wavelets during termination cannot be discarded. Nevertheless, some
organization processes could be observed in both models, although at different degrees.
Indeed, in both AF models, spontaneous terminations more often involved extinction
sites located in one atrium only. This lateralization of fibrillatory activity prior to termi-
nation can be interpreted as an organizing process, as one of the atrium started to control
the other before termination occurred. However, additional indicators of organization
were observed in the model of paroxysmal AF, such as the progressive decrease of the
number of wavefronts or the progressive increase of global AFCL several seconds before
termination.
Thus, the present study suggests that spontaneous termination mechanisms may dif-
fer depending on the dynamics of the AF under study, and especially its underlying
complexity. This proposition is in line with previous mapping studies demonstrating
the polymorphic nature of spontaneous AF [122]. According to our simulation results
for low-complexity AF dynamics such as the ones encountered in simulated acute AF,
spontaneous termination processes can be precisely described in both time and space and
are characterized temporally by a progressive increase in global atrial organization with
distinct timings in LA and RA as in previous studies [122, 125], and spatially by prefer-
ential sites of extinction. On the other hand, spontaneous terminations in highly complex
AF such as long-lasting persistent AF or recent chronic AF are more difficult to obtain
and take place in a less predictible way. This interpretation seems relatively intuitive,
since it is well known that the complexity of AF increases over time [141]. However, it
remains difficult to confirm these hypotheses experimentally, because observing sponta-
neous terminations in long-lasting AF such as recent chronic AF is a very difficult task,
and no study, to the best of our knowledge, could describe such phenomena on a large
recorded database. In this context, modeling studies represent an attractive alternative
to investigate the differences in AF termination patterns between distinct stages of the
arrhythmia, since it is possible to generate spontaneous terminations of developed AF
through the fine-tuning of specific ionic properties as described in section 4.2.1.
4.4.2 Termination Patterns during Simulated Paroxysmal Atrial Fibrilla-
tion
An interesting aspect of modeling studies is the possibility to have access at any in-
stant to the temporal evolution of transmembrane potential maps over the whole atrial
surface together with its corresponding dynamical parameters such as AFCL or the num-
ber of fibrillating wavefronts present on the tissue. Based on this extensive amount of
information, we tried to perform in-depth analyses of termination mechanisms in each
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AF models with special attention to the spatial distribution of extinction sites. While
the model of recent chronic AF did not show any preferential termination sites and was
therefore not appropriate for such investigation, it was possible for the simulated parox-
ysmal AF to identify recurrent termination patterns by grouping simulations according
to the location of their extinction sites. Doing so, termination mechanisms that were
particular to each group as well as common mechanisms across the four groups were
extracted.
Figures 4.10 and 4.11 showed that spontaneous termination mechanisms can vary
widely from one termination episode to another. Indeed, temporal traces of both AFCL
and #WF differed markedly in simulations associated to one subgroup of termination or
another. For instance, short periods where AFCL was transiently longer in LA than in
RA could be observed in the IVC group several times before termination, as if termina-
tion took place after multiple attempts. In opposition, there was no sign in the AFCL
evolution of the RAW subgroup that could announce the imminence of termination on-
set. Another feature is the difference in wavefronts dynamics between the IVC and SVC
groups: while there were more wavefronts in RA than in LA in the IVC group during the
whole termination process, simulations of the SVC group were characterized by a more
homogeneous number of wavefronts between atria during most of the eight seconds pre-
ceding termination. Taken together, these differences between spontaneous termination
mechanisms illustrate well the multiple facets of the phenomenon and the difficulty to
describe it in a complete manner.
Nevertheless, common mechanisms could also be observed between the subgroups
of terminations. These mechanisms are of particular interest, as they may constitute a
more robust basis for the development of therapeutical approaches. Indeed, the detailed
analysis of section 4.3.4 helped to clarify the average termination process of simulated
paroxysmal AF that was presented in sections 4.3.2 and 4.3.3. In all four groups of ter-
minations, it could be confirmed that termination involved a decoupling of atria in terms
of dynamical parameters several seconds before termination. Indeed, it was consistently
observed that one of the atrium systematically started to present higher AFCL values and
a decreased fibrillating activity, while the other atrium maintained its fibrillatory rate for
a longer period of time before termination. Moreover, it was shown that the atrium with
the lower AFCL was the one where the last reentrant activity could be observed. This
decoupling of left and right atria prior to termination was also observed during mapping
studies [122], and the modeling approach presented here could therefore further describe
the putative mechanisms leading to this decoupling. The proposed mechanistical inter-
pretation of these observations is that several seconds prior to spontaneous AF termina-
tion, one of the atria starts fibrillating faster than the other one. As a consequence, the
faster atrium sends regular waves towards the other side and entrains the activity of the
slower atrium, therefore taking progressively control of it, the same way as a pacemaker
would do to capture the atrial electrical activity. The multiple annihilations of reentries
taking place in the slower atrium due to the overdriving waves of the faster atrium can
explain the progressive decrease of #WF and increase of AFCL observed before termi-
nation. Thus, fibrillating activity becomes lateralized in one atrium, therefore reducing
the surface available for reentries to propagate. Following the principle of critical mass
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[138, 143], this lateralization in AF dynamics makes it subsequently more probable that
wavefronts get annihilated, provoking AF termination.
When looking specifically at AFCL and #WF prior to termination onset, it was also
possible to determine critical values of these parameters provoking terminations. Indeed,
it was observed across the four groups of simulations that the decoupling phase between
LA and RA was triggered whenever the combination of a global AFCL superior to ∼ 275
ms and a number of wavefronts in LA inferior to ∼ 3.5 were measured. Interestingly,
this situation leading to dynamical decoupling of atria occurred with different timings
(ranging between 3 and 2 seconds prior to spontaneous termination) depending on the
location of the last extinction site. As such, the absolute values of these critical AFCL
and #WF are of little physiological interest, because they are strongly specific to the AF
model used in the study. Indeed, due to the low CV of the paroxysmal AF model, its
average AFCL is known to be higher than accepted values for AF. Nevertheless, this
observation suggests that specific dynamical states of the atria may act as bifurcation
points triggering termination. These dynamical states could be described with informa-
tion about AFCL and wavefront dynamics. In a study of AF ablation, the usefulness of
AFCL as a quantitative tool for monitoring substrate changes during ablation of ongoing
AF was already demonstrated, and prolongation of AFCL indicated successful extinc-
tion of fibrillating foci [144]. Similarly, it was hypothesized and verified very early that
the number of fibrillating wavefronts present on the atria was proportional to the ability
of AF to be sustained [96, 97]. Thus, a decrease in #WF under a certain level is likely
to announce spontaneous termination. Overall, these results suggest that paroxysmal
AF spontaneous termination is likely to be preceded by a specific dynamical state of
atrial electrical activity. Such consideration is of interest for therapy development, since
forcing AF towards this particular dynamical states (AFCL increase and #WF decrease)
could make spontaneous terminations more likely to occur. Interestingly, antiarrhythmic
drugs (AADs) somehow provoke similar dynamical changes [11]. For instance, class III
AADs prolonge refractoriness without altering CV. Thus, the resulting shortening of the
excitable gap is likely to reduce the average number of wavefronts, which can in turn
trigger conversion to sinus rhythm. Besides, class I AADs provoke an AFCL increase
(AF deceleration) through CV reduction.
Despite the various mechanisms of termination proposed above, some observations
lack a clear interpretation. First, the reason why AF lateralization prior to termination
occurs more often in the RA than in the LA is still unknown. It can be suggested that
atrial geometry may have an influence on this phenomenon. Indeed, the total area of the
RA is larger than the LA area in the biophysical model used in this study. Therefore,
according to the critical mass principle, SAF should more likely terminate in the LA
first [138, 143]. However, further investigations will be needed to better understand why
extinction sites tended to form clusters near RA valves. For instance, using different
geometries (with atria of equal size, differences in diameters of valves and veins, or
with a dilated LA) could bring new information about the putative role of atrial anatomy
on the process of termination. Finally, termination patterns involving extinction sites
located in the LA could not be described in a precise manner. Possibly, the presence
of small obstacles such as the PVs make the whole termination process less predictible.
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Clearly, more simulations will have to be conducted, because there were not enough
occurrences of such termination episodes to obtain a sufficiently clear average pattern.
Although the interpretations proposed in this section remain speculative, the pro-
posed modeling approach brings new insights into the possible mechanisms underlying
spontaneous termination and appears useful to complement clinical experiments based
on surface electrocardiograms or mapping studies in which detailed and systematic ob-
servations of AF terminations cannot be easily performed.
4.4.3 Study Limitations
The biophysical models of AF used in this study have several limitations. First, both
cell models used in this work only provide approximate AF dynamics. On one hand, the
model of recent chronic AF presents AFCL values between 100 ms and 110 ms, which
is slightly shorter than reported clinical values for highly complex AF [74]. On the
other hand, the CV of the paroxysmal AF model is too slow, and the resulting AFCL is
consequently longer than accepted values. Moreover, the models did not include fibrosis
or anisotropy.
Another limitation is that the atrial geometry was based on a three-dimensional
monolayer surface and therefore did not take into account atrial tissue thickness. Model-
ing studies suggested that increasing tissue thickness could add dynamical instability and
therefore modulate termination processes [138]. Moreover, several three-dimensional
anatomical structures such as Bachmann’s bundle, pectinate muscles or crista terminalis
were not added to our monolayer geometry. This choice was motivated by the need to
assess the effect of more fundamental anatomical structures such as valves or veins on
termination. Moreover, in the case of simulated paroxysmal AF, the observed mecha-
nisms of termination seem to be consistent with what has been reported in the literature.
4.4.4 Future Works and Clinical Implications
Guiding Future Fundamental Research
There is only sparse experimental research investigating the mechanisms of AF spon-
taneous termination because it is difficult to observe this phenomenon with sufficient
precision to accurately describe it. Several guidelines could be derived from the results
obtained in this study, in order to design future studies trying to validate experimentally
what was obtained in this model-based investigation. First, it was shown that sponta-
neous termination mechanisms could be very different depending on the stage of the
arrhythmia. Most studies so far investigated populations of patients with various histo-
ries of AF, sometimes mixing patients with paroxysmal and persistent AF. Special care
should be taken in the future to document AF duration and to group patients accord-
ing to their AF development stage. Such procedure may help uncovering termination
mechanisms specific to each AF type. More generally, several observations made in the
present work could be the object of targeted experimental validation. For instance, bia-
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trial high-density mapping of patients with paroxysmal AF could be used to assess the
potential existence of a lateralization process of fibrillating activity prior to AF spon-
taneous termination. Similarly, such studies could be conducted to explore the spatial
distribution of AF extinction sites during termination. However, the latter investiga-
tion requires extensive methodological developments, as automatic detection methods
to track AF wavelets are better suited for model data and reliable reentry tracking during
ongoing AF has not been demonstrated so far [145, 146, 147]. Finally, it was suggested
that specific dynamical states of atrial electrical activity could act as bifurcation points
and trigger termination, and that changes in AFCL or #WF could potentially act as in-
dicators of this transition. Recent studies on population dynamics demonstrated that
the extinction of a population through transcritical bifurcation could be predicted early
by simple variables such as population size [148]. Besides, it was shown that multiple
fibrillating spiral waves could be modeled by interacting populations of predators and
preys and could be analyzed with this innovative point of view [149]. Merging these
studies could provide an interesting analysis framework to better understand dynamical
processes preceding AF extinction.
Towards New Therapeutic Approaches
A better understanding of spontaneous AF termination can also inspire new thera-
peutic approaches that would imitate nature by forcing AF activity towards termination.
A major finding of the present work is that different types of AF can potentially present
different mechanisms of spontaneous termination. As a consequence, therapeutic strate-
gies aiming at provoking spontaneous terminations should be different depending on
whether the patient under treatment is diagnosed with acute or chronic AF. Moreover, in
the specific case of a paroxysmal AF, our study suggests that guiding current AF activity
towards certain dynamical states, including increased global AFCL or decreased number
of wavefronts, could promote spontaneous terminations of ongoing AF. Based on these
guidelines, innovative non-pharmacological solutions could be designed and tested for
the termination of AF; we propose some solutions here, although they remain highly
speculative. For instance, low-energy rapid pacing sequences of short duration could be
applied to transiently reduce the number of fibrillating waves in the atrial surface, and
hopefully trigger termination processes. Ablation schemes involving a minimal number
of ablation lines could aim at the same goal, or hybrid solutions could combine both
strategies for an optimal outcome. Finally, a better description of the spatial patterns
preceding spontaneous terminations could help finding preferential anatomical areas for
terminations to occur. Such knowledge could lead to the development of refined abla-
tion procedures that would constrain fibrillating wavefronts into a controlled and robust
termination process.
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4.5 Conclusion
In this chapter, the biophysical modeling framework introduced in chapter 2 and 3
was used to describe important dynamical processes of AF several seconds before its
spontaneous termination. Due to the transient nature of AF spontaneous terminations, a
modeling approach appears useful as spontaneous termination in various types of AF can
be provoked by modifying ionic properties of different AF substrates at will. As a result,
it was demonstrated that different levels of AF complexity led to different termination
mechanisms, which illustrates the polymorphic nature of AF.
As such, a better understanding of AF spontaneous termination through model-based
studies is valuable, since computer simulations can bring new insights into the funda-
mental mechanisms underlying AF terminations. Based on these modeling results, fu-
ture experimental studies will hopefully use optimized designs targeted to the precise
description of these putative mechanisms. Furthermore, the field of AF therapy may
benefit from a better understanding of AF spontaneous terminations, since AF termina-
tion processes could be imitated and artificially reproduced to provide more robust and
natural therapeutic solutions.
Part II
Towards New Therapeutic
Strategies for Atrial Fibrillation
The second part of the dissertation is devoted to the development of
new lines of research for atrial fibrillation therapy with the help of
biophysical modeling and signal processing methods. The properties
of low-energy rapid pacing and its influence on atrial fibrillation is
studied in detail in chapter 5. In chapter 6, a novel pacing scheme
for the suppression of chronic atrial fibrillation is presented, together
with a statistical analysis of its performance in the biophysical model
of human atria. In chapter 7, innovative signal processing methods to
characterize the level of organization of atrial fibrillation activity are
presented, and their use as potential diagnostic tools for AF patient
management is demonstrated.

Rapid Pacing of Atrial
Fibrillation: Influence
of Pacing Sites, Pacing
Cycle Length and
Tissue Property 5
5.1 State of the Art of Therapeutic Pacing for AF
The properties of cardiac stimulation were already known in the early 1800s [150],
and the first cases of cardiac resuscitations through defibrillation were reported in the
1870s [151, 152]. From 1932, when Hyman first proved the clinical applicability of pac-
ing devices [153], the therapeutic potentials of cardiac pacing became a major focus of
attention in the quest for cardiac therapies. In parallel with pioneering studies of cardiac
pacemaking allowing ventricular defibrillation [154], valuable efforts were made dur-
ing the remaining of the 20th century to further develop pacemaker devices in terms of
battery efficacy, electrode design, transvenous implantation procedures [155] and porta-
bility [156]. At the end of the 1980s, some ventricular and atrial arrhythmias could
already be treated either by defibrillation [154, 157] or low energy pacing [158, 159].
Therapies for AF were also developed in the light of cardiac pacing. Following the
successful model of implantable devices for ventricular fibrillation, internal atrial defib-
rillation was first proposed in 1993 as a way to reach cardioversion with an energy shock
[157, 160]. However, unlike for ventricular fibrillation, an electrical shock aiming at
cardioverting an episode of AF cannot be considered as life saving [16]. Thus, the acute
pain perceived during such electrical shocks could be considered unacceptable. More-
over, a risk of proarrhythmic effects following atrial defibrillation, possibly leading to
ventricular fibrillation, could not be discarded. Such considerations raised doubts about
the reliability and justification of atrial defibrillation for the treatment of AF, suggesting
the need to find other protocols involving low-energy stimulations 1.
1. From now on, the term "pacing" will implicitly refer to low-energy stimulations.
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Overdrive pacing is a sequence of atrial pacing at a cycle length that is shorter than
the detected arrhytmia. The goal of the procedure is to access reentrant circuits dur-
ing any potential excitable gap, take control of AF activity, and possibly terminate it.
In 1991, Allessie et al. first demonstrated the existence of an excitable gap during AF
induced in dogs, meaning that AF could be paced and entrained with overdrive pacing
[161]. This observation was then refined by high resolution mapping [162], and finally
demonstrated in humans [163] and during spontaneous chronic AF [164]. In these pi-
oneering studies, the capture obtained was local, restricted to a small area around the
pacing site. Nevertheless, it was shown that a local capture in one of the atrium could
have a distant effect on the underlying organization of the contralateral atrium [165].
Thus, these results demonstrated the potential of low-energy pacing for the therapy of
AF, and an increasing number of both clinical and experimental studies were conducted
to investigate therapeutic pacing solutions to AF. Among these solutions, the pacing
strategies proposed for the treatment of AF can be divided into two main categories,
namely methods for prevention of AF on one hand and for termination of AF on the
other hand. These distinct families of pacing therapies will be reviewed below.
5.1.1 Pacing Algorithms for AF Prevention
Preventive methods aim at providing prophylactic pacing schemes to either prevent
the appearance of paroxysmal AF or minimize the early recurrences of AF episodes.
Since a suppression of compensatory pauses or "short-long-short" cycles is supposed to
reduce arrhytmia onsets, most of the preventive pacing schemes are designed to reach
this goal [22]. Three families of pacing algorithms were developed for AF prevention
[166]:
• Preferential atrial pacing: this pacing protocol consists in pacing the atrium at
a rate slightly superior to sinus rate in order to entrain the cardiac rhythm and
thereby prevent abrupt pauses.
• PAC response: it was shown during analysis of stored pacemaker memory data
that a significant portion of episodes of paroxysmal AF are triggered by premature
atrial complexes (PACs) [167]. Therefore, PAC response algorithms are designed
to initiate atrial pacing whenever a PAC is detected, in order to take control of
atrial activity.
• Post-atrial fibrillation termination response: this algorithm applies atrial pacing
for a sustained duration immediately upon AF termination, and then returns grad-
ually to sinus rate in order to suppress PACs. This method is motivated by the fact
that AF is more likely to be reinitiated just after an AF episode, as a consequence
of electrophysiologic remodeling [92].
Several large clinical studies tried to assess the effectiveness of these preventive pac-
ing algorithms for AF, but reported results have been mixed. During the Atrial Dynamic
Overdrive Pacing Trial (ADOPT), preferential atrial pacing efficacy was investigated
in 319 patients [168]. Only a small, but significant reduction in symptomatic AF bur-
den over the subsequent six months was observed. The Atrial Septal Pacing Efficacy
Clinical Trial (ASPECT) was designed to test a combination of the three preventive pac-
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ing schemes described above, randomized to septal or non-septal atrial lead placement
[169]. No significant difference in AF burden could be demonstrated, but the frequency
of symptomatic AT/AF episodes was significantly lower in therapy group compared with
control group only in the septal pacing recipients. During the same year, the Atrial Ther-
apy Efficacy and Safety Trial (ATTEST) evaluated a combination of prevention and ter-
mination therapies for AF [170]. The study showed that such pacing strategies did not
reduce AT/AF burden or frequency in the patient population under study. One year later,
the Prevention of Atrial Fibrillation (PIPAF) study reported a lower AF burden only in
a subgroup of patients with a low percentage of ventricular pacing, but no significant
difference over the total patient population [171]. In 2006, the so-called PMOP study
assessed the efficacy of the post-mode switch overdrive pacing algorithm (utilized by
the AT500 pacemaker, Medtronic Inc.), which was designed to prevent new episodes of
AF occurring shortly after the termination of a previous AF episode [172]. The study
demonstrated that overdrive pacing could be effective in preventing early recurrence of
AT/AF, although no significant differences in burden and total number of AF episodes
were found in the overall patient population. Nevertheless, a significant reduction in
AT/AF burden could be demonstrated in a subgroup of patients with high percentage of
early recurrence of AF [173]. In 2007, the AFTherapy study evaluated four different pre-
ventive pacing algorithms on patients with paroxysmal AF [174]. Although a 37% lower
mean AF burden was observed in the therapy group, no statistically significant difference
could be found compared with patients treated with conventional pacing. The same year,
the Pacemaker Atrial Fibrillation Suppression (PAFs) study evaluated the effect of atrial
overdrive and ventricular rate stabilization pacing algorithms in patients with paroxys-
mal AF. Although the percentage of AF induced by PACs was significantly reduced, total
AF burden, patients’ symptoms and quality of life did not show any differences between
therapy and control groups. A more recent study of Atrial Pacing Preference (APP) pre-
sented in 2008 showed that preferential atrial pacing could possibly reduce the number of
AF episodes and thus represent a promising alternative, although the observed reduction
of the total duration of AT episodes did not reach statistical significance [175]. Finally,
a large-scale Study of Atrial Fibrillation Reduction (SAFARI) tested different preven-
tive algorithms in a worldwide prospective randomized clinical trial [176]. This study
reported a modest but significant reduction of AF burden in the group with prevention
therapies, while no change in AF burden was observed in the control group. Moreover,
a subgroup of patients with high AF burden at baseline showed an even greater decrease
of AF burden when treated with preventive pacing schemes.
Taken together, these results are not conclusive on the real potential of preventive
AF pacing, and several limitations of these studies and of the proposed pacing schemes
have to be kept in mind. Importantly, these algorithms have not been studied over long
periods of time. Potential problems of patient disconfort or tachycardia-induced car-
diomyopathy may arise during long-term application of the proposed pacing sequences.
Especially, continuous overdrive pacing is unlikely to be well-tolerated in the long term.
In addition, several studies found significant results only in subgroups of the total pa-
tient population under study. Since each preventive pacing algorithm presented above
aims at specific but different AF-inducing mechanisms to prevent AF occurrence, this
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observation suggests that the exact AF-onset mechanism of a given patient plays a de-
termining role in the efficacy of the algorithms used to prevent AF [177]. It would be
therefore necessary to treat each case on an individual basis, which would considerably
complicate the preventive approach for AF pacing therapy.
5.1.2 Pacing Algorithms for AF Termination
On the other hand, pacing solutions for the direct termination of detected AF episodes
were also investigated, both during clinical studies and in electrophysiological experi-
ments. The demonstration of the existence of an excitable gap in dogs and humans
during AF [161, 163] motivated the testing of overdrive pacing. Moreover, standard
overdrive pacing protocols such as 50 Hz pacing bursts and ramps were already pro-
grammed in implanted devices, and could directly be tested for AF treatment. In 1997,
three pioneering studies tested the ability of overdrive pacing to terminate AF. The first
study applied 50 Hz burst pacing at the high right atrium in patients with atypical atrial
flutter or AF [178]. While burst pacing of AFL patients resulted in a termination success
rate of 60%, no termination could be observed in patients with AF. Similarly, Paladino
and colleagues tried to terminate AF in 28 patients with a 50 Hz burst pacing either
by single-site pacing in the high right atrium or by multi-site pacing in the high right
atrium, mid septum and coronary sinus [179]. As a result, no pace-induced termination
of AF was observed. Finally, in electrophysiological settings, Pandozi et al. were able
to capture atrial tissue with rapid pacing but failed to terminate AF [164].
These pioneering studies were followed some years later by large-scale clinical stud-
ies made possible by the refinement of implanted devices and by the development of
automatic detection of AT/AF episodes integrated in the devices [180, 181]. The perfor-
mance of the 50 Hz burst pacing applied to detected AT/AF episodes was assessed by
Gold and colleagues, resulting in a termination success rate of 22.7% for AF episodes
[182]. A similar study found an AF termination success rate of 24%, with a significant
decrease of arrhytmia burden [183]. Two other studies with the same protocol showed
slightly lower, but still impressive AF termination success rates of 13.5% and 16.8%
[184, 185].
These termination success rates can be considered surprisingly high, and even mis-
leading when compared with the first electrophysiological experiments, where AF could
not be terminated at all [164, 178, 179]. However, it was rapidly demonstrated that
the embedded automatic detection algorithms could not always reliably distinguish be-
tween AF and more organized AT episodes, resulting in misclassifications of arrhythmia
[181, 186]. Therefore, since AT episodes are more easily terminated by burst pacing,
overestimated success rates for pace-induced AF termination could be expected. More-
over, it was shown by Schmitt and colleagues that spontaneous terminations of AF were
sometimes detected and classified as successful therapeutic interventions by implanted
devices [181, 187]. Thus, the above results must be considered carefully. In a large-scale
evaluation of the 50 Hz burst pacing on paroxysmal AF episodes, a termination success
rate of 29.8% was first observed for detected AF episodes [180]. However, after careful
inspection of the detected AF episodes, an average AF cycle length of more than 200 ms
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was observed, which is too high for AF and is certainly due to imperfect classifications of
the automatic detection algorithms. Selecting only the episodes with an AF cycle length
under 160 ms, the termination success rate dropped to 11%. The issue of wrongly classi-
fied spontaneous termination episodes was not considered in this study. In another work
by Mitchell and colleagues, in which spontaneous termination episodes were controlled,
both ramp pacing protocols and 50 Hz burst pacing failed to terminate a single case of
persistent AF [25]. Other studies sorted the detected AF episodes in terms of their un-
derlying organization. Israel and colleagues distinguished atrial flutter, highly organized
AF episodes, and complex AF episodes [188], and applied both adapative ramps and 50
Hz burst pacing on each group. While termination success rates of 62% and 34% were
obtained for atrial flutter and highly organized AF respectively, no success at all was
observed for the complex AF group. Similarly, an organization index based on spectral
analysis was used to detect periods of highly organized AF in dogs and to trigger a 20
Hz burst pacing [189]. The study showed that synchronizing the burst pacing sequence
with the beginning of an organized AF segment could significantly improve subsequent
termination success rates during both single-site and bi-atrial pacing.
Several larger clinical studies were then conducted to assess the efficacy of ATP pro-
tocols for AT/AF termination on a larger scale. Published in 2003, the Atrial Therapy
Efficacy and Safety Trial (ATTEST) was a prospective and randomized study to evalu-
ate preventive pacing and two ATP protocols (ramp and burst pacing) in patients with
AF and AT [170]. Using the automatic criteria for successful termination embedded
in the device, ATP protocols applied to AT and AF episodes indifferently resulted in a
termination success rate of 54%. Once again, AF episodes could not be clearly sep-
arated from AT episodes, and spontaneous terminations were possibly counted by the
device as successful therapeutic interventions, which explains this high score. More-
over, the study failed to demonstrate statistically significant differences in AT/AF bur-
den and AT/AF frequency between the groups with ATP algorithms engaged and con-
trols. During the same year, Hügl and colleagues tested the possible benefits of more
agressive ATP protocols (incremental programming) compared to the usual sequences
programmed in implanted devices [190]. Although aggressive programming showed a
modest but significant improvement in efficacy compared to nominal programming, no
differences were found in AT/AF burden or frequency. During a similar study to test the
efficacy of ATP sequences and their effect on AT/AF burden, the patient population was
divided in a group with high ATP efficacy and low ATP efficacy [191]. In the high effi-
cacy group, following ATP initiation, total AT/AF burden decreased significantly; how-
ever, total AT/AF burden increased slightly but significantly in the low efficacy group,
illustrating the issue of patient-specific performance of ATP therapies. In 2006, during
the Pitagora (Prevention Investigation and Treatment: A Group for Observation and Re-
search on Atrial arrhythmias) study, another comparison was made between ramp pacing
and 50 Hz burst pacing [192]. Ramp pacing was shown to be more effective in termi-
nating AT episodes, with its efficacy being directly correlated with the cycle length of
the AT under treatment. However, neither ramp pacing nor burst pacing showed any
clear ability to terminate AF episodes. Similar findings were obtained in the Prevention
and Termination (POT) study, where ATP sequences were tested on top of preventive
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pacing algorithms [193]. While a significant reduction of AF burden could be obtained
when performing preventive pacing, no incremental benefit was observed when ATP was
activated in the therapeutic sequence. A recent study of Gillis and colleagues with the
same design resulted in even worse conclusions [24]. When applying preventive pacing
combined with ATP sequences, the AT/AF burden did not change over a 3-years follow-
up period. However, when applying ATP pacing sequences alone, the AT/AF burden
increased significantly over time.
These results demonstrate that current pacing strategies to terminate AF are not ef-
ficient, if not inappropriate; considerable research and developments will be needed to
finally come up with a reliable pacing solution for AF termination. Recently, innova-
tive developments were proposed as an alternative to low-energy pacing for terminating
AF episodes [194, 195, 196, 197]. The method called far-field antifibrillation pacing
consists in the delivery of a short train of low-intensity electric pulses at the frequency
of current ATP sequences, but from field electrodes surrounding the atria. The electric
field created by the field electrodes during the applied burst sequence takes advantage of
the heterogeneities of the atrial tissue by abruptly changing their potential, and therefore
creating secondary sources that act as virtual pacing electrodes [194]. The number of
these virtual electrodes increases as the electric field becomes stronger, which in turn
maximizes the efficacy in terminating AF. When testing the method in isolated perfused
canine atrial preparations, it was shown that a series of pulses from field electrodes is suf-
ficient to terminate atrial arrhythmias including AF and atrial flutters with a success rate
of 93% [195]. A recent study conducted in a rabbit model using the same method was
shown to be even more successful, with AF termination rates of 100% [197]. Although
this method could be a promising approach, important drawbacks must be mentioned.
First, it is not clear whether the stimulations applied would be below the pain threshold.
Although a single pulse uses only 13% of the energy required for defibrillation, it is
likely that a series of pulses during a burst pacing sequence could affect pain perception,
as it is well know that a series of shocks seems more painful that a single shock, and
subsequent shocks subjectively feel stronger even when they are weaker than previous
shocks [198]. Finally, such pacing system with field electrodes is more complicated to
design and implant than catheter-based pacing devices, and could certainly not be im-
planted in a minimally invasive way with current technologies. Therefore, it is still of
the utmost importance to search for low-energy pacing algorithms that could be directly
programmed in current implanted devices and terminate AF in a reliable way. Very re-
cently, the septal area was proposed as a potentially serious pacing site candidate. The
Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) study, launched in
2009 and currently ongoing, is a single-blinded, parallel randomized multicenter study
to assess the therapeutic potential of septal pacing in patients with paroxysmal AF [199].
In this dissertation, several studies were conducted with our biophysical model to better
understand the mechanisms and influences of pacing applied to AF. A systematic study
of rapid pacing in several pacing sites including the septum is proposed in this chapter,
and in chapter 6, a septal pacing algorithm for AF suppression is presented together with
its termination success rates when tested in the biophysical model.
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5.2 Motivation of the Proposed Study
So far, rapid pacing of AF was shown to induce a local capture of the atrial tissue
but no pacing solution was successfully proposed to terminate AF consistently, although
these algorithms are of interest since they appear to be safe and usually add little in-
cremental cost [176, 200]. Moreover, clinical studies often focus on AF frequency and
burden but few of them are aimed at evaluating the effect of AF pacing on the atrial
tissue [201]. A better understanding of the ability to induce local capture in atrial tissue
may have implications for the design of pacing algorithms for AF termination.
The purpose of the study presented in this chapter is to systematically determine the
conditions leading to capture of AF by rapid pacing and to understand more fully the
influence of atrial tissue properties in our biophysical model of human atria. Mapping
experiments are routinely carried out on a limited fraction of the atrial tissue and thus
provide an incomplete view of its electrical activity. Moreover, a large variability in the
range of frequencies leading to AF capture has been observed in different experimental
models. We propose here a model-based approach, which enables access to any vari-
able of interest at any time and provides the possibility of repeating experiments under
controlled conditions. Different AF dynamics in terms of conduction velocity and action
potential duration as well as multiple pacing sites were studied, in order to have a general
view of AF capture properties in the computer model used. This work was the object of
two publications [139, 202].
5.3 Methods
5.3.1 Reference Model for Sustained AF
In this study, the MRI-based biophysical model of human atria described in chapters
2 and 3 was used. The simplified design of its three-dimensional monolayer geometry
permitted the simulation of long runs of AF (minutes of real time), while the geometry
still included all major anatomical obstacles to propagation, as shown in the left panel
of Figure 5.1. Three-dimensional anatomical structures such as Bachmann’s bundle,
pectinate muscles or crista terminalis were not included. The model was specifically
designed to investigate the effect of the dynamics of AF (wavelength, excitable gap) on
the success of rapid pacing of AF regardless of structural factors (although thought to
probably play an important role).
The propagation of atrial electrical activity was computed on the atrial geometry ex-
actly as presented in detail in section 3.3.3. The coarse discretization (0.6 mm) selected
for this model was motivated by the need to simulate thousands of 30-seconds runs of
AF, which represented a significant amount of computational load.
At each node, electrical cellular activity was modeled by the remodeled modified
LRI model presented in section 3.3.3 [35, 60, 91]. All nodes were assigned the same
ionic properties, and conduction anisotropy was not considered. The model was adjusted
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to mimic electrical remodeling as observed in permanent AF, such as shortening of APD,
as shown in the right panel of Figure 5.1 [56]. For the reference model for sustained AF,
channel conductances were parametrized exactly as in section 3.3.3: the K+ channel
conductance was set to GK = 0.423 mS/cm2, the Na+ channel conductance GNa = 16
mS/cm2, and the L-type Ca2+ channel conductance to Gsi = 0.055 mS/cm2, resulting
in an APD value of 242 ms. With the resistivity value ρ set at 250 Ωcm the mean CV
during sinus rhythm was 60 cm/s.
SAF was initiated as described in section 3.3.3, by 20 Hz pacing for 3 seconds in the
sinoatrial node region (Figure 5.2). When pacing was stopped, SAF was sustained and
was allowed to evolve freely during 10 minutes. The resulting SAF dynamics showed
multiple reentrant wavelets that continuously changed in size and direction, accompa-
nied by important variations in AFCL over time. This model provides a tool to explore
the mechanisms of rapid pacing applied to AF sustained by multiple wavelet reentries,
in the absence of ectopic foci or influence of the autonomic nervous system.
Figure 5.1: The biophysical model of AF and its components. 1. Atrial geometry. 2. Atrial
tissue: resistivity ρ sets CV values. 3. Atrial cellular model: K+ channel conductance GK sets APD
values. The shape of the action potential is represented for the reference model of sustained AF for
the following pacing cycle length values: 80, 100, 120, 150 and 200 ms.
5.3.2 Variants of the Reference Model
Using the same geometry, four variants of the reference model were specified by
setting either the CV values at 50 cm/s (ρ = 300 Ωcm) or 70 cm/s (ρ = 200 Ωcm), or by
changing the intrinsic APD values of the cells through modifications of GK (Figure 5.1),
all other parameters remaining the same. Longer APD values of 248 ms were obtained
with GK = 0.402 mS/cm2, while GK = 0.5 mS/cm2 provided shorter APDs of 228 ms.
These four variants represent models with different AF dynamics.
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5.3.3 Characterization of AF Dynamics
In computer modeling, a direct and complete access to transmembrane potential
maps is possible at any time. These maps were color-coded, red representing a de-
polarized cell and blue, the resting potential (Figure 5.1). The link between simulation
results and clinical or electrical mapping data was provided by the simulation of en-
docardial electrograms at any location of interest. The extracellular potential (unipolar
electrogram) was modeled using a current source approximation for large homogeneous
volume conductor as described in section 2.3.3 and in Jacquemet and colleagues [69].
AFCLs were computed from electrogram interbeat intervals.
During sinus rhythm the average CV value across all nodes was obtained from a map
of activation gradients computed over the whole surface. APD values were defined as
the intervals between −60 mV level crossings during propagation, paced at 100 bpm. An
estimate of the wavelength [91], defined as the distance traveled by the depolarization
wave during the effective refractory period, was obtained by the product of CV and APD,
the latter being taken as a surrogate for the effective refractory period [53].
Figure 5.2: Simulation of rapid pacing in the biophysical model of AF. 1. AF initiation. 2. AF
database created from 20 transmembrane potential maps at 30 seconds intervals during sustained AF.
3. The five pacing sites studied. 4. Application of rapid pacing at cycle lengths based on AFCLmean.
5.3.4 Rapid Pacing Protocol
AF Database
From the 10 minutes of sustained SAF, 20 instantaneous transmembrane potential
maps were selected at 30-second intervals to form an SAF database. These maps dif-
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fered in terms of activation patterns (Figure 5.2, second row) and were taken as initial
conditions for the application of the rapid pacing protocol, for purposes of subsequent
statistical analysis.
Pacing Sites and AF Dynamics
Single-site rapid pacing during SAF was evaluated at five sites (Figure 5.2, third
row): two sites on the RA, two on the LA, and one on the septum. These pacing sites are
regions that are accessible with clinically used stimulation electrodes. For each atrium,
one site was located away from anatomical obstacles and the other site was close to major
vessels. A comparison of the results at the five pacing sites was performed using the
reference model for sustained SAF. Pacing results for the four variants of the reference
model (changes in CV or APD) were simulated for the pacing site located in the RA free
wall only.
Pacing Protocol
Rapid pacing at constant cycle length was studied systematically. For each pacing
site, pacing cycle lengths were based on a mean AFCL (AFCLmean) computed at the
pacing site over 1 minute of sustained SAF. Twenty-six pacing intervals were tested in
the range 60-110% AFCLmean with 2% increments. The duration of each pacing episode
was 30 seconds, a value based on preliminary studies indicating that AF capture could
be typically achieved within this time window.
5.3.5 Assessment of AF Capture
The assessment of local capture was based on results published on humans [164].
For each pacing site, electrograms were computed at four nodes on a circle of ∼ 2 cm
radius centered on the pacing site. During pacing, a node on the circle was considered
to be entrained if during at least five consecutive beats the measured cycle length was
within ±3 ms around the pacing cycle length. Capture was achieved if at least three out
of four nodes were entrained (Figure 5.3, panel A). By definition, this type of capture
is local only, and can not be generalized to a global capture of both atria. Temporal
properties of capture were quantified by the following variables (Figure 5.3, panel B).
The percentage of capture was the percentage of time spent in capture during the total
pacing sequence of 30 seconds. The capture window was defined as the range of pacing
cycle lengths for which the percentage of capture was above 70%. Within the capture
window, time to capture was defined as the duration from the beginning of pacing to the
onset of the first capture episode. Capture robustness was the percentage of time spent
in capture between the first capture episode and the end of pacing. The spatial extent of
capture, specified by the area of capture, was assessed for each pacing site.
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Figure 5.3: AF capture assessment. (a) Local capture defined if 3 out of 4 nodes on a circle of 2
cm radius around the pacing site were entrained. (b) The quality of capture, quantified by percentage
of capture, capture window, time to capture, and capture robustness. The bars highlighted in red
correspond to the example in panel (a), representing one simulation at 88% AFCLmean pacing cycle
length.
5.3.6 Statistical Analysis
Results were averaged across the 20 SAF initial conditions in order to minimize
the bias resulting from a single, random testing of the pacing protocol. Variables were
reported as mean ± SD. Comparisons were performed using Wilcoxon’s rank sum test.
Results were considered to be statistically significant at p < 0.01.
5.4 Results
5.4.1 Local Capture of AF
For each of the five pacing sites tested in the reference model, all 26 pacing cycle
lengths were tested and results were documented for 20 SAF initial conditions, resulting
in a total of 2600 simulations. Similarly, 2080 simulations were carried out for the
four AF models with modified dynamics at the single RA pacing site. In all the 4680
simulations performed no AF termination could be observed. Different degrees of local
capture could be achieved depending on the pacing site, the pacing cycle length and the
SAF dynamics.
Figure 5.4 shows an example of progressive local capture in the RA free wall. After
one second of pacing at 80% AFCLmean, a capture episode was observed with the pacing-
induced wavefront being fast enough to spread in the RA free wall, gradually blocking
AF reentries. However, AF reentrant wavefronts could still enter the paced area during
the installation of capture, resulting in a transient loss of capture after two seconds of
pacing. After about four seconds, robust local capture was achieved in the anterior RA,
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with a regular electrogram phase-locked to the pacing cycle length.
Figure 5.4: Example of local capture by rapid pacing in the RA free wall. (a) Upper row: electro-
gram at the pacing site. Bottom row: transmembrane potential maps at the time of the black dots on
the electrogram. The transmembrane potential map on the left represents the element of AF database
on which rapid pacing at 80% AFCLmean was started. After 1 second of pacing, the first phases of
capture can be observed, followed by a loss of capture after 2.5 seconds. Finally, at about 4 seconds,
the RA is captured. (b) Examples of electrograms and percentages of capture for rapid pacing in the
RA free wall at 90, 86 and 82% AFCLmean. Rapid pacing was applied during 30 seconds, and the
segments where local capture was observed are represented in red.
5.4.2 Temporal Aspects of AF Capture
Successful AF Capture
Three pacing sites led to capture during more than 70% of the total pacing simulation
time (Figure 5.5): RA free wall, LA appendage, and PV, with capture windows of 72-
88%, 68-80%, 70-84% AFCLmean respectively. The capture window bounds, expressed
as a percentage of AFCLmean, were not statistically different for PV and RA free wall
(p > 0.03), but significantly lower for the LA appendage (p < 0.01). No significant
difference was found between the widths of the capture window at these three sites (p >
0.23), which was on average 14.6 ± 3.0% AFCLmean. Capture windows computed from
the literature are shown in Table 5.1. Widths of the capture window were in the range
14-16% AFCLmedian in dogs and 8-25% AFCLmean in humans.
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For each of these three pacing sites, an optimal pacing cycle length was identified
in the middle of the capture window, which also corresponded to the shortest time to
capture and the highest capture robustness (Figure 5.5). For these optimal pacing cycle
lengths, no significant difference in time to capture (p > 0.16) and capture robustness
(p > 0.19) was observed across pacing sites.
Unsuccessful AF Capture
When pacing in the RA isthmus or in the septum, the average percentage of capture
did not reach 70%, although sporadic capture episodes could be observed in the same
range of pacing cycle lengths as reported for the other sites (Figure 5.5). Interestingly,
the different curves obtained for the septum were bimodal, although one of the modes
(78% AFCLmedian) tended to show better capture with greater robustness. Compared
to the pacing sites with capture above threshold, capture robustness was significantly
reduced (p < 10−4) at optimal pacing cycle length for both RA isthmus and septum,
while time to capture remained similar (p > 0.06). Pacing the septum tended to yield a
higher percentage of capture (p < 0.03) and higher capture robustness (p < 0.02) than
for RA isthmus pacing.
Figure 5.5: Summary of the temporal aspects of AF capture. For each pacing site, the measures of
AF capture are presented, averaged over the 20 pacing simulations. The horizontal red line represents
the 70% capture threshold. The blue bar indicates the optimal pacing cycle length within the capture
window.
5.4.3 Spatial Aspects of AF Capture
Areas of capture were comparable for the group of three pacing sites with capture
above threshold (RA free wall, LA appendage and PV): the area encompassed most of
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Publication Subjects Pacing Sites
AFCL mean
or median
Capture
Window
(Width) [ms]
Capture Window
(Width)
[%AFCLmed/mean]
Allessie et
al. [161]
Dogs
(5)
LA/RA
appendage
LA/RA lateral
wall
85 ± 8 ms 60-80 ms
(12 ms)
80-94% (14%)
Kirchhof et
al. [162]
Dogs
(6)
LA appendage 98 ± 16 ms 89-105 ms
(16 ms)
91-107% (16%)
Kalman et al.
[163]
Humans
(3)
Anterolateral
RA
170 ± 27 ms 150-178 ms
(28 ms)
88-104% (16%)
180 ± 17 ms 157-175 ms
(18 ms)
87-97% (10%)
165 ± 30 ms 157-170 ms
(13 ms)
95-103% (8%)
Daoud et al.
[165]
Humans
(24)
High RA/Distal
CS
163 ± 22 ms 113-153 ms
(40 ms)
69-94% (25%)
Capucci et
al. [125]
Humans
(7)
RA/Septum/CS 151 ± 16 ms 129-158 ms
(29 ms)
85-104% (19%)
Table 5.1: Capture windows computed from published data. Capture windows expressed in per-
cents were computed by dividing the range of capturing pacing cycle lengths by the mean or median
AFCL. CS = Coronary sinus.
the atrium under pacing without implying capture in the non-paced fibrillating atrium
(Figure 5.6). For a given pacing site and cycle length, experiments with different AF
initial conditions could lead to variations in the time needed to reach the state of lo-
cal capture, but the final area of capture was the same. The pacing-induced wavefronts
highlighted in red in Figure 5.6 show that propagation around the pacing site was uni-
form. The presence of PV did not alter the ability to capture the LA. On the contrary,
the presence of bigger anatomical obstacles near the pacing site, such as valves, greatly
decreased the ability to capture. In the RA isthmus, the capture pattern resembled a
macro-reentry around the inferior vena cava; pacing did not capture the whole atrium.
The only pacing site likely to consistently capture both atria was the septum, although
fibrillating wavefronts survived in the RA lateral wall and the LA appendage.
5.4.4 Effect of AF Dynamics on Capture
Capture results obtained when pacing in the RA free wall with the modified AF
dynamics of Figure 5.1 are summarized in Figure 5.7. Moving left/right of the center
panel of Figure 5.7 corresponds to a selective increase/decrease in CV, while moving
up/down corresponds to a selective increase/decrease in APD.
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Figure 5.6: Summary of the spatial aspects of AF capture. For each pacing site, the upper trans-
membrane potential map represents an instant during rapid pacing where the most favorable capture
is achieved and the pace-induced wavefronts are highlighted in red. The lower transmembrane poten-
tial shows the maximum area of capture.
Effect of CV
Increasing CV led to a significant decrease of the capture window width (horizontal
shrinking from 14.6 ± 3.0% to 11.4 ± 1.7% AFCLmean, p < 0.002), meaning that the
threshold of capture could still be reached, however, for fewer values of the pacing cycle
length (Figure 5.7). Inversely, a decrease in CV was related to a significant stretching
of the capture window (18.7 ± 2.0% AFCLmean, p < 10−5). No significant effect of CV
was found on the percentage of capture, time to capture or capture robustness observed
at optimal pacing cycle length.
Effect of APD
Decreasing APD led to a significant stretching of the capture window (21.0 ± 1.8%
AFCLmean, p < 10−7) (Figure 5.7). In addition, at the optimal pacing cycle length,
percentage of capture was significantly increased (p < 10−5) and time to capture signifi-
cantly reduced (p < 0.002). On the other hand, an increase in APD implied an important
decrease in percentage of capture and capture robustness, meaning that capture was lost.
Prediction of AF Pacing Outcome
Simulation results suggest that AFCL is not a good predictor of the response of SAF
to rapid pacing. Indeed, a decrease in AFCL induced by an increase in CV led to a
shorter capture window, while a decrease in AFCL induced by a shorter APD led to the
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opposite effect, i.e., a longer capture window (Figure 5.7). On the other hand, the esti-
mate of wavelength could be linked to capture effectiveness, with a shorter wavelength
corresponding to a better capture and vice versa.
Figure 5.7: Effect of AF dynamics on capture. Measures of AF capture are presented in the case of
rapid pacing in the RA free wall for the different AF dynamics. Central panel: reference model. Up-
per/lower panel: effect of a increase/decrease in APD. Left/right panel: effect of an increase/decrease
in CV.
5.5 Discussion
5.5.1 Local Capture and Capture Window
In a theoretical AF model based on multiple reentries, wavelets reenter after they
have recovered excitability from previous activation, so that no excitable gap should
exist. However, an excitable gap can appear if a newly excitable area is not immediately
invaded by a reentrant wavelet. Allessie et al. first demonstrated the presence of such
an excitable gap in dogs and the fact that pacing could influence a fibrillating atrium
[161]. By pacing at a cycle length shorter than the median fibrillation interval, it was
possible for the pacing-induced wavefronts to penetrate into the excitable gap and to
induce local capture. The feasibility of local capture of AF in humans has also been
shown [163, 164, 165]. Daoud et al. demonstrated the presence of an excitable gap and
the possibility to entrain either RA or LA by rapid pacing during AF in humans [165].
This chapter presents a systematic exploration of the mechanisms of local capture
induced when applying rapid pacing during SAF. Five different pacing sites were com-
pared and a large range of pacing cycle lengths was scanned. Our computer simulations
are in agreement with the observation made in animals [161] and humans [163, 164, 165]
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that it is possible to obtain local SAF capture using rapid pacing. An optimal pacing
cycle length could be determined for each specific pacing location, although no termi-
nation could be achieved. Results were consistent across repeated simulations. For the
three pacing sites with capture above the 70% threshold (RA free wall, LA appendage
and PV), the optimal pacing cycle length corresponded simultaneously to the maximum
percentage of capture, the minimum time to capture and the highest capture robustness.
Capture window widths obtained in the computer model (14.6±3.0% AFCLmean) were in
the range of values reported for animal and human experiments, if pacing cycle lengths
were expressed as a percentage of the median or mean AFCL. This formulation led
to comparable results in terms of capture window even for different values of baseline
AFCL. This formulation was also used by Capucci et al. when performing a study on
the time window of capture during AF [203]. In the study by Daoud et al. on 24 patients,
pacing cycle lengths of 69%, 75%, 81%, 87% and 94% AFCLmean led to capture in 29%,
42%, 75%, 96%, and 87% of patients respectively [165]. This distribution is similar to
that of the percentage of capture obtained in the present study with comparable pacing
cycle lengths.
Protocol for in vivo studies varied widely across published studies. First, the type
of AF and patient population varied. Second, the pacing protocols were different and
did not necessarily scan the whole range of cycle lengths. Finally, capture assessment
differed across studies. Many only addressed the feasibility of AF entrainment, stopping
pacing once capture was achieved. In the present work, the accent was put on capture
reproducibility through the computation of an average over 20 SAF initial conditions,
and on long-term capture properties, since capture robustness and time to capture were
measured during sequences of 30 seconds of continuous pacing. This explains why the
resulting capture windows tended to be slightly shorter than published values.
5.5.2 Comparison of Pacing Sites
Robust and consistent capture was achieved both temporally and spatially for the
RA free wall, the LA appendage and the PV. Percentage of capture in the septum and
in the RA isthmus did not reach the 70% threshold. This is in agreement with data in
humans published by Pandozi et al., in which capture was achieved more frequently in
the RA lateral wall (96.8%) than in the septum (66.7%) [164]. The published values for
the radius of the capture region in the RA were 2-3 cm in dogs [161, 162] and 2.8 cm in
humans [163]. It should be noted that in clinical mapping experiments, due to the limited
number of recording sites, it is difficult to assess the exact area of capture or to determine
if capture is uniform in all directions. In computer simulations, a precise identification
of the area of capture was possible, and higher values were obtained compared to clinical
data, such as for example a capture radius of 4.5 cm in the RA. This can be explained
by the choice of a computer model with homogeneous and isotropic substrate, which
provided a theoretical limit to the maximum area of capture. However, pacing at any of
the three sites with robust capture did not lead to a systematic capture in the non-paced
atrium. This can be explained by the asymmetric location of these pacing sites and the
inhomogeneous distribution of refractory periods during multiple reentrant AF, creating
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conduction disturbances of the pacing-induced wavefronts between the pacing sites and
potentially distant reentry circuits in the opposite atrium [162].
In a simplified geometry such as a sphere, single-site pacing would lead to a full
capture of SAF after some time. Therefore the differences in ability to capture AF from
one pacing site to another can be explained by the strong influence of atrial anatomy on
the propagation of pacing-induced wavefronts around the pacing site. Results obtained
in this study suggest that pacing sites located close to major anatomical obstacles such
as valves should be avoided. Indeed, the presence of large obstacles interacting with
pacing-induced waves promotes anchoring and the formation of macroreentries, as it is
the case with RA isthmus pacing. On the contrary, the presence of smaller obstacles such
as PV did not alter the ability to capture. Robust capture was obtained when pacing from
the RA free wall and the LA appendage due to the relatively uninterrupted propagation
of the pacing-induced wavefronts. Interestingly, septum pacing was the only location
allowing for sporadic capture episodes of both atria from a single site due to its specific
location. However, this capture was difficult to maintain and occurred at best during
62% of the time, compared to 89% for the RA free wall.
5.5.3 Effect of Modified AF Dynamics on Capture
The effect of changes in cellular properties (APD changes) and in tissue properties
(CV changes) on SAF capture was investigated separately. An increase/decrease in CV
led to a significant shrinking/stretching of the capture window, yet keeping percentage
of capture above the 70% threshold. This can be explained by the fact that when CV
increased, the excitable gap between two successive wavefronts became shorter, making
capture more difficult to achieve. Inversely, a decrease in CV led to an increase of the
excitable gap, and therefore a stretching of the capture window. Interestingly, the effect
on capture window width was proportionally less important than during CV increase,
probably due to the fact that the CV decrease facilitated reentrant processes, thus reduc-
ing the net increase in the excitable gap. Similarly, decreasing APD led to a significant
stretching of the capture window via increasing the excitable gap. However, when in-
creasing APD, the capture window was not only shortened, but also lost its efficacy and
robustness, reducing capture ability to the point that it did not reach the 70% threshold
that we arbitrarily defined. Therefore, APD changes were shown to have a more dramatic
impact on rapid pacing outcomes than CV changes. In animal and clinical experiments,
variations in capture window widths were frequently observed across different subjects
[162, 163]. However, these experiments cannot dissociate the impact of CV and APD
changes, whereas computer simulations can.
5.5.4 Limitations of the Study
The biophysical model used in this study was based on a three-dimensional mono-
layer surface and did not take into account anatomical details such as Bachmann’s bun-
dle, pectinate muscles or crista terminalis. The tissue had homogeneous properties and
did not include fibrosis or anisotropy. These simplifications are part of the trade-off
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between model accuracy and computational load needed to perform large-scale evalu-
ations such as the ones presented here. A similar approach using the same model has
been successfully applied in a previous study for the simulation of different ablation
procedures, showing that ablation outcomes were not significantly different from clin-
ical experience in humans [113]. In the case of pacing, it is suspected that substrate
heterogeneities could influence capture properties, in particular the area of capture. The
results presented here can be considered as a theoretical limit of the highest achievable
capture. This simple model has the advantage that simulations are done under controlled
conditions and therefore that underlying mechanisms of AF capture could be derived.
Although values of CV and APD are within values reported for the human atria,
AFCL values in the model are slightly lower than human responses, with AFCL values
of 100 ms only rarely measured [74]. However, our study focused more on the effect
of changes in AF dynamics (varying CV and/or APD) during rapid pacing than on the
absolute values of these parameters.
Burst pacing sequences (30 seconds) were much longer than those currently used in
implantable devices. This choice was a feature of our systematic study, in which not
only the capture intervals were assessed but also the ability to maintain capture during
long periods of time.
Finally, clinical AF is a polymorphic disease varying from one individual to another
and different types of AF may respond in different ways to atrial pacing. The model-
based study conducted here was based exclusively on a model of permanent AF, and
results cannot be generalized to other types of AF.
5.5.5 Clinical Implications
Prediction of the Ability to Capture AF
This study suggests that AFCL is not predictive of the ability to capture AF by rapid
pacing, since simulations with similar measured AFCL could end with opposed capture
window values. This was also observed in clinical data in which subjects with the same
AFCL had different capture responses [203]. The ability to capture SAF in our simula-
tions depended on the atrial substrate as characterized by its wavelength, computed as
a combination of CV and APD. Better capture was consistently achieved when wave-
length was decreased, as highlighted in Figure 5.7. This implies that patients may not be
equal with respect to rapid pacing of AF since different AF substrates (CV and APD) can
lead to different capture outcomes for a given pacing site and cycle length. Therefore,
a measure proportional to wavelength could give an estimate of the capture abilities in
a specific patient. This value could be assessed using an S1-S2 protocol from which
simultaneous measures of CV and APD could be derived.
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Towards Pacing Strategies for AF Termination
This model-based study also confirms the clinical observations that single-site rapid
pacing of AF does not lead to AF termination in a model of permanent AF. For pacing
sites such as the RA free wall, the LA appendage and the PV, rapid pacing can lead to a
robust local capture of the paced atrium, but multi-site pacing schemes would be needed
to control both atria. The only pacing site leading to a capture of both atria is the sep-
tum, at the expense, however, of having residual wavelets still present in LA appendage
and the RA free wall that reinitiate AF when the pacing cycle length is increased. The
systematic results on local capture presented in this chapter may help in the design of
future AF pacing protocols, which may include more complex pacing protocols to avoid
AF reinitiation due to residual wavelets and/or multi-site stimulation for the control of
AF.
5.6 Conclusion
In this chapter, a model-based approach to the study of AF rapid pacing offered
new insights into its underlying mechanisms. To conduct such analyses, a considerable
amount of simulations was performed in order to understand in a systematic way the
effect of very different parameters on the outcome of AF pacing, such as pacing sites,
pacing frequencies, or properties of the tissue under stimulation.
An automatic algorithm to assess the presence of local capture of AF by rapid pac-
ing was implemented in the biophysical model of atria, as well as different measures
describing the quality of this capture. Thanks to these quality measures, not only were
episodes of local capture detected, but their efficacy and robustness could also be quan-
tified. Pacing sites and pacing frequencies could be compared to find optimal pacing
configurations.
Pacing sites in the RA or LA lateral wall provided consistent local capture of the
atrium under pacing, whereas pacing on the inter-atrial septum led to sporadic capture
episodes of both atria. The ability to capture AF depended on the atrial substrate as
characterized by its wavelength, a better capture being consistently achieved for shorter
wavelengths. An optimal pacing cycle length was determined for specific pacing loca-
tions, although no termination could be achieved. Nevertheless, this study underlined the
necessity to capture both atria before considering any attempt to terminate AF. Taking
these considerations into account, a new pacing algorithm based on septum stimulation
is proposed in chapter 6 as a new therapy for AF termination.
A Novel Atrial Septal
Pacing Algorithm for
the Termination of
Atrial Fibrillation 6
6.1 Introduction
Pacemaker-based therapies for AF offer an alternative to drugs and ablation for pa-
tients with a conventional indication for pacing [166]. Today, many pacemakers and
implantable defibrillators include pacing algorithms developed for the prevention or the
termination of AF. Most existing pacing algorithms have a preventive nature, designed
to suppress AF triggers and to reduce the dispersion of atrial refractoriness [23]. In
this context, different single- or multi-site atrial pacing strategies have been compared.
Pacing at a single site offers the advantage of simplicity. On the other hand dual-site
or multi-site pacing strategies are considered as promising approaches for achieving a
more complete atrial synchronization, but experimental studies have not yielded conclu-
sive results [204, 205].
One factor that predisposes to reentry is the dispersion in atrial refractoriness. There-
fore, it might be desirable to find a pacing location from which the stimulation of both
atria is rapid and uniform. Septal pacing has been proposed as a simple and attractive
alternative to multi-site pacing since it may produce simultaneous biatrial stimulation
using a single pacing location, without the need of complex methods for synchroniz-
ing pacing sites. The feasibility of pacing both atria simultaneously from a single lead
placed in the interatrial septum has been demonstrated [206]. These results motivated
the testing of atrial septal pacing both as a way to prevent AF occurrence, or to terminate
ongoing AF. Clinical studies evaluating the preventive effect of atrial septal pacing have
led to mixed results [207]. Becker et al. showed in a canine model that septal pacing pro-
duced comparable results as quadruple site pacing in terms of prevention of paroxysmal
AF and activation times [208]. Kale et al. showed that atrial septal pacing in combi-
nation with antiarrhythmic drugs resulted in a subjective improvement of symptoms in
patients with drug-refractory paroxysmal AF [209]. On the other hand, Hermida et al.
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showed that atrial septal pacing did not prevent the occurrence of AF [210]. Hakacova
et al. found no significant difference between septal and high atrial preventive pacing,
using AF duration and the number of AF episodes as endpoints [211]. A multicenter
prospective randomized study by Padeletti et al. showed that preventive pacing of atrial
tachycardias from the septum was associated with a decreased frequency of symptomatic
episodes and premature atrial contractions [169]. In all these studies safety of interatrial
septal pacing was demonstrated [169, 211]. Interest in septal pacing still persists, as
seen in a multicenter parallel randomized study on 380 patients with paroxysmal AF,
currently being conducted to evaluate whether septal pacing with or without atrial over-
drive pacing could have an effect on AF suppression [199].
In this chapter, we propose a novel algorithm of septal pacing for AF termination.
It is aimed at terminating an atrial arrhythmia by applying rapid (overdrive) pacing at a
cycle length shorter than that of the detected arrhythmia [23]. In chapter 5, during a sys-
tematic testing of single site rapid pacing of SAF in a biophysical model of human atria,
septal rapid pacing was shown to lead to SAF capture in both atria [139]. However, the
capture obtained was not robust enough to provoke SAF termination when rapid pacing
was stopped, because of residual fibrillating activity near the atrial appendages. In the
pacing scheme presented in this chapter, the initial rapid septal pacing leads to capture in
both atria. This is followed by a transition to a slow septal pacing phase at a cycle length
longer than that of the detected arrhythmia. In both experimental and computer studies,
perpetuation of AF was shown to be promoted by short cardiac wavelength [86, 91]. The
sharp transition to slow pacing presented here, translating into a brutal lengthening of the
wavelength of paced waves, contributes to eliminate any residual SAF activity and thus
leads to termination. The effectiveness of this new septal pacing algorithm was tested
and optimized in a model-based study, and compared to the one using rapid pacing only.
6.2 Methods
6.2.1 Biophysical Model of AF
Model of Electrical Propagation on an Atrial Geometry
The MRI-based biophysical model of human atria described in chapters 2 and 3
was used. The simplified design of its three-dimensional monolayer geometry permitted
the simulation of long runs of AF (several minutes in real time), while the geometry
still included all major anatomical obstacles to propagation including the septal area, as
shown in panel A of Figure 6.1.
The model of recent chronic AF was used with ionic properties and numerical inte-
gration parameters set exactly as described in section 3.3.3. The same ionic properties
were assigned to all nodes and conduction anisotropy was not taken into account. The
resistivity value between two neighboring atrial cells was set to 200 Ωcm, resulting in a
mean CV during sinus rhythm of 70 cm/s. ERP and CV restitution properties of the pro-
posed model as computed in a 1-D cable are presented in panels B and C of Figure 6.1.
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Creation of a Database of AF Initial Conditions
As already presented in section 3.3.3, SAF was initiated by 20 Hz pacing for 3 s in
the sinoatrial node region of the model. When pacing was stopped, SAF was sustained
and allowed to evolve freely for 10 minutes. The resulting SAF dynamics showed multi-
ple reentrant wavelets that continuously changed in size and direction, accompanied by
important variations in AFCL over time. As in the systematic model-based study of AF
rapid pacing presented in chapter 5 and in [139], from the 10 minutes of sustained SAF,
40 instantaneous transmembrane potential maps (IC1 to IC40) were selected at 15 s in-
tervals to form an SAF database (Figure 6.2). These maps differed in terms of activation
patterns, making them equivalent to a randomly chosen set of SAF initial conditions.
They were used to test the effectiveness of the proposed septal pacing algorithm.
6.2.2 Study Protocol
Proposed Septal Pacing Algorithm
Pacing was applied from the septal area (Figure 6.1, panel A). Septal pacing con-
sisted in the simultaneous stimulation of the 1248 nodes located in the septal area (cor-
responding to a surface of 4.36 cm2) by injecting an intracellular current of 80 A/cm2
(total injected current: 0.3 mA). This relatively large area was considered as a theoreti-
cal limit of an ideal stimulation site, ignoring the potential issues of imperfect electrodes
placement. Using this stimulation, the specific efficiency of the pacing protocol could
be studied. Pacing cycle length (PCL) values were based on a mean AFCL (AFCLmean)
computed as the 10 minutes average on 4 endocardial electrograms from the septal area
during sustained SAF. The extracellular potential (unipolar electrogram) was modeled
using a current source approximation for large homogeneous volume conductor [69].
The septal pacing algorithm comprised two phases (Figure 6.2): 1) a rapid pacing phase
for 10 to 30 s at a PCL shorter than AFCLmean in order to capture the electrical activ-
ity of a substantial portion of both atria, 2) a slow pacing phase lasting 1.5 s at a PCL
longer than AFCLmean, aimed at lengthening the wavelength of the paced wavefronts,
and thus eliminating any residual fibrillating wavelets that might have survived in areas
distant from the septum during the rapid pacing phase. An abrupt transition was applied
between these two phases.
Rapid Pacing Phase
During the first phase of the proposed AF pacing algorithm, capture of both atria
(bilateral capture) has to be established by rapid septal pacing. In order to select the
PCL needed to achieve this bilateral capture, the capture window was first determined
following the same procedure as in chapter 5. PCLs were systematically tested in the
range of 50-100% AFCLmean with 2% increments. The duration of each pacing episode
was 30 s and capture results were averaged across the 40 initial conditions of the SAF
database (IC1 to IC40). The percentage of capture was computed as the percentage
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Figure 6.1: The biophysical model of AF. (A) Anterior and posterior view of the atrial geometry.
The septal area where the pacing protocol is applied (1248 nodes of the atrial geometry, 4.36 cm2)
is highlighted in red for the LA and RA separately. (B) ERP restitution curve of the modified Luo-
Rudy model with Gsi =0.055 mS/cm2. Restitution properties are measured in a cable with the same
parameters as the ones used for the three-dimensional atrial geometry, and following a standard S 1-
S 2 protocol. (C) CV restitution curve for the same set of parameters.
of time spent in bilateral capture during the total pacing sequence of 30 s. The capture
window was defined as the range of the PCL for which the percentage of bilateral capture
was above 70%. Within this capture window, PCL values corresponding to stable capture
results (standard deviation of the mean percentage of capture less than 5%) were retained
to test the proposed septal pacing scheme.
The assessment of capture was based on the method used in chapter 5. In each
atrium, electrograms were computed at four nodes located distantly from the septal pac-
ing site, two nodes being placed on the posterior atrial side, and two nodes on the anterior
one (Figure 6.3, panel A). During rapid pacing, a node was considered to be entrained
if over at least five consecutive beats the measured cycle length was within ±3 ms of
the PCL. In each atrium separately, capture was considered effective if at least three out
of four nodes were entrained. This capture criterion combined with the node placement
ensured the detection of spatially consistent capture episodes of the atrium under study.
Bilateral capture from the septum was considered to be achieved when both the right
atrium (RA) and the left atrium (LA) were simultaneously in a state of capture.
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Slow Pacing Phase
As was shown in chapter 5, single site rapid pacing of the septal area could not re-
liably lead to SAF termination, because of fibrillating spiral waves surviving in areas
distant from the septum and sustained by the rapid stimulation [139]. In both exper-
imental and computer studies, perpetuation of AF has been shown to be promoted by
short cardiac wavelengths, the latter being computed as the product of CV and effective
refractory period (ERP) [86, 91, 212]. Based on these considerations, it was hypoth-
esized that a second phase with paced waves at longer PCLs, i.e. with wavelengths
prolonged through restitution adaptation, could eliminate this fibrillating residue and
leave the tissue free from AF. The PCL parameters of the slow pacing phase were deter-
mined based on preliminary observations. After testing various slow PCLs, the value of
180% AFCLmean was selected as the optimal value. It was the shortest PCL provoking
sufficient wavelength lengthening to suppress fibrillating activity and lead to complete
capture of the whole atrial tissue. A detailed analysis of the restitution properties of the
cellular model used in this study was performed in a 1-D cable and is presented in the
Figure 6.2: Study protocol for the testing of the septal pacing algorithm. 1. Creation of a database
of AF initial conditions by selecting 40 transmembrane potential maps at 15 s interval from the 10
minutes of sustained AF. The subsequent steps are applied to each initial condition separately (IC1
to IC40). 2. Rapid pacing phase from the septal area during 10 to 30 s: capture is achieved after
10 s and 50 transmembrane potential maps are selected at 400 ms interval after 10 s of septal rapid
pacing and will serve as initial conditions for the transition to the slow pacing phase (T1 to T50). 3.
Abrupt transition to a slow pacing phase during 1.5 s and assessment of AF termination for T1 to T50.
Electrograms were recorded in the septal area.
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panel B of Figure 6.1. Switching abruptly from a rapid PCL of 65% AFCLmean to a slow
PCL of 180% AFCLmean increases the ERP value from 60 ms to 127 ms, while the CV
is increased from 60 cm/s to 72 cm/s. As a result, the wavelength of the paced waves
is lengthened by 5.5 cm (from 3.6 cm to 9.1 cm) after the transition towards the slow
PCL. A potential problem was that the abrupt transition from the rapid PCL to 180%
AFCLmean resulted first in a long pause without electrical activity in most parts of the
atrial tissue during which it was possible for residual reentries to reinitiate AF from the
appendages. To avoid this problem, the transition was smoothed in a stepwise manner
and the slow pacing phase at 180% AFCLmean was preceded by one single pacing pulse
at an interval of 130% AFCLmean.
Evaluation of the Septal Pacing Algorithm Using the AF Database
The study protocol for the evaluation of the septal pacing algorithm is presented in
Figure 6.2. For each initial condition of the SAF database (IC1 to IC40), the rapid pacing
phase was applied during a variable period of 10 to 30 s, followed by an abrupt transition
to the slow pacing phase of 1.5 s duration. The transition from rapid to slow pacing was
tested at 50 different time instants (T1 to T50) taken 10 to 30 s after the start of the rapid
pacing phase with 400 ms increments. At the end of the slow pacing phase, the atrial
tissue was allowed to evolve for another 0.5 s to assess SAF termination. For each initial
condition IC1 to IC40, the SAF termination success rate was therefore computed as an
Figure 6.3: Capture window for septal pacing. (A) Assessment of capture induced by septal pacing:
four electrodes are placed in the RA and the LA (black dots) corresponding to the area of capture
represented in red. (B) Capture window for septal pacing. PCL tested were in the range 50-100%
AFCLmean with 2% increments. Results were averaged on the 40 elements of the AF database (IC1
to IC40). The rectangles highlighted in red represent the 5 PCL values having a standard deviation
of less then 5% on the mean percentage of capture, and therefore selected for the testing of the rapid
septal pacing phase (62%, 64%, 66%, 68% and 70% AFCLmean).
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average on T1 to T50.
SAF termination success rates obtained with the proposed septal algorithm (rapid
pacing phase followed by an abrupt transition to the slow pacing phase) were compared
to results obtained when applying the rapid septal pacing phase only to terminate SAF.
Comparisons were made using Wilcoxon’s rank sum test.
Analysis of the Septal Capture Pattern
After 10 s of rapid pacing, capture was considered stable, meaning that a periodic
pattern was observed, with a large portion of atrial tissue being controlled by the PCL
(except for the reentrant wavelets still present in areas distant from the septum). This
capture pattern could occasionally involve anchored waves rotating periodically around
anatomical obstacles. We hypothesized that the presence of these anchored waves could
reduce the SAF termination rates by sending wavelets back to the stimulation site during
the transition between rapid and slow pacing. To test this hypothesis, for each capture
pattern obtained after 10 s of rapid pacing of one of the initial conditions (IC1 to IC40)
of the SAF database, the number of anchored waves was documented as well as their
location around the nine major anatomical obstacles: tricuspid valve (TV), superior and
inferior vena cava (SVC and IVC), coronary sinus (CS), mitral valve (MV), superior
right and left pulmonary veins (RSPV and LSPV), and inferior right and left pulmonary
veins (RIPV and LIPV). The impact of the number of anchored waves (independently
of their anatomical location) on the SAF termination rate was computed for each SAF
initial condition shown in Figure 6.2 (IC1 to IC40), and comparisons were made using
Wilcoxon’s rank sum test. Finally, further statistical tests were conducted within the
analysis of variance (ANOVA) framework to determine specific anatomical locations of
anchored waves significantly impacting subsequent termination rates. For each of these
analyses, the case of rapid pacing only was systematically compared to the proposed
pacing sequence combining rapid and slow pacing
6.3 Results
6.3.1 Capture Window for Septal Rapid Pacing
The lower panel of Figure 6.3 shows the capture window obtained for septal rapid
pacing. For an average AFCLmean=99.76 ± 25.20 ms, the capture window was 62-74%
AFCLmean. Within this capture window, five PCL values were selected for the testing
of the rapid pacing phase: 62%, 64%, 66%, 68%, and 70% AFCLmean. These values
were either used to test the efficiency of rapid pacing alone to terminate SAF resulting in
200 simulations (5 PCL × 40 initial conditions), or were combined with PCL values of
the slow pacing phase (180% AFCLmean pacing preceded by one pacing pulse at 130%
AFCLmean), resulting in a total of 10,000 simulations (5 PCL × 40 initial conditions ×
50 time instants for the transition between rapid and slow pacing).
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6.3.2 Example of Successful AF Termination
Figure 6.4 presents an example of successful termination. Before pacing was ap-
plied, SAF was sustained by multiple reentrant wavelets (from 2 to 12) propagating on
the whole atrial surface. Considering a random 10 s segment of freely evolving SAF, an
average of 8.5±2.5 wavefronts were observed over the whole atrial surface. After appli-
cation of the rapid pacing phase at 64% AFCLmean, a gradual capture of both atria was
visible, starting in this case with a capture in the posterior RA (t=2350 ms), followed by
the posterior LA (t=3320 ms: posterior LA and RA captured), and finally by the anterior
LA and RA. During this process, pace-induced wavefronts were fast enough to spread
in both atria and gradually block AF reentries. In this example, bilateral capture was
achieved after 5 s of rapid pacing, with both atria controlled at the rapid PCL, except
for some residual reentries in the LA appendage and the RA wall (t=9425 ms). It was
also observed that anchored waves around anatomical obstacles could be present during
bilateral capture. In this case two anchored waves were present, one around the tricuspid
valve, the other around the left superior pulmonary vein. The transition from rapid to
slow pacing was applied after 10 s. The first beat of the slow pacing pulse was at 130%
AFCLmean and a longer period with no electrical activity was observed between the last
rapid pacing pulse and the first slow pacing pulse, where the atrial tissue had time to
repolarize (t=10090 ms), implying for the next wavefronts a prolongation of APD and
an increase in CV, i.e. a lengthening of the wavelength through restitution adaptation.
Anchored waves could reenter the atrial tissue after its repolarization but were stopped
by the first slow pacing pulse before being able to propagate to the whole atrium. This
first slow pacing pulse had a longer APD, leaving less space for the reentrant wavelets to
be sustained, and this phenomenon was amplified by the increased CV of the reentries
(t=10235 ms: self-annihilation of the residual reentries due to the presence of the first
slow pacing wave). In this example, all reentrant waves could be stopped by the first
slow pacing pulse (t=10320 ms: repolarization of the first slow pulse after annihilation
of all residual reentries) and the second and subsequent slow pacing pulses at 180%
AFCLmean took control of both atria at a reduced pacing cycle length (t=10960 ms). In
other simulations, more than one slow pulse was needed to annihilate all reentrant waves
and subsequently control the atria. At this point, slow pacing could be stopped at any
moment since fibrillating activity was not present anymore in the tissue. In a physiolog-
ical situation, the sinoatrial node would now be able to take control of the atria as soon
as slow pacing is stopped, in order to restore normal sinus rhythm in the atria.
6.3.3 Example of Unsuccessful Septal Pacing
Figure 6.5 presents an example in which the septal pacing algorithm did not succeed
in terminating SAF when started on different SAF initial conditions while using the
same rapid and slow PCL as in Figure 6.4. The establishment of the bilateral capture
pattern was similar to what had been observed in Figure 6.4, starting with a progressive
control of the anterior LA and posterior RA (t=2725 ms and t=3635 ms). However,
the final capture state was different, with a higher number of anchored waves. In this
example, five anchored waves were present, located around the TV, the IVC, the MV
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and the RIPV and LIPV (t=9710 ms). The abrupt transition from rapid to slow pacing
was applied after 10 s. The longer period with no electrical activity between the last
rapid pacing pulse and the first slow pacing pulse at 130% AFCLmean, during which the
atrial tissue had time to repolarize, was also observed (t=10090 ms). However, the first
slow pacing pulse could take control of the RA only but could not prevent the anchored
waves from reentering the atrial tissue in the LA appendage and around the left inferior
pulmonary vein (t=10220 ms). During the repolarization of the RA, these reentries
gradually invaded the anterior and posterior LA (t=10300 ms: just before the application
of the second slow pacing pulse). SAF could then also spread to the RA even in the
presence of the 180% AFCLmean slow pacing, that could no longer capture the atria
(t=10730 ms). In such situation, slow pacing should be stopped as it will not be able
to capture the activity of the atria due to the faster rate of the reinitiated SAF. The only
solution here is to launch again the whole pacing sequence for a supplementary attempt
to terminate SAF .
6.3.4 Performance of the Septal Pacing Algorithm
SAF termination results are summarized in Table 6.1 for rapid pacing only, as well
as for the proposed septal pacing algorithm combining rapid and slow pacing. We found
3320 9425-1340 2350
10090 10235 10320 10960
Figure 6.4: Example of application of the septal pacing algorithm with successful AF termination.
This example corresponds to IC2 and T1 for a rapid PCL of 64% of AFCLmean and a slow PCL con-
sisting of one pacing pulse at 130% AFCLmean followed by continuous pacing at 180% of AFCLmean.
Transmembrane potential maps are shown at time instants represented by red dots on the electrogram.
Electrograms were recorded in the septal area.
94 Atrial Septal Pacing For the Termination of Atrial Fibrillation
that the combination leading to the highest SAF termination rate of 29% was a rapid
pacing at 64% AFCLmean for 10-30 s followed by an abrupt transition to slow pacing
at 130% AFCLmean for one pacing pulse and then 180% AFCLmean for 1.5 s. Using a
rapid PCL different from 64% AFCLmean tended to create more complex bilateral capture
patterns before the transition to the slow pacing phase, and decreased the average SAF
termination rate as the PCL was moved away from the optimum. Compared to the
case where only rapid septal pacing was applied, the proposed septal pacing algorithm
could in most cases double the SAF termination rate. When considering the average
performance of the pacing scheme over the 5 rapid PCLs tested, the addition of the slow
pacing phase provided a significant increase of the SAF termination rate from 10.2% to
20.2% (p < 0.05).
Histograms of the SAF termination rates considering all rapid PCLs taken together
are shown in Figure 6.6, septal rapid pacing only (panel A) and with the proposed pac-
ing sequence with rapid and slow pacing combined (panel B). For both cases, most SAF
initial conditions led to an SAF termination rate between 0-20%. However, the propor-
tion of initial conditions resulting in failures was lower when the slow pacing phase was
added (88.5% of initial conditions with rapid pacing only compared to 77.5% with rapid
and slow pacing combined). Interestingly, an important proportion of initial conditions
2725-1755 3635 9710
10090 10220 10300 10730
Figure 6.5: Example of application of the septal pacing algorithm without AF termination. This
example corresponds to IC28 and T1 for a rapid PCL of 64% AFCLmean and a slow PCL consisting
of one pacing pulse at 130% AFCLmean followed by continuous pacing at 180% AFCLmean. Trans-
membrane potential maps are shown at time instants represented by red dots on the electrogram.
Electrograms were recorded in the septal area.
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led to an SAF termination rate in the range 80-100%, with a higher occurrence when
using the complete septal pacing algorithm (7.0% for septal rapid pacing only compared
to 15.5% when slow pacing was added). Very few initial conditions led to an SAF ter-
mination in the range 20-80%.
Rapid Pacing Cycle Length [% AFCLmean]
62 64 66 68 70 Average 62-70
Rapid Pacing Only 8.8% 21.2% 11.5% 3.4% 6.0% 10.2%
Rapid Pacing + Slow Pacing 20.9% 29.0% 24.2% 15.9% 11.2% 20.2%
Table 6.1: AF termination rates for the septal pacing algorithm compared to rapid pacing only.
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Figure 6.6: (A) Histogram of the AF termination rates obtained when applying septal rapid pacing
only on the 40 initial conditions of the AF database and the 5 PCLs tested (62%, 64%, 66%, 68%,
70% AFCLmean). (B) Histogram of the AF termination rates obtained when applying the whole atrial
septal pacing algorithm, including the slow pacing phase.
6.3.5 Effect of the Capture Pattern on AF Termination
A detailed inspection of the simulations revealed that the success of the septal pacing
algorithm was determined by the configuration of the capture pattern obtained at the end
of the rapid pacing phase. The time needed to achieve bilateral capture varied from
one simulation to the other, but 10 s was a safe pacing duration to obtain a stabilized
bilateral capture pattern in all cases. For the 40 SAF initial conditions and the 5 PCLs
tested in the rapid pacing phase (N = 200), the number and locations of the anchored
waves present in the bilateral capture pattern achieved after 10 s of rapid pacing were
documented. Moreover, the influence of capture pattern configurations on subsequent
termination rates was also investigated.
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Influence of the number of anchored waves
In a first stage, the number of anchored waves, independently of their anatomical
location, and its impact on subsequent termination success rates were investigated. De-
pending on the simulation, the number of anchored waves ranged between 0 and 8, with
an average of 4.1±1.4 during the stabilized capture patterns over the 200 simulations per-
formed. In Figure 6.7, simulations were grouped according to the number of anchored
waves present in their capture pattern, and the corresponding average termination rate
was computed in order to investigate the influence of the number of anchored waves on
termination rates. It was observed that higher termination rates were consistently linked
to a low number of anchored waves and vice versa. For both pacing configurations (rapid
pacing only or rapid pacing combined with slow pacing), termination rates were not sig-
nificantly different when only 1 or 2 anchored waves could be detected (p = 0.58 and
p = 0.86 respectively). However, they started to decrease significantly when three or
more anchored waves were present in the capture pattern (p = 0.0046 and p = 0.0052
respectively).
Based on these results, it was attempted to determine, for each pacing configuration,
a critical number of anchored waves above which termination success rates would be
significantly degraded. The results of this investigation are summarized in Figure 6.8.
When only septal rapid pacing is applied (panel A of Figure 6.8), it can be shown that
grouping simulations with more than three anchored waves and computing the resulting
average termination rates results in a value of 4.6 ± 15.4%. This represents a signifi-
cant decrease compared to the average termination rate of 11.8 ± 28.2% observed when
grouping simulations with exactly three anchored waves. This significant degradation
of termination rates as the number of anchored waves increases can not be observed
anymore when comparing the simulations with exactly four anchored waves to the ones
with more than four anchored waves. Thus, the critical number of anchored waves when
applying septal rapid pacing only is equal to three. In panel B of Figure 6.8, the same
analysis was performed for the proposed pacing sequence combining rapid and slow pac-
ing. Here, it can be demonstrated that the critical number of anchored waves is equal to
four. Indeed, even with four anchored waves, an average termination rate of 16.0±31.5%
can still be obtained. However, when more than four anchored waves are present, the
termination rates are significantly degraded.
Influence of the location of anchored waves
Next, we investigated whether the anatomical location of an anchored wave had
a significant impact on subsequent termination success rates. First, the percentage of
occurrence of anchored waves on each anatomical obstacle was documented as follows:
TV 51%, SVC 44.5%, IVC 53%, CS 39.5%, MV 54%, LSPV 45%, LIPV 38.5%, RSPV
36.5%, RIPV 44%. This provided no indication of any preferential site for the anchoring
during the rapid pacing phase.
The effect of the locations of anchored waves on the subsequent AF termination rate
was evaluated using a 9-way ANOVA, the results of which are summarized in Table
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Figure 6.7: (A) Impact of the number of anchored waves around anatomical obstacles after 10 s
of rapid pacing on the AF termination rate when applying septal rapid pacing only. (B) Impact of the
number of anchored waves around anatomical obstacles after 10 s of the rapid pacing phase on the
AF termination rate when applying the complete atrial septal algorithm including a combination of
both rapid and slow pacing phases.
6.2. In order to keep the computational load tractable, we only considered the impact on
termination rates of the 9 main effects, i.e. the 9 anatomical locations (veins or valves)
taken independently, as well as the impact of the two-factor interactions, i.e. each of
the 36 possible pairs of anatomical locations. Significant effects and interactions are
shown in Table 6.2 for both pacing configurations. When rapid pacing only is applied,
the anatomical locations significantly impacting termination rates are the CS, the MV
and both right PVs. Interestingly, these are the four anatomical obstacles nearest to the
septal stimulation site. In addition, significant interactions between anatomical locations
with anchored waves were also shown to involve at least one obstacle near the stimula-
tion site. When applying both rapid and slow pacing, results were only slightly different,
as a smaller number of anatomical locations was shown to impact termination rates sig-
nificantly. While right pulmonary veins did not impact termination rates anymore when
considered individually (main effect not significant), the critical role of waves anchored
around CS and MV was clearly confirmed for this pacing configuration as well.
6.4 Discussion
6.4.1 Possibility of AF Termination by Septal Pacing
Existing antitachycardia pacing algorithms were designed to terminate atrial tachy-
cardias by delivering rapid pacing bursts or ramps at a single electrode with cycle lengths
shorter than the detected arrhythmia [23, 166]. While these methods have been suc-
cessful at terminating atrial flutter or slower and organized atrial tachycardia [213],
it has proved difficult to interpret results from clinical studies evaluating pacing for
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B) Rapid pacing + slow pacing
p<3,=3=9.1098e-4
p=3,>3=0.0076
p<4,=4=5.2112e-4
p=4,>4=0.6807
p<4,=4=5.9395e-4
p=4,>4=0.0307
p<5,=5=5.5202e-4
p=5,>5=0.1323
Figure 6.8: Assessment of a critical number of anchored waves. (A) Assessement of the number of
anchored waves critically impacting subsequent termination rates when applying septal rapid pacing
only; p-values between bins are indicated in each graph. (B) Same as (A) when applying the complete
atrial septal algorithm including a combination of both rapid and slow pacing phases.
Rapid Pacing Only Rapid Pacing + Slow Pacing
Anchored wave(s) p-value Anchored wave(s) p-value
CS 0.012 CS 0.0001
MV 0.006 MV 0.035
RSPV 0.008 LSPV 0.048
RIPV 0.012
CS + MV 0.025 CS + MV 0.013
CS + LSPV 0.025 CS + RIPV 0.039
MV + RSPV 0.001 CS + LSPV 0.016
MV + RIPV 0 TV + RIPV 0.021
RIPV + LSPV 0.033
Table 6.2: Locations of anchored waves with significant impact on termination rates as computed
with an ANOVA. The effects of anatomical locations and their pairwise interactions on subsequent
SAF termination success rates were investigated. Only statistically significant results (p <0.05) are
shown.
AF termination and, hence, evidence for treating AF through pacing remains limited
[191, 192, 201]. In chapter 5, the systematic study of single site rapid pacing of AF
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using the same biophysical model of AF as the one used in the present study indicated
that it is possible to obtain local capture of SAF using rapid pacing, but that in general
this did not result in SAF termination or in permanent changes in SAF patterns [139].
While the use of low-energy pacing from a single electrode was not conclusive for AF
termination, cardioversion with a single high voltage shock could terminate AF reliably,
the major side effect being pain experienced by the patient. Based on this observation,
Fenton et al. developed a method to terminate AF called far-field antifibrillation pacing,
delivering trains of rapid low-energy pacing from field electrodes [195]. The method
was tested in isolated canine hearts, showing a termination success rate for AF and atrial
flutters of 93% with 13% of the energy needed for cardioversion applied in a single
shock. Very recently, similar findings with even better termination rates for AF specif-
ically were found in a rabbit model [197]. It is not sure however whether the energy
of such stimulation bursts would be below the threshold of pain, as the cumulative ef-
fect of subsequent shocks could be subjectively perceived as more painful. The method
proposed here uses the same energy as antitachycardia pacing, with a stimulation of the
whole septal area (4.36 cm2). This large stimulation site was voluntarily chosen to sim-
ulate an ideal pacing device placed in the septum; a similar stimulation pattern remains
to be implemented and tested experimentally, for instance by means of a ring-shaped
stimulation device encompassing the septal area. As such, this approach lies between a
single electrode rapid pacing for which almost no AF termination could be achieved and
the approach proposed by Fenton et al. [195]. The multi-stage septal pacing scheme pre-
sented in this study is the first algorithm leading to SAF termination in the biophysical
model, with a termination rate of up to 29%.
6.4.2 Rapid Pacing Phase
The first phase of the proposed septal pacing scheme aimed at capturing atrial elec-
trical activity through rapid pacing in order to facilitate the installation of the subsequent
slow pacing. During this rapid pacing phase, pace-induced wavefronts were injected
into the septal area at a cycle length shorter than the one of the fibrillating wavelets in
order to progressively move SAF activity away from the stimulation site. It was ob-
served that in most cases atrial capture could be obtained in less than 10 s. The resulting
capture patterns were characterized by a periodic activity at the pacing cycle length in
a major portion of atrial tissue. The possibility of creating an area of local capture of
the atrial tissue by rapid pacing of AF was first demonstrated in animals by Allessie et
al. [161]. In the present study, entrained waves could either propagate from the septum
to appendages, or be anchored on anatomical obstacles and rotate periodically around
them. The observed capture patterns remained stable as long as rapid pacing was main-
tained. This was also valid for the anchored waves, which stayed anchored around their
specific anatomical obstacle even if rapid pacing was prolonged. Results showed that a
PCL of 64% AFCLmean was optimal to take control of electrical activity during the rapid
pacing phase. Interestingly, this PCL corresponds to the 5th percentile of the AFCL his-
togram, which was used by Duytschaever et al. to obtain an approximated value of the
excitable gap [214]. Therefore, the optimal way to control atria during the rapid pacing
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phase is to stimulate at a PCL near the lower limit of the excitable gap. Finally, it can
be seen in Table 6.1 that rapid pacing only can already reach termination success rates
of up to 21.2%, with an average of 10.2%. This could seem in opposition to numerous
publications stating that rapid pacing cannot terminate AF at all. However, it must be
kept in mind that ideal septal stimulation was considered in this study, and not single
site pacing. This difference in the stimulation protocol can certainly account for these
unexpectedly high termination rates. In chapter 5, using single site pacing and the same
biophysical model as here, no termination could be observed when pacing in the septal
area.
6.4.3 Slow Pacing Phase
The second phase of the proposed pacing scheme involved a transition from rapid
pacing to slow pacing at a PCL longer than the measured AFCL. The rationale behind
this procedure is to take advantage of the brutal wavelength lengthening due to restitution
adaptation after PCL increase. Rensma et al. demonstrated in chronically instrumented
conscious dogs that fibrillating phenomena occur at wavelengths shorter than a critical
value of 7.8 cm [86]. The necessity of short wavelengths to ensure AF perpetuation
was later confirmed in a computer study using the same model of multiple wavelets as
in the present work [91]. Consequently, wavelength lengthening can serve as a mech-
anism to eliminate residual fibrillation preventing AF termination during rapid pacing
alone. In the proposed pacing scheme, once sufficient capture is obtained by rapid pac-
ing, the abrupt transition towards slow pacing provokes an immediate increase of both
APD and CV via restitution adaptation within a time window shorter than 500 ms. As
a result, the wavelength of the paced waves is shifted from 3.6 cm to 9.1 cm, in turn
creating wavefronts less prone to reentrant phenomena. These extensive depolarizing
wavefronts could therefore take control of a larger area in the atria, leaving less space
for the remaining fibrillating wavelets and forcing their annihilation. During the slow
pacing phase, the train of pacing pulses at 180% AFCLmean was preceded by one single
pacing pulse at 130% AFCLmean. The role of this stepwise transition was to help install
the slow pacing in a more robust way. Indeed, it was observed that a direct transition
towards slow pacing at 180% AFCLmean permitted SAF reinitiation in some cases since
the first long pause following the last rapid pacing pulse gave enough time for reentrant
waves to invade the septal area. Alternatively, a direct transition towards the slow pacing
phase at 130% AFCLmean tended to provoke a better suppression of reentrant waves after
the application of the first slow pacing pulse due to a shorter pause, but the subsequent
pulses were too close to allow for a full repolarization of the atrial tissue and showed a
tendency to reinitiate SAF. Therefore the proposed stepwise transition was a good trade-
off to avoid SAF reinitiation both during the transition from rapid to slow pacing and
during slow pacing. To our knowledge, this is the first time that such a combination of
rapid and slow pacing is proposed as a therapeutic solution to AF. Compared to rapid
pacing only, the average SAF termination rate obtained by the proposed pacing scheme
was doubled. Furthermore, when only rapid pacing was applied, the SAF termination
rate showed a substantial drop when pacing at a suboptimal PCL, while the addition of
6.4 Discussion 101
the slow pacing phase made the overall procedure less dependent on the choice of the
rapid PCL, as shown in Table 6.1. Indeed, SAF termination rates in the range 20-30%
were obtained even when the rapid PCL selected for the first phase differed from the
optimal PCL of 64% AFCLmean (except for PCLs of 68 and 70% AFCLmean).
6.4.4 Practical Aspects of Septal Pacing
Pacing from the septum offers many advantages from a practical point of view. The
strategic anatomical location of the septal area provides a pacing solution offering sym-
metric propagation on both atria while pacing from a single site. Pacing strategies in-
volving the stimulation of the septal area have proven to be feasible [206], and have been
widely tested in the framework of AF prevention, although leading to mixed conclusions
[207, 208, 209, 210, 211]. However, the ability of septal pacing for suppressing ongoing
AF episodes remains to be more fully addressed [199]. In our previous systematic study
of single site rapid pacing of SAF in a biophysical model of human atria, the septum was
the only pacing site that yielded sporadic capture episodes in both atria simultaneously
[139]. However, using only a single septal electrode, it was difficult to maintain this
capture and no termination could be observed. In the present study, a rapid pacing of
the whole septal area led to a more synchronous depolarization of both atria and to the
possibility of observing SAF termination. The key feature of the septal pacing presented
here is that a greater amount of current was injected in the tissue at each pacing pulse,
and in a more homogeneous way, than with single or multiple electrodes. This septal
area stimulation provided more uniform depolarization patterns linked to a higher ef-
fectiveness in blocking SAF reentries. The delivery of the septal stimulus in this model
study was ideal and the results obtained can be seen as a theoretical limit representing
the best performance achievable. The step towards a practical version of the proposed
pacing scheme requires the design of an electrode configuration reproducing the depo-
larization pattern offered by the ideal septal pacing used throughout this study. Future
work will be devoted to finding a suitable electrode design.
6.4.5 Importance of Capture Patterns
The advantage of the modeling approach adopted in this work is that the temporal
and spatial evolution of depolarization waves and reentries on the whole atrial surface
can be observed in detail through inspection of transmembrane potential maps during
the whole AF septal pacing procedure. Such analysis could highlight the importance of
the capture patterns created by rapid pacing on the subsequent SAF termination rates.
In particular, the number of anchored waves present in the capture pattern at the end
of the rapid pacing phase was shown to have a significant effect on the ability to termi-
nate SAF: a low number of anchored waves was correlated to a high SAF termination
rate and vice versa. Most importantly, it was possible to demonstrate that compared to
a simple rapid pacing sequence, the proposed septal pacing algorithm showed more ro-
bustness with respect to the number of anchored waves present at the end of the rapid
pacing phase. Indeed, the critical number of anchored waves above which results were
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strongly degraded was shown to be higher when adding the slow pacing phase. This
increased robustness can be explained by the presence of the first slow pacing pulse at
130% AFCLmean that helped blocking anchored waves trying to propagate back to the
stimulation site once rapid pacing was stopped.
The importance of the anatomical location of anchored waves could also be demon-
strated, with anchored waves nearer to the stimulation site having significant impact on
subsequent termination success. Once again, the proposed pacing sequence compared to
a mere rapid pacing was more robust with respect to certain anatomical locations such
as the pulmonary veins.
In the light of these results, it would be of great interest to actively optimize the
capture patterns during the rapid pacing phase, for instance by minimizing the number
of anchored waves before applying the transition towards the slow pacing phase. Several
studies have explored the phenomenon of anchored spiral waves and how to unpin these
waves by means of external pulsation trains [215]. Such methods could be included in
the proposed pacing scheme in order to optimize overall SAF termination success.
6.4.6 Study Limitations
The biophysical model used in this study was based on a three-dimensional mono-
layer surface and did not take into account anatomical details such as Bachman’s bundle,
pectinate muscles or crista terminalis. Moreover, the tissue had homogeneous properties
and did not include fibrosis or anisotropy. In this sense, the model corresponds to a pa-
tient with electrical remodeling but no structural remodeling, and is therefore a model
of recent chronic AF. These simplifications are part of the trade-off between model ac-
curacy and computational load needed to perform large scale evaluations such as the
ones presented here. For instance, a similar approach using the same model has been
successfully used in a previous study for the simulation of different ablation procedures,
showing that ablation outcomes in the model were not significantly different from clin-
ical experience in humans [113]. Finally, although values of CV and APD are within
values reported for the human atria, AFCL values in the model are slightly lower than
human responses, where AFCL values of 100 ms are only rarely measured. Throughout
this study, the activity from the sinoatrial node was not simulated since it was consid-
ered silent due to overdrive suppression. It is a reasonable approximation to hypothesize
that during SAF or rapid pacing the contribution of sinus rhythm to the global electri-
cal activity is negligible, since the area of the sinoatrial node is most of the time in a
refractory state. However, during the slow pacing phase, sinonatrial node activity could
occasionally interact with the pacing stimulus, possibly disturbing it. Nevertheless, the
slow pacing rate is still several times faster than the discharge rate of the sinoatrial node
and such interferences are relatively unlikely.
Finally, it is important to mention that the proposed algorithm was specifically de-
signed for patients with early persistent AF, and not for patients with long-standing per-
sistent or permanent AF. Indeed, it was shown in both animals and humans that restitu-
tion properties are modified during late chronification of AF, so that restitution curves
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are progressively flattened [92, 116]. These changes are likely to alter the ability of the
proposed algorithm to terminate AF, because the wavelength lengthening supposed to
occur during the transition to slow pacing would not be possible in the case of a flat
restitution curve. Thus, the proposed pacing solution will only express its full potential
when applied during early stages of AF chronification. This remark validates our choice
to focus on a model of recent chronic AF.
6.4.7 Clinical Implications
The model-based results obtained in this study suggest that a pacing protocol com-
bining rapid and slow pacing in a sequential way from the interatrial septal area could
provide a new therapy to terminate ongoing AF episodes by means of low-energy stim-
ulation. This is the first time that such a multi-stage septal pacing sequence for the
treatment of AF is proposed and tested. The procedure appears to be more robust and
efficient in terminating AF episodes than currently used rapid pacing strategies. Such a
pacing therapy could represent an alternative to drugs and catheter-based ablation, and
could easily be implemented in patients who already have an indication for pacing. The
interesting property of the proposed pacing scheme is its short duration (about 30 s in
total) and its reproducibility. Therefore the whole procedure could be repeated as many
times as needed until SAF termination occurs. In this perspective, the SAF termination
rates of up to 29% obtained in this model-based study for a single run of the pacing
sequence are encouraging. Even if the termination rates of the pacing scheme drop to
lower values when tested in real electrophysiological settings, the effective AF termina-
tion ability of the protocol would be increased by its repeatability.
6.5 Conclusion
In this chapter, a novel atrial septal pacing algorithm was specifically designed for
AF termination, and was tested in a model-based study leading to AF termination rates of
up to 29% when optimal pacing cycle lengths were considered. The systematic analysis
framework developed in chapter 5 could be used to determine which pacing cycle lengths
were the most efficient at controlling atrial electrical activity for each phase of the pacing
protocol.
Innovations compared with previous pacing protocols for AF termination were the
selection of a septal stimulation site, as well as the combination of a rapid pacing and
a slow pacing in a sequential way. The proposed multi-stage pacing approach could
suppress AF reentries in a more robust way than classical single site rapid pacing. Ex-
perimental studies are needed to determine whether similar termination mechanisms and
rates would be observed in animals and humans, and for which types of AF populations
the procedure might be most effective.
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Measures of Atrial
Fibrillation
Organization for
Improved Patient
Management 7
7.1 Introduction
In this chapter, novel measures of AF organization are presented and used on real
surface ECG signals to optimize AF management. After a brief summary of past devel-
opments in AF complexity quantification, a new analysis framework based on advanced
signal processing methods is presented in detail and proposed as an automatic diagnostic
tool to discriminate between persistent and permanent AF and therefore to better orient
therapeutic decisions.
7.1.1 Quantifying Atrial Fibrillation Complexity: a State of the Art
Atrial fibrillation is known to be a polymorphic disease whose dynamical complexity
and electrophysiologic properties strongly depend on its state of development, a longer
AF often presenting higher levels of disorganization and alteration in electrical activ-
ity [92, 216]. As a result, AF was progressively considered as a continuous spectrum
of dynamical phenomena with different levels of complexity. This evolutive nature of
AF led researchers to propose various classifications of its organization based on elec-
trophysiological measurements. First, Wells and colleagues performed bipolar EGM
measurements of the human RA and observed the morphology, polarity and beat-to-beat
cycle length of the acquired signals [73]. They found that AF signals could be classified
in four different classes of increasing complexity, but no statistical difference was found
between the four types of AF with regard to disease state. Moreover, two measurements
made on the same patient at different time instants could lead to a classification in a dif-
ferent AF type. These results suggest that, although interesting, this complexity measure
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was somehow not robust enough, maybe because observing only one or two bipolar sig-
nals in the RA provided a measure of dynamics complexity that was too local. A more
global classification of AF complexity was proposed by Konings and colleagues, during
high-density mapping of AF in humans [74]. In this study, fibrillating wavefronts prop-
agating on the RA free wall could be observed by means of a spoon-shaped electrode
of 244 unipolar leads. Three AF types of increasing complexity were defined according
to the number of AF wavelets detected on the RA and their dynamical patterns. This
classification soon became a reference one and was used in many electrophysiological
studies to depict the level of AF complexity under observation.
In parallel, numerous methods based on basic or advanced signal processing tech-
niques and dedicated to the quantification of AF organization emerged from the biomed-
ical engineering field, offering electrophysiologists new ways to understand the under-
lying dynamics of AF [217]. Linear methods were designed to exploit relationships
between atrial recordings in both the time and the frequency domain. Spatial correla-
tion estimates were first used to show that AF was spatially ordered, but with a degree
of correlation decreasing with distance between measurement points [216, 218, 219].
Temporal and spatial phase analyses of ECG atrial waveforms were then proposed to
quantify intracardiac organization, leading to the successful distinction of atrial flutter
from highly organized AF sequences [220, 221, 222]. On the other hand, frequency-
domain analyses provided a simple and powerful approach to explore AF activity, and
several techniques were rapidly derived to depict its dynamics and measure its organi-
zation. Fourier analysis was used to extract dominant frequencies (DF) of AF activity,
and 3D DF maps were constructed by extracting DFs from each electrode of epicardial
mapping recordings separately. Such techniques opened the way to global analyses of
AF spectral activity, and could demonstrate that AF was not a random phenomenon,
but was characterized by spatial inhomogeneities in AF spectrum [223, 224] as well
as differences in oscillatory properties for AFs at different stages [225, 226]. Magni-
tude square coherence was used to quantify the phase consistency between two cardiac
signals, therefore returning a measure of stability of cardiac activity [227, 228, 229].
Two indices computed from power spectrum analysis were also proposed to describe
specifically the degree of organization within AF: a regularity index (RI) was defined
as the ratio of the area under the dominant peak in the power spectrum to the total area
[230], while the organization index (OI) was computed as the sum of the areas under
the dominant peak and its harmonic divided by the total area [231, 232]. This family
of indices was successfully used to describe variations of AF spatiotemporal disorga-
nization due to left atrial dilatation [233], and could also help to better understand the
impact of therapies such as defibrillation, low-energy pacing, catheter ablation or drugs
[189, 232, 234, 235, 236]. Finally, other linear measures of AF organization were pro-
posed based on principal component analysis [237] and on the linear prediction error
between two atrial recordings [238]. The latter technique proved to be efficient for dis-
tinguishing different levels of AF organization in the presence of noise.
Non-linear methods for AF organization quantification were also investigated, as the
possibly chaotic nature of fibrillation was questioned early [239]. It was first demon-
strated in 1995 that basic measures from chaos theory could already detect non-linear
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interactions in AF signals [240]. Then, numerous other non-linear techniques were
specifically proposed for the analysis of cardiac arrhythmias. Trajectory analysis in re-
constructed phase space was used to better describe fibrillating spiral dynamics [133].
Methods based on wave morphology analysis [241] or recurrence plots [242] were de-
signed to track periodicities in AF signals, and could distinguish AF of different types.
Finally, various measures were based on entropy computation. Approximate and sample
entropies were developed to quantify the degree of repetitiveness of a physiological sig-
nal [243]. The sample entropy was then extensively used as an organization measure to
study the complexity of atrial electrical activity during both AF onset and spontaneous
termination [120]. Similarly, a regularity index based on corrected conditional entropies
[244] and a synchronization index computed from Shannon entropy [245] were both
used to discriminate between different types of AF.
The methods described above coupled with the progressive improvements in elec-
trophysiological recordings accuracy contributed to shed new lights on the complexity
and subtleties of AF dynamics. In particular, the organization level of electrical activity
during ongoing AF proved to be even less predictible than foreseen, as it could vary
suddenly in a single AF episode. Indeed, it was first shown in 1992 and confirmed later
that transient linking of fibrillating wavefronts occurred during AF in humans, with a
related decrease of AF rate [246, 247]. Such short and transient episodes of organized
AF were later observed during monophasic action potential measurements, endocardial
mapping and ECG recordings in humans, as well as through wide bipolar electrodes in
dogs [229, 232, 247, 248, 249]. The duration of these short organized AF sequences
ranged between 1 and 5 seconds [232, 246, 249]. Moreover, changes in AF complexity
were also shown to be determinant during onset and termination of AF episodes, as AF
organization tended to decrease immediately after AF onset and increase progressively
before AF spontaneous termination [126, 127, 188, 250]. These results tend to suggest
that time segments with higher AF organization may provide a favorable window for its
termination [251]. Indeed, it was proposed that the efficacy of both atrial defibrillation
and burst pace termination could be improved when shocks or bursts were applied during
episodes of high AF organization [189, 232], and that atrial defibrillation outcome could
be predicted by non-linear organization measures [252]. Similarly, it was shown that AF
cycle length and OI could be used as a quantitative tool for monitoring substrate changes
during ablation of ongoing AF, with longer cycle length and higher OI corresponding
to progressive elimination of fibrillating activity [144, 234]. Taken together, these stud-
ies confirm that optimized measures of organization can reveal new aspects of cardiac
arrhythmias such as AF, and show great promise for future monitoring and therapeutic
tools.
7.1.2 Motivation of the Proposed Study
It is now well known that the presence of AF in atrial tissue tends to provoke electri-
cal and structural remodeling of its substrate, which will in turn modify the dynamical
features of AF and promote its long-term perpetuation [92, 103, 253, 254]. Due to this
evolutive nature, AF was classified by clinicians according to its state of development
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[1, 2, 3]. AF is called paroxysmal or acute when its duration is shorter than seven
days and when it returns spontaneously towards normal sinus rhythm. When it becomes
sustained beyond seven days due to remodeling, and is not likely to spontaneously self-
terminate anymore, the arrhythmia is called persistent. Finally, AF is termed permanent
when cardioversion attempts are not worth trying anymore because the arrhythmia is
now definitively installed. Chronic AF is used to depict recurrent and long-lasting AF,
which can be considered as encompassing both persistent and permanent AF.
For each stage of the arrhythmia, standard management guidelines were defined
[1, 2, 3]. Of particular interest is the management of non-terminating AF episodes, i.e.
the management of patients with AF lasting many weeks (Figure 7.1). For this category
of patients, initial therapy may be anticoagulation and rate control while the long-term
goal, if AF is persistent and not yet in a permanent state, is to restore sinus rhythm espe-
cially when the presence of AF implies disabling symptoms for the patient (Figure 7.1,
Panel (A)). If permanent AF has been diagnosed, cardioversion is not considered and
anticoagulation and rate control is the only indicated treatment (Figure 7.1, Panel (B)).
In this context, it becomes essential to know accurately, for a given patient, the degree of
chronification of the arrhythmia, because it will provide valuable information about the
future effectiveness of a potential cardioversion or ablation procedure, and could even
directly discard such interventions in case of a too developed AF. Indeed, the decision
of entering a long therapy process or a ablation procedure for normal rhythm restora-
tion may have a significant impact on the patient’s quality of life, as well as on health
expenditures. In other words, being able to discriminate reliably between persistent and
permanent AF before any cardioversion attempt would directly improve patient manage-
ment as cardioversion options could be considered appropriately in the case of a diag-
nosed persistent AF, and alternatively substantial cost savings could be made through
the bypass of the whole cardioversion procedure in the case of a permanent AF.
AF management is always a difficult task, especially when patient history has not
been documented correctly or sufficiently. In such situations, it appears difficult for
practitioners to clearly evaluate the degree of development of the arrhythmia and clas-
sify it as persistent or permanent. Thus, it would be of critical importance to benefit from
an automatic diagnostic tool able to make this distinction directly based on dynamical
features of AF electrical activity. So far, many of the methods mentioned in the last
section were proposed to discriminate between paroxysmal AF and chronic AF. Indeed,
these two AF categories could be successfully distinguished by means of activation map-
ping [255], spatial correlation mapping [216], DF mapping [225, 256], linear prediction
error analysis [238], wave similarity mapping [257], entropy-based analysis [258, 259],
AFCL analysis [260] and ECG F-wave analysis [261]. However, to our knowledge, no
method has been proposed to distinguish persistent from permanent AF, although such a
method would be of clinical interest. In the present study, a multivariate frequency anal-
ysis framework is proposed to develop AF organization indices based on the combined
analysis of multiple surface ECG leads. These measures were used to classify persistent
and permanent AF signals.
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Persistent AF
(A)
Permanent AF
(B)
Minimal or no 
symptoms
Disabling
symptoms in AF
Anticoagulation and rate 
control as needed
Anticoagulation and 
rate control as needed
Anticoagulation and 
rate control as needed
AAD therapy
Electrical cardioversion as 
needed
Continue anticoagulation as needed and 
therapy to mainain sinus rhythm
Consider ablation for severely symptomatic
recurrent AF after failure of greater than or 
equal to 1 AAD plus rate control
Figure 7.1: Pharmacological management of patients with (A) persistent AF or (B) permanent AF.
AAD indicates antiarrhythmic drug. Modified from [1].
7.2 Clinical Electrocardiogram Database and Data Prepro-
cessing
A clinical ECG database was created in collaboration with the cardiology department
of the CHUV (Centre Hospitalier Universitaire Vaudois). Standard ECG recordings of
5 minutes duration were acquired in patients with either persistent AF (N = 20) or
permanent AF (N = 33) as diagnosed based on their known clinical history. Patients with
multiple pathologies leading to an unclear AF classification were avoided. Signals were
recorded and stored using a commercial system (CardioLaptop R©, AT-110, SCHILLER).
The acquisition system used electrocardiographic filtering (0.05 to 150 Hz), a dynamic
range of ±10 mV AC (resolution of 5 µV) and a sampling rate of 500 Hz. The following
preprocessing was performed on each ECG lead of each acquired signal to prepare it for
further analysis:
• Ventricular complexes were detected and subtracted following the single beat can-
cellation method described in [262].
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• Resulting signals of atrial activity were downsampled to 50 Hz.
• High-pass filtering was applied using a digital Butterworth filter with a 3 Hz cut-
off frequency.
• To get rid of any residual artifacts, segments of 10 seconds were truncated at the
beginning and at the end of each recording.
The resulting preprocessed signals were then used for AF organization assessment.
7.3 Multivariate Analysis of Atrial Fibrillation Organization
The proposed approach to quantify AF organization based on a standard ECG record-
ing is composed of distinct steps which will be described in detail in the sections below.
First, a multivariate frequency analysis extracts oscillatory features from multiple ECG
electrodes by means of the so-called spectral envelope method, and organization mea-
sures are then computed on the resulting spectrum to assess AF complexity. Finally, a
classification procedure is performed to distinguish persistent from permanent AF sig-
nals. In Figure 7.2, a block diagram summarizes the whole analysis procedure.
x1(t)
x2(t)
...
xm(t)
spectral
envelope
organization
index
spectral
entropy
MOI
MSE
λ(ω)
Figure 7.2: Block diagram of the multivariate analysis framework. In this scheme, the different
parts of the proposed method are illustrated. First, several ECG leads are selected and analyzed
collectively by means of the spectral envelope method to obtain a multivariate spectrum. Then, orga-
nization measures such as the organization index or the spectral entropy are computed on the spectral
envelope.
7.3.1 Multivariate Spectral Analysis: the Spectral Envelope
The spectral envelope was first developed to explore the periodic nature of cate-
gorical time series, and can be described as a frequency-based, principal component
technique applied to multivariate time series [263]. The basic idea is to assign numerical
values to each category of the time series under study and then perform a spectral analy-
sis of the resulting discrete valued signal. Furthermore, the method was extended to deal
directly with real-valued time series [264]. More generally, the spectral envelope can be
used to run multivariate spectral analysis, as several variables of a multidimensional sig-
nal describing the same phenomenon can be processed by the method in order to detect
and emphasize the periodic components common to them. This type of analysis has al-
ready been used succesfully in the field of industrial data to detect plant-wide oscillations
[265]. Thus, such approach seems to be particularly well suited for detecting spectral
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components in multiple lead systems such as ECG recordings, where cardiac oscilla-
tions are recorded by several surface electrodes simultaneously but are at the same time
heavily altered by substantial measurement noise. The definition and implementation of
the spectral envelope method as well as practical examples are exposed below.
Definition of the Spectral Envelope
Let
x(t) =

x1(t)
x2(t)
...
xm(t)
 t = 0,±1,±2, · · · (7.1)
be a multivariate, vector-valued time series on<m. Its covariance matrix is Vx = E[xxT ],
assuming that E[x] = 0 and that T is the transpose operator, and its associated power
spectral density (PSD) is denoted by Px(ω), with ω representing normalized frequency
and −1/2 < ω ≤ 1/2. Let g(t,β) = βHx(t) be a scaled time series from <m to < or, in
other words, a linear combination of the rows of x(t). β is a m×1 real or complex column
vector, and H stands for the conjugate transpose operator. The variance of g(t,β) can be
expressed as Vg(β) = βHVxβ, and the expression of its PSD is Pg(ω,β) = βHPx(ω)β.
The spectral envelope λ(ω) of x is defined as:
λ(ω) = sup
β,0
{
Pg(ω,β)
Vg(β)
}
= sup
β,0
{
βHPx(ω)β
βHVxβ
}
− 1/2 < ω ≤ 1/2 (7.2)
The quantity λ(ω) can be interpreted as follows. It represents the largest portion of
power (or variance) that can be obtained at the frequency ω for any scaled series g(t,β).
The scaling vector associated with λ(ω) is denoted by β(ω) and is called the optimal
scaling vector at frequency ω. Therefore, this optimal scaling vector is not necessary
the same for all ω. Throughout this work, it was decided to constrain β to βHVxβ = 1,
so that the scaled series g(t,β) has a unit variance. Doing so, it ensured that (7.2) had a
unique solution, and that the magnitude of the elements of β(ω) were easily comparable.
The name of "spectral envelope" is appropriate since λ(ω) "envelopes" the standardized
spectrum of any scaled processes. Indeed, given any β normalized so that g(t,β) has a
unit power, Pg(ω,β) ≤ λ(ω), with equality if and only if β is colinear to β(ω) [263].
Considering the optimal scaling vector β(ω), (7.2) can be rewritten as
λ(ω)Vxβ(ω) = Px(ω)β(ω) (7.3)
This new formulation is a generalized eigenvalue problem. Thus, λ(ω) is the largest
eigenvalue of Px(ω) in the metric of Vx, i.e. λ(ω) is the largest eigenvalue associated
with the determinant equation:
|Px(ω) − λ(ω)Vx| = 0 (7.4)
and β(ω) is the corresponding eigenvector satisfying (7.3).
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The spectral envelope method can be useful to detect and emphasize spectral compo-
nents present simultaneously in several measurement channels altered by noise. The fol-
lowing example proposed in [266] illustrates this situation. Let us assume that the mea-
surement channels are modeled by m univariate time series xi(t), 1 ≤ i ≤ m, −∞ < t < ∞,
and that they share a common signal of interest s(t) perturbed by independent identically
distributed noise, i.e. xi(t) = s(t) + εi(t). The power spectrum of each channel will be
Pxi(ω) = Ps(ω) + σ
2
 . It is interesting to note that the power spectrum of a simple linear
combination of {xi(t)} such as x¯(t) = m−1 ∑mi=1 xi(t) will read Px¯(ω) = Ps(ω) + m−1σ2 .
The signal to noise ratio of x¯(t) has increased by a factor of m compared to the individual
xi(t). This simple example suggests that the scaling procedure performed by the spectral
envelope computation will tend to enhance periodic signatures common to several input
variables and attenuate noise. Moreover, the spectral envelope method will systemat-
ically select for each frequency ω the optimal linear combination maximizing spectral
component enhancement. Thus, the proposed technique appears particularly suitable for
clinical electrophysiological measurements such as surface ECG recordings.
Estimation of the Spectral Envelope
This section describes in more practical detail how the spectral envelope method was
implemented in this work. The multivariate input signal to be analyzed is a m× n matrix
of m variables and n samples, i.e. [x(0), x(1), · · · , x(n − 1)] ∈ <m×n. Data were first
normalized to make spectral envelopes between different signal sets more interpretable.
The first step was to calculate the periodogram of the normalized matrix as an estimate
of Px(ω):
Iˆn(ω) =
1
n
n−1∑
i=1
x(t)e−j2piitω

n−1∑
i=1
x(t)e−j2piitω

H
− 1/2 < ω ≤ 1/2 (7.5)
The continuous expression of (7.5) was implemented using the discrete Fourier transfor-
mation, translating into the following formulation:
Iˆn(ωk) =
1
n
n−1∑
i=1
x(t)e−j2piitωk

n−1∑
i=1
x(t)e−j2piitωk

H
(7.6)
with ωk = k/n, for k = 1, · · · , [n/2], being the harmonic (or Fourier) frequencies. How-
ever, the periodogram expressed in (7.6) is not a consistent estimator of the PSD [267].
To overcome this, periodogram averaging or smoothing can be used [268, 269]. In the
present work, a smoothing technique consisting of a symmetric moving average of the
periodogram was applied as suggested in [269]. The periodogram estimate then becomes
Pˆx(ωk) =
d∑
q=−d
hqIˆn(ωk+q) (7.7)
where the smoothing weights {hq} are symmetric (hq = h−q) and ∑dq=−d hq = 1. The
parameter d is chosen to obtain a desired degree of smoothness. Large values of d will
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lead to smoother estimates, but a trade-off has to be made in order to avoid leakage, i.e.
significant peaks being smoothed away. For Pˆx(ωk) to be consistent, the weights must
satisfy
∑
h2q → 0 as d → ∞, but d/n → 0 as n → ∞. In this work, the set of weights
{hq} for periodogram smoothing was chosen similarly as in [265]:
hq =
d − |q| + 1
(d + 1)2
|q| = 1, 2, · · · , d (7.8)
and a default value of d = 2 was used throughout the different computations of the study.
The periodogram estimate Pˆx(ωk) can then be used together with the sample estimate
of the covariance matrix Vˆx to estimate the spectral envelope defined in (7.2):
λˆ(ωk) = sup
β,0
{
βHPˆx(ωk)β
βHVˆxβ
}
(7.9)
The estimate of β(ω) at the Fourier frequencies is denoted by βˆ(ωk), and the constraint
βˆ(ωk)HVˆxβˆ(ωk) = 1 was enforced as mentioned above. One obtains λˆ(ωk) as the largest
eigenvalue of the matrix Hˆ(ωk) defined by
Hˆ(ωk) = Vˆ
− 12
x Pˆx(ωk)Vˆ
− 12
x (7.10)
The optimal scaling vector βˆ(ωk) was computed as βˆ(ωk) = Vˆ
− 12
x βˆ0(ωk), where βˆ0(ωk)
is the eigenvector of Hˆ(ωk) associated with λˆ(ωk).
Example on Synthetic Signals
In the following example based on synthetic signals, interesting properties of the
spectral envelope method and its superiority over simple PSD averages for the detection
of common oscillations in a noisy environment are demonstrated. A set of three uni-
variate time series sharing three noisy periodic components (normalized frequencies of
ω1 = 0.1, ω2 = 0.15, ω3 = 0.2) and altered by normally distributed white noise εi(t),
i = 1, 2, 3, is first created:
x1(t) = cos(2piω1t) + 0.5 cos(2piω2t + pi/4) + 0.5 cos(2piω3t − pi/2) + ε1(t) (7.11a)
x2(t) = cos(2piω1t) + 0.8 cos(2piω2t + pi/4) + ε2(t) (7.11b)
x3(t) = 0.7 cos(2piω1t) + 0.5 cos(2piω2t + pi/4) + cos(2piω3t − pi/2) + ε3(t) (7.11c)
In these times series, t = 1, · · · , 256. The white Gaussian noise ε1(t) has unit vari-
ance, while ε2(t) and ε3(t) have variances of 4 and 9 respectively. Each signal contains
at least two of the periodic components and the amplitude of each oscillation varies from
one signal to another. The PSD of each signal was computed individually using the same
smoothing procedure as for spectral envelope computation, and averaged for purposes
of comparison with the spectral envelope applied directly to the three input variables.
The results of these simulations are shown in Figure 7.3. First, it can be observed that
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individual PSDs indeed contain the oscillations at frequencies ω1 to ω3, but also display
several spurious frequency peaks induced by noise, especially for the signals x2(t) and
x3(t) for which the background noise is so strong that some peaks of interest are hardly
visible. Even when computing the average PSD of the three signals, these interferences
remain important. In particular, a peak at ω = 0.33 shows a higher amplitude than the
ω2 component, although the latter was present in each of the three input signals. As
a result, a crude average of PSDs would not be able to detect the common oscillatory
components in this particular case. Inversely, the spectral envelope of the input variables
clearly emphasizes the frequency peaks ω1 to ω3, while all other spurious frequency
peaks are systematically attenuated compared to those of the average PSD. Thus, this
example shows that the spectral envelope, due to the optimal scaling of the input sig-
nals, is better than a simple PSD average for the detection of common oscillations and
is especially suitable for the analysis of noise-corrupted data. In a past study, the su-
periority of the spectral envelope over spectral principal component analysis [270] was
demonstrated in the same context [265].
Spectral Envelope Computation on the ECG Database
The ECG database used in this study contains continuous recordings of 5 minutes
duration, resulting in long AF episodes. In order to best investigate the properties of AF
organization, an appropriate time-scale for AF complexity analysis must be determined.
Past studies performing such analyses on various types of AF used different segment
lengths, but converging evidence suggests that considering AF segments of 8 s to 10 s can
reveal important features of AF organization [255, 256, 271]. In the present work, it was
therefore decided for each ECG recording to compute spectral envelopes on successive
segments of 10 s with an overlap of 5 s between two adjacent segments. The spectral
envelopes computed over the 5 minutes segment with discarded first and last 10 seconds
were then averaged to give a global value for the ECG recording. Univariate PSDs
that were used throughout this study for comparison with the multivariate case were
computed following the same protocol. It was observed that such a procedure tended to
optimize the smoothness of the resulting spectra for further calculations of organization
indices.
An example of spectral envelope applied to a typical ECG recording of AF is shown
in Figure 7.4, using the computation procedure detailed above. Precordial leads V1 and
V6 were used as input variables for the spectral envelope, and their respective PSDs
were also computed and are shown for comparison purpose. When looking at the indi-
vidual PSDs, it appears that a common periodic component at 6.5 Hz can be observed on
both ECG electrodes, but at a lower power on electrode V6. The first harmonic of this
frequency peak is also visible at 13 Hz on both leads, although not strikingly apparent.
At the same time, other frequency peaks are present on one or the other electrode, but
are not common to both. For instance, the 7.5 Hz oscillation visible on electrode V1
cannot be found on electrode V6. Similarly, a spectral component at 4.7 Hz on lead V6
is almost as powerful as the 6.5 Hz frequency of interest, but cannot be distinguished
properly on lead V1.
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The result of applying the spectral envelope method to leads V1 and V6 is shown
in the panel (C) of Figure 7.4. Here again, the ability of the spectral envelope to de-
tect and amplify common oscillations while attenuating noise and non-shared spectral
features is well illustrated in this real-life example. First, the common frequency of 6.5
Hz is significantly amplified, as its second and even third harmonics (19.5 Hz) become
clearly visible (indicated by vertical arrows). At the same time, the frequency peaks that
were not common to both electrodes, although present, are strongly attenuated. Thus,
the spectral envelope proves useful for the investigation of non-invasive physiological
recordings such as ECG. In particular, analyzing spatially distant ECG leads like V1
and V6 is of special interest, since the spectral envelope will emphasize global oscilla-
tory properties observable on the whole atrial surface more than local phenomena. Such
information is highly relevant for global AF organization analysis.
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Figure 7.3: Detection of common oscillations in a noisy environment. Panels (A) to (C) show the
individual PSDs of the synthetic signals of system (7.11). Panel (D) shows the comparison between
the average PSD and the spectral envelope of the input signals. Amplitudes were normalized by the
total power for comparison purpose.
7.3.2 Two measures of Atrial Fibrillation Organization
Once a spectral envelope has been estimated from a group of ECG electrodes, mea-
sures of complexity can be designed to assess the global level of AF organization (Figure
7.2). In this work, two measures of AF organization were tested and are presented below.
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Figure 7.4: Spectral envelope of an ECG recording of AF. Panels (A) and (B) show the individual
PSDs of leads V1 and V6. Panel (C) shows the spectral envelope obtained with V1 and V6 as input
variables. The second and third harmonics of the common frequency component are indicated by
vertical arrows.
Multivariate Organization Index
The first method, originally called organization index (OI), was developed by Ev-
erett and colleagues to assess spatiotemporal organization of AF [231, 232]. The initial
version of the algorithm was as follows: a univariate spectrum is first computed and its
maximum peak is detected and considered as the dominant atrial frequency. Then, the
areas under the maximum peak and three of its harmonic peaks are calculated over a 1
Hz window. The OI is defined as the ratio of the area under these four peaks to the total
spectrum area. In the present study, we used the multivariate frequency analysis frame-
work presented in the last section to derive a multivariate organization index (MOI) by
simply computing the OI on the spectral envelope. Compared to the original algorithm,
it was also decided to give more freedom to the different parameters of the measure:
• Instead of taking the maximum frequency peak and its three harmonics for area
computation, the MOI algorithm looked for the Np highest peaks of the spectrum
regardless of their location, the only constraint being that two detected peaks had
to be distant from each other by at least 0.5 Hz. The latter constraint ensured that
each peak represented a distinct physiological oscillation. The number of peaks
Np was left as a variable parameter for feature selection.
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• The bandwidth (BW) parameter was defined as the length (in Hz) of the window
encompassing each detected peak to define the integration bounds. Different val-
ues of this parameter were also considered during feature selection (see section
7.3.3).
The ratio of the area under the Np peaks to the total spectral area was then computed to
give a MOI value. The general mechanism behind this measure is the following: when
common oscillations between observed leads are predominant, the spectral envelope
tends to emphasize their corresponding frequency peaks compared to the rest of the
spectrum. As a result, the MOI is boosted. Inversely, heterogeneous frequencies create
numerous frequency peaks in the spectral envelope, and decrease the MOI.
Multivariate Spectral Entropy
The second measure proposed is based on the concept of spectral entropy (SE) [272].
To compute SE, the PSD must be first computed and normalized, in order to make it
equivalent to a probability mass function. Then, the Shannon’s entropy is computed on
this normalized PSD to give an estimate of the SE of the process:
SE = −
∑
f
p f log2(p f ) (7.12)
where p f is the normalized PSD value at frequency f .
Randomly distributed noise typically shows a relatively flat spectrum and a high
entropy value, whereas isolated oscillations such as sinusoids present sharp frequency
peaks and therefore give low entropy values. As a result, the SE can be considered as
a measure of the flatness of a spectrum. The multivariate spectral entropy (MSE) is
defined as the measure obtained by computing the SE on a spectral envelope.
Application to the ECG database
In order to illustrate the behavior of the proposed measures, two examples of MOI
and MSE computations on real ECG signals presenting different levels of AF organi-
zation are shown in Figure 7.5 together with their corresponding univariate measures.
Spectral envelopes were computed on ECG leads V1 and V6. OI/MOI parameter BW
was set to 1 Hz and Np to 4 for both examples in order to provide proper comparisons
between each case.
The first ECG signal (signal A of Figure 7.5) is a typical example of organized
activity, in which common oscillations are observed on distinct ECG leads. Indeed,
electrodes V1 and V6 present a relatively similar spectral content (leading to comparable
OI values), with two dominant frequency components at 5 Hz and 9 Hz. As in previous
examples, the spectral envelope of leads V1 and V6 detects these shared frequencies,
filtering other components of lesser interest. As a result, the MOI computation returns a
higher value than the corresponding univariate measures, indicating global organization.
118 Measures of Atrial Fibrillation Organization
0 5 10 15 20 25
0
0.5
1
1.5
2
Frequency [Hz]
P
o
w
e
r 
S
p
e
c
tr
u
m
 D
e
n
s
it
y
 [
m
V
2
]
0 5 10 15 20 25
0
0.5
1
1.5
2
Frequency [Hz]
P
o
w
e
r 
S
p
e
c
tr
u
m
 D
e
n
s
it
y
 [
m
V
2
]
0 5 10 15 20 25
0
2
4
6
8
Frequency [Hz]
S
p
e
c
tr
a
l 
E
n
v
e
lo
p
e
0 5 10 15 20 25
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Frequency [Hz]
P
o
w
e
r 
S
p
e
c
tr
u
m
 D
e
n
s
it
y
 [
m
V
2
]
0 5 10 15 20 25
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Frequency [Hz]
P
o
w
e
r 
S
p
e
c
tr
u
m
 D
e
n
s
it
y
 [
m
V
2
]
0 5 10 15 20 25
0
2
4
6
8
Frequency [Hz]
S
p
e
c
tr
a
l E
n
v
e
lo
p
e
Electrode V1+V6
MOI = 0.486
MSE = 6.946
Electrode V1
OI = 0.453
SE = 6.883
Electrode V6
OI = 0.458
SE = 7.068
Electrode V1+V6
MOI = 0.438
MSE = 7.020
Electrode V1
OI = 0.458
SE = 6.865
Electrode V6
OI = 0.450
SE = 7.155
(i) (ii)
(iii)
(i) (ii)
(ii)
(1) Signal A
(2) Signal B
Figure 7.5: Examples of MOI and MSE measures on ECG signals. (1) Signal A: example of an AF
signal with globally homogeneous oscillations. PSDs and univariate OI and SE are given in (i) and
(ii), while multivariate measures are shown with spectral envelope in (iii). Dashed circles indicate the
location of spectral peaks used for OI/MOI computation. (2) Same as (1) with a signal with spatially
heterogeneous spectral content.
7.3 Multivariate Analysis of Atrial Fibrillation Organization 119
As opposed to the first example, signal B of Figure 7.5 is characterized by a spatially
heterogeneous spectral activity, since the frequencies observed are different from one
electrode to another. Indeed, a dominant oscillation at 6.1 Hz can be observed on lead
V1, while the main frequency peak of lead V6 is at 5.1 Hz. The corresponding spectral
envelope makes this difference even more obvious. Interestingly, both peaks are present
in the spectral envelope with equal importance, even though they were measured at very
different intensities in their respective PSDs (panels (i)-(ii)). This example shows that
the spectral envelope can detect multiple frequencies from multiple input variables, re-
gardless of individual importance. Thus, the resulting multivariate spectrum summarizes
the mixed spectral content of leads V1 and V6, and presents several peaks of similar pre-
dominances as well as a wider spectral content. As a consequence, the MOI computed
on signal B returns a lower value than the one obtained for the organized signal A. Sim-
ilarly, the MSE value of signal B is higher than the MSE of signal A, indicating a less
predictable oscillatory activity.
7.3.3 Feature Selection and Classification
In order to test the ability of both MOI and MSE measures to discriminate between
persistent and permanent AF signals and to compare the multivariate and univariate ap-
proaches, a systematic classification using a leave-one-out cross-validation across pa-
tients was performed based on an extensive set of features:
• ECG leads combinations: Several combinations of ECG leads were tested as
input variables for the multivariate organization measures. First, all possible
pairs of precordial leads (V1 to V6) were considered. In addition, the follow-
ing combinations were also tested: {V1,V2,V3}, {V4,V5,V6}, {V1,V2,V5,V6},
{V1,V2,V3,V4,V5,V6}. This resulted in a set of 19 different configurations. For
the computation of univariate OI and SE, the 6 precordial ECG leads V1 to V6
were tested.
• MOI/OI parameters: the number of peaks Np to be detected during MOI/OI com-
putation was varied between 2 and 5, while the following values were tested for
the bandwidth parameter: {0.5, 1, 1.5, 2} Hz. These values were determined after
extensive empirical testing during which it was observed that further increasing
or decreasing parameter values could not improve results. Thus, 16 parameter
configurations were investigated.
Thus, for each patient, 304 parameter configurations were systematically tested for the
multivariate measures and 96 for the univariate measures. For each of these config-
urations, quadratic discriminant analysis (QDA) [273] was run to classify signals as
persistent or permanent AF. Classification performance was assessed with leave-one-out
cross-validation and using receiver-operating characteristic analysis [274]. Correct clas-
sification and predictive values (also called precision rates) for each type of AF were
documented for the five best configurations of features [275], and the multivariate and
univariate approaches were compared in terms of these performance scores. In addition,
Wilcoxon rank-sum tests were conducted on each feature retained in this classification
ranking to assess its individual statistical power for the discrimination between AF types
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(5% significance level). Finally, the whole classification procedure was conducted using
all possible combinations of 2 or 3 features.
7.4 Results
7.4.1 Two-Feature Classification Results
Using the database presented in section 7.2, the performance of the methods for
classification of AF feature pairs are presented in Table 7.1 and in Figure 7.6. For the
multivariate case, discrimination between persistent and permanent AF could be per-
formed with classification accuracies of up to 84.9% with a combination of MOI and
MSE measures. The optimal classification is represented in Figure 7.6(A). Persistent
AF signals were well clustered in a range of MOI-MSE values that could be effectively
delineated by a quadratic classifier. Permanent AF signals were more diffused and occa-
sionally presented a large variability in their organization as measured by the MOI and
MSE, although most of them showed lower MOI values than the persistent AF signals.
Furthermore, the predictive value for permanent AF was 93.1%. This valuable result
suggests that the method proved to be very precise when diagnosing an advanced AF
development. When looking at the features retained for classification in the optimal con-
figurations of Table 7.1(A), several observations can be made. First, the optimal feature
pairs were either combinations of MOI and MSE measures or pairs of MOI measures.
The optimal MOI parameter configuration was very stable, as the five best classifica-
tions all used values of BW = 1 Hz and Np = 5. Furthermore, the ECG electrodes
providing the best results when considered as input variables were mainly combinations
of the three most lateral leads, V4 to V6. The features selected for classification in the
five best configurations were also investigated individually by means of statistical tests
to assess their discriminative power in the classification task considered, as shown in
Table 7.2. Among all features, only one could provide a statistically significant sepa-
ration between persistent and permanent AF, namely the MOI measure applied to ECG
electrodes V5 and V6. With this feature, the medians obtained for persistent and perma-
nent AF were 0.545 and 0.511 respectively with relatively small variabilities, indicating
that AF organization was degraded in permanent AF compared to persistent AF. The
other MOI features could not distinguish alone persistent from permanent AF with sta-
tistical significance, although they pointed towards persistent AF being more organized
than permanent AF. This tendency could not be found consistently in all MSE features,
because their respective ranges were clearly overlapping due to a strong variability.
Using univariate organization measures did not result in a clear discrimination be-
tween persistent and permanent AF. Classification scores did not exceed 66.0%, with
a maximal predictive value for permanent AF of 71.9%. As shown in Figure 7.6(B),
signals from different AF classes were not clearly separated, and both classes were char-
acterized by high variability. Optimal features configurations always involved a combi-
nation of SE and OI measures with different ECG electrodes, but it was difficult to find
any tendency in the selection of OI parameters, as their combination changed from one
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classification to another. Finally, none of the univariate features considered alone could
distinguish persistent AF from permanent AF in a significative manner (not shown).
(A) Multivariate Approach
Feature #1 Feature #2 BW NBP
Correct
Classif.
Rate
Permanent
AF P.V.
Persistent
AF P.V.
1. MOI(V5,V6) MSE(V4,V6) 1 5 84.9% 93.1% 75.0%
2. MOI(V5,V6) MOI(V4,V5) 1 5 81.1% 92.6% 69.2%
3. MOI(V5,V6) MSE(V4,V5) 1 5 81.1% 87.1% 72.7%
4. MOI(V5,V6) MOI(V4,V6) 1 5 79.3% 86.7% 69.6%
5. MOI(V5,V6) MOI(V3,V5) 1 5 79.3% 86.7% 69.6%
(B) Univariate Approach
Feature #1 Feature #2 BW NBP
Correct
Classif.
Rate
Permanent
AF P.V.
Persistent
AF P.V.
1. SE(V1) OI(V4) 1.5 5 66.0% 71.4% 55.6%
2. SE(V1) OI(V4) 2 4 64.2% 71.9% 52.4%
3. SE(V1) OI(V5) 2 2 62.3% 71.0% 50.0%
4. SE(V3) OI(V4) 2 5 62.3% 71.0% 50.0%
5. SE(V1) OI(V3) 1 5 60.4% 70.0% 47.8%
Table 7.1: Two-feature classification results. (A) Five best configurations of features and param-
eters to classify AF signals using the two-feature multivariate approach. ECG electrodes taken as
inputs are shown in brackets. Correct classification rates and predictive values for permanent and
persistent AF are specified. (B) Same as (A) for the univariate approach.
Feature Persistent AF Permanent AF p-value
(median±mad) (median±mad)
MOI(V5,V6) 0.545 ± 0.015 0.511 ± 0.024 p = 0.0054
MOI(V1,V2,V5,V6) 0.551 ± 0.039 0.527 ± 0.025 p = 0.1834
MOI(V4,V6) 0.540 ± 0.029 0.530 ± 0.021 p = 0.2914
MOI(V3,V5) 0.561 ± 0.041 0.540 ± 0.044 p = 0.3541
MSE(V4,V6) 6.986 ± 0.085 6.956 ± 0.120 p = 0.5509
MOI(V4,V5) 0.530 ± 0.022 0.526 ± 0.029 p = 0.6010
MOI(V1,V6) 0.554 ± 0.034 0.545 ± 0.021 p = 0.6398
MSE(V2,V3) 6.895 ± 0.121 6.910 ± 0.114 p = 0.6797
MSE(V4,V5) 6.959 ± 0.106 6.955 ± 0.111 p = 0.7205
Table 7.2: Multivariate features statistics. This table shows the list of multivariate features selected
for classification in the five best configurations shown in Table 7.1(A) and 7.3(A). For each feature,
the median and median absolute deviation (MAD) values are shown for each condition (persistent AF
or permanent AF), with the corresponding statistical power expressed as a p-value.
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Figure 7.6: Two-feature classification of persistent and permanent AF signals. (A) Two-feature
classification example obtained for the best multivariate configuration of Table 7.1(A). The continuous
black line indicates the discrimination boundaries computed by a quadratic classifier trained on the
whole dataset. (B) Same as (A) for the best univariate configuration of table 7.1(B).
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7.4.2 Three-Feature Classification Results
Classification results using a combination of three features are presented in Table 7.3,
as well as in Figures 7.7 and 7.8, and show that slight improvements can be obtained in
classification accuracy compared to two-feature classification. For the multivariate ap-
proach, correct classification rates could be increased up to 88.7%, and predictive values
for permanent AF and persistent AF reached values of 96.6% and 81.0% respectively.
As shown in Figure 7.7, AF signals of different classes were relatively well separated,
following the same patterns as in the two-feature case. Selected parameters BW and Np
for the MOI methods were similar as for two-feature classification, and showed the same
stability. The ECG electrodes retained as optimal input variables were also comparable
to those of the two-feature case. Interestingly, for the third input feature, a global and
symmetric electrode combination ({V1,V2,V5,V6} in two cases and {V1,V6} in two
other configurations) was preferentially added to the electrodes already selected in the
two-feature case. These newly selected features were not able, when considered alone,
to discriminate between persistent AF and permanent AF with statistical significance
(Table 7.2).
The three-feature classification scheme using the univariate approach only slightly
increased correct classification rates to 67.9%. However, several interesting improve-
ments were observed. First, the predictive value for permanent AF was boosted to
78.6%, which represents a 10% increase compared to the two-feature case. Moreover,
the selected parameters for OI computation were much more stable, with a preferen-
tial configuration of BW = 0.5 Hz and Np = 4. Finally, input features could be either
combinations of OI and SE or sets of OI measures only. Despite these significant im-
provements, clear separation between persistent and permanent AF signals remained a
difficult task when using the univariate approach, as is shown in Figure 7.8.
7.5 Discussion
In this work, a combination of advanced spectral analysis and standard AF organiza-
tion measures (i.e. OI and SE) was used to explore new dynamical aspects of AF (Figure
7.2). The spectral envelope is a principal component technique for multidimensional
spectral analysis that was already used to analyze genetic and industrial data [265, 269].
For the first time, in this study, this method was applied to AF signals, and showed
its numerous advantages for the analysis of oscillatory phenomena in biomedical signal
processing. Concerning the proposed implementation of the OI, slight differences with
respect to its original version were introduced: instead of considering the DF peak of
AF activity and its harmonics for area computation, it was decided to take into account
the highest peaks in the power spectrum, regardless of their relative frequency locations.
Following this procedure, several components at different frequencies could be consid-
ered in the OI computation. Thus, it was possible to assess the global organization of AF
activity in the presence of multiple competing oscillations, as it would be the case with
a multiple wavelet AF [96, 97].
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(A) Multivariate Approach
Feature #1 Feature #2 Feature #3 BW NBP
Correct
Classif.
Rate
Permanent
AF P.V.
Persistent
AF P.V.
1. MOI(V5,V6) MSE(V4,V6) MOI(V1,V2,V5,V6) 1 5 88.7% 96.6% 79.2%
2. MOI(V5,V6) MSE(V4,V5) MOI(V1,V2,V5,V6) 1 5 86.8% 90.6% 81.0%
3. MOI(V5,V6) MSE(V4,V5) MOI(V1,V6) 1 5 86.8% 90.6% 81.0%
4. MOI(V5,V6) MSE(V4,V6) MSE(V2,V3) 1 5 86.8% 90.6% 81.0%
5. MOI(V5,V6) MSE(V4,V6) MOI(V1,V6) 1 5 84.9% 90.3% 77.3%
(B) Univariate Approach
Feature #1 Feature #2 Feature #3 BW NBP
Correct
Classif.
Rate
Permanent
AF P.V.
Persistent
AF P.V.
1. OI(V2) OI(V4) OI(V6) 0.5 4 67.9% 78.6% 56.0%
2. OI(V2) OI(V4) SE(V4) 0.5 4 67.9% 78.6% 56.0%
3. OI(V2) OI(V4) OI(V5) 0.5 4 66.0% 75.9% 54.2%
4. OI(V1) OI(V4) SE(V3) 0.5 4 64.2% 73.3% 52.2%
5. OI(V2) OI(V4) OI(V5) 0.5 3 64.2% 75.0% 52.0%
Table 7.3: Three-feature classification results. (A) Five best configurations of features and param-
eters to classify AF signals using the three-feature multivariate approach. ECG electrodes taken as
inputs are shown in brackets. Correct classification rates and predictive values for permanent and
persistent AF are specified. (B) Same as (A) for the univariate approach.
7.5.1 A Discriminative Measure of Atrial Fibrillation Chronification
To our knowledge, this study is the first to propose an analysis framework provid-
ing reliable and automatic discrimination between persistent and permanent AF signals
from patient without previously known AF history. The results suggest that the tran-
sition from a persistent AF towards a permanent AF is characterized by a decrease in
global AF organization that can be detected by the proposed multivariate measures. This
finding is supported by previous studies pointing to the same increase in disorganization
when evolving from a paroxysmal AF to a persistent or chronic AF [216, 225, 259].
Considered together, these results confirm the existence of a continuous spectrum of
increasing AF disorganization as AF chronification progresses. Similar ideas were pro-
posed early when the self-sustained and evolving nature of AF was first demonstrated
[92]. However, it can be argued that the difference between persistent and permanent
AF is more subtle and difficult to quantify than the changes occurring between an acute
and a chronic AF state. Indeed, electrical and structural remodeling of atrial tissue are
the first manifestations of AF chronification, and these massive substrate changes are
known to modify AF properties dramatically [46, 254]. Therefore, differences in AF dy-
namics between acute AF and chronic AF are likely to provoke changes easy to observe
in underlying AF organization. In comparison, the gradual process leading AF from a
persistent to a permanent state is certainly more difficult to describe and quantify, as it
is probably due to a strengthening of already existing remodeling processes, and not by
7.5 Discussion 125
(A) (B)
(C) (D)
6.4 6.5 6.6 6.7 6.8 6.9 7 7.1 7.2 7.3
0.4
0.45
0.5
0.55
0.6
0.65
MSE(V4+V6)
M
O
I(
V
5
+
V
6
)
0.45 0.5 0.55 0.6 0.65
0.4
0.45
0.5
0.55
0.6
0.65
MOI(V1+V2+V5+V6)
M
O
I(
V
5
+
V
6
)
6.4 6.5 6.6 6.7 6.8 6.9 7 7.1 7.2 7.3
0.45
0.5
0.55
0.6
0.65
MSE(V4+V6)
M
O
I(
V
1
+
V
2
+
V
5
+
V
6
)
Permanent AF
Persistent AF
6.4
6.6
6.8
7
7.2
0.4
0.45
0.5 0.55
0.6 0.65
0.45
0.5
0.55
0.6
0.65
MOI(V5+V6)
MSE(V4+V6)
M
O
I(
V
1
+
V
2
+
V
5
+
V
6
)
Figure 7.7: Multivariate three-feature classification of persistent and permanent AF signals ob-
tained for the best configuration of Table 7.3(A). Two-feature projections of each possible pair of
features are shown in panels (A)-(C), and the three-feature visualization is shown in panel (D).
the occurrence of totally different dynamical phenomena. For this reason, the changes
in AF organization that we targeted in this study were difficult to measure.
Among all features tested to discriminate between persistent and permanent AF, only
one could demonstrate a significant decrease in AF organization during transition to
permanent AF. The most sensitive multivariate measure was the MOI, with all related
features showing a tendency towards more disorganized permanent AF, but only com-
binations of MSE and MOI features during two-feature or three-feature classification
could clearly distinguish both classes of AF. MSE features considered alone could not
provide accurate discrimination due to their high variability, but were systematically
selected combined with MOI features for the configurations providing the best clas-
sification scores. Possibly, MOI and MSE measures could be complementary for the
description of the underlying global organization of AF.
7.5.2 Advantages of the Multivariate Approach
It is also interesting to consider the improvements brought by the multivariate ap-
proach compared to its univariate counterpart. First, the multivariate framework resulted
in a high stability and interpretability of selected features compared to the univariate
126 Measures of Atrial Fibrillation Organization
(A) (B)
(C) (D)
0.25 0.3 0.35 0.4 0.45 0.5
0.2
0.25
0.3
0.35
0.4
OI(V2)
O
I(
V
4
)
Permanent AF
Persistent AF
0.22 0.24 0.26 0.28 0.3 0.32 0.34 0.36
0.2
0.25
0.3
0.35
0.4
OI(V6)
O
I(
V
4
)
0.25 0.3 0.35 0.4 0.45 0.5
0.22
0.24
0.26
0.28
0.3
0.32
0.34
0.36
OI(V2)
O
I(
V
6
)
0.25 0.3
0.35 0.4
0.45 0.5
0.2
0.25
0.3
0.35
0.4
0.25
0.3
0.35
OI(V2)
OI(V4)
O
I(
V
6
)
Figure 7.8: Univariate three-feature classification of persistent and permanent AF signals obtained
for the best configuration of Table 7.3(B). Two-feature projections of each possible pair of features
are shown in panels (A)-(C), and the three-feature visualization is shown in panel (D).
approach. Indeed, the optimal MOI parameters were always the same for each con-
figuration of two-feature and three-feature classifications. On the contrary, optimal OI
parameters were variable, making any interpretation or comparison more difficult. It
would be thus easier to design an automatic tool based on the multivariate approach,
since the values of BW = 1 Hz and Np = 5 could be fixed a priori. Furthermore,
the multivariate approach was superior in terms of classification performance. For the
univariate approach, only three-feature classification could provide stable parameters,
although predictive values and correct classification rates remained relatively low. In
comparison, two-feature classification using multivariate features was already satisfac-
tory with high accuracy and stable parameters, so that three-feature classification only
provided small improvements. Once again, it would be much more practical to setup a
classification scheme based on multivariate features, since the number of parameters and
features to choose would be significantly minimized.
As mentioned above, the spectral envelope method was used for the first time in this
study to investigate ECG signals of atrial arrhythmias. In the light of the results, the valu-
able properties of the method consisting in detecting common oscillations between ECG
leads while removing non-shared spectral content such as noise or irrelevant oscillations
have proved very useful and innovative for AF analysis. Applying spectral envelope on
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ECG electrodes and measuring OI/SE on its output implies that the resulting measures
are quantifying spectral homogeneity between different leads of the ECG, i.e. global
spatiotemporal organization.
A highly interesting finding in this study is the set of ECG precordial electrodes
selected by the multivariate classification schemes. Indeed, most of the combinations
of ECG leads selected as optimal features were lateral left electrodes, i.e. combinations
of leads V4 to V6 (Table 7.1(A)). Historically, it has been widely accepted that lead V1
reflects best the right atrial fibrillatory activity hidden in the ECG signal, the other leads
presenting other components of the cardiac signal such as ventricular activity [276, 277].
However, two recent studies aiming at precisely determining the contribution of left
and right atrial activity to standard and non-standard ECG leads strongly challenged
this theory [278, 279]. A first study used standard ECG leads V1 and V2, and added
posterior leads V7, V8 and V9, to assess the contribution of AF oscillations at these
locations of the body surface [278]. V1 was found to be strongly correlated to RA
activity, as predicted by past studies. However, it was also found that LA fibrillatory
activity was observable in posterior lead V9. The study of Platonov and colleagues went
even further, reproducing the same analysis with the standard ECG system on two unique
clinical cases of AT confined to the left atrium [279]. This particular situation created a
massive interatrial frequency gradient, and precise analysis of the contribution of atrial
activity on each ECG lead could be conducted. It was found that the electrodes V1, V2,
V5 and V6 reflected both RA and LA activity, with V5 and V6 better emphasizing the
oscillatory activity of the LA. V3 and V4 were shown to contain RA activity exclusively.
Thus, these studies demonstrate that precordial ECG leads not only provide information
about RA activity, but also contain oscillatory components of the LA, especially in lateral
precordial leads. They also suggest that, in surface ECG signals, AF activity is more
difficult to detect than the ATs presented in [279], because AF involves oscillations of
smaller amplitudes than AT. This observation could explain why Petrutiu and colleagues
did not detect LA activity in V1, while Platonov and colleagues did.
In our study, the pairs of lateral EGC leads V4 to V6 selected as optimal features (Ta-
ble 7.1(A)) were combined and processed by the spectral envelope. This computation
resulted in a multivariate spectrum containing relevant oscillatory components common
to the neighboring leads. Based on the findings of [279], it can be argued that in our case
AF spectral activity stemming from the LA and hidden in lateral precordial electrodes
was emphasized by the spectral envelope and helped discriminating between persistent
and permanent AF. The additional electrode combinations retained by the multivari-
ate three-feature classification ({V1,V2,V5,V6} and {V1,V6}) give further information
about the global activity of both RA and LA, as was suggested in [279]. Furthermore,
a MOI measure applied to V5 and V6 demonstrated a significant decrease in AF orga-
nization when AF becomes permanent (Table 7.2). Thus, it could be speculated that
late-stage chronification of AF is characterized by a global decrease in AF organization
due to dynamical changes localized in LA fibrillatory activity. Moreover, these dynam-
ical changes may be provoked by an alteration in LA substrate such as LA dilation or
fibrosis, which is known to be associated with AF sustainability and increased risks of
strokes [280]. This hypothesis is supported by a recent study of chronic AF ablation,
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in which patients undergoing successful maze procedures (i.e. patients with persistent
AF) were compared to those with unsuccessful ablations (i.e. patients with permanent
AF) in terms of their respective atrial substrates [281]. Patients with unsuccessful maze
procedures showed advanced LA fibrosis and larger LA dimensions than patients with
successful ablation outcomes. Interestingly, there was no difference in RA properties
between groups. Thus, according to this ablation study, patients with permanent AF
could be distinguished from patients with persistent AF on the basis of LA pathological
features only. Moreover, it was shown in past literature that the spatial distribution of
fibrosis over the atrial surface has a direct influence on subsequent AF wave dynam-
ics [282]. Based on these studies, we propose that the transition from persistent AF to
permanent AF caused by LA substrate degradation results in modifications of LA fibril-
lating patterns, and that these dynamical changes can be detected non-invasively by the
multivariate analysis framework we described in the present work.
The superiority of analyzing combined ECG electrodes with multivariate methods
becomes evident in the above results, as the univariate approach showed poor classifi-
cation performances and could not deliver any interpretation about the underlying phys-
iological phenomenon. The multivariate framework proposed in this study may be of
interest for numerous fields of cardiovascular research from fundamental research to
therapy testing, since it provides advanced spectral analysis performed non-invasively
by means of standard surface ECG recordings.
7.5.3 Clinical Implications
The multivariate measures of AF organization may be used in clinical settings as
a diagnostic tool to optimize patient management and consider optimal cardioversion
options. Indeed, anticipating the probability of success of a cardioversion procedure on
a case-by-case basis would greatly help both clinicians and patients in their decision
making. On one side, clinicians would be assisted in their diagnosis based on patient
history by an objective measure quantifying the degree of chronification of the diagnosed
arrhythmia from a simple surface ECG recording. On the other side, the detection of a
permanent AF could help patients and clinicians to take the decision of avoiding a long
and sometimes heavy treatment, e.g. drug therapy or ablative procedures. Such decision
could potentially increase the quality of life of the patient and also allow substantial cost
savings. To realize such a diagnostic tool, the proposed measures will have to ensure
highly reliable diagnostic power. The very high prediction values for permanent AF
obtained in this study are encouraging results towards a practical implementation for
clinical settings, but further developments will be needed to determine optimal features
combinations that would be robust in the case of larger database and higher inter-patients
variability.
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7.6 Conclusion
In this chapter, multivariate spectral analysis and complexity measures were com-
bined to develop an automatic method able to describe subtle changes in AF organi-
zation as measured by non-invasive ECG recordings. Accurate discrimination between
persistent and permanent AF was made possible, and potential applications in clinical
settings to optimize patient management were demonstrated. More generally, this anal-
ysis framework may be of valuable importance for the field of cardiovascular research,
as it provides an innovative monitoring tool based on standard recording systems.
Nowadays, it is more and more obvious that the clinical world can strongly benefit
from the active contribution of engineering sciences and technology. This signal process-
ing development is a striking demonstration of how clinicians and engineers can interact
and work hand in hand towards a common objective, namely helping both patients and
practitioners by improving current heatlhcare systems.
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Conclusion 8
Nowadays, many developments in life sciences are characterized by continuous in-
teractions between medicine, biology and engineering. Especially, the importance of the
contributions from the engineering field is progressively growing, as computer-guided
medical instrumentation and monitoring devices become essential for the clinical world,
and therapies improvements are often proportional to technology developments. In this
context, the activities of clinicians, biologists and scientists appear strongly interrelated,
and the boundaries between each respective area become blurred. This multidisciplinary
approach is at the core of the philosophy of the Lausanne Heart Group, whose objective
is to bring together engineering and medicine. Each project supported by this research
team combines the different approaches mentioned above in order to tackle the problem
of cardiac arrhythmias with innovative points of view. The multifaceted approach of the
Lausanne Heart Group already proved fruitful for the investigation of atrial fibrillation
and the development of dedicated therapeutic strategies, and is reflected in the present
dissertation.
A major part of the developments of therapeutic strategies for AF presented in this
work are based on a computer model of human atria. Adopting a modeling approach
presents several advantages compared to experimental approaches. First, the investi-
gator using computer models can get rid of systematic animal experiments. The ethical
impact of such consideration is obvious, as methods and therapies can be tested and opti-
mized ad libitum in the computer modeling framework before starting potential preclini-
cal studies, therefore avoiding massive animal experiments. But economical advantages
can also be mentioned, because running long-term animal experiments is a very compli-
cated and expensive process, whereas computer simulations only requires investments in
the development phase and limited maintenance costs. The other advantage of computer
modeling is unlimited access to any variable of interest and repeatability of experiments
under controlled conditions. Of course, models are by definition simplified descriptions
of reality, but they represent an appropriate framework for therapy development before
extensive validation in animal and human clinical trials.
The biophysical model of human atria used in this dissertation was developed in our
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group during more than a decade, and was the object of several PhD theses [38, 40, 41].
Thus, the present work must be considered in the continuation of these past develop-
ments. Since the model was developed and validated in previous works, it could be
then used for extensive therapy testing. Optimization of AF ablation strategies using the
model was already investigated in a previous project, but only few observations were
made in the field of low-electrical stimulation of AF [41]. Moreover, this previous con-
tribution demonstrated that the biophysical model was ready to be used as a standard
tool to investigate new therapies. For these reasons, the present work focused mainly
on the development of a therapeutic pacing solution specifically dedicated to the treat-
ment of AF. Overall, the goal of the project was to take the available computer model
to a practical level, and search for implementable therapeutic solutions. Following this
line, several properties of AF pacing were determined, and a novel pacing protocol for
automatic AF termination was designed and tested, opening the way to experimental
validation studies.
In the last chapter of this dissertation, advanced signal processing methods were
applied to real cardiac signals. This approach differs from the modeling framework
mentioned above, and can be related to other past PhD theses conducted within the
Lausanne Heart Group [283, 284]. For this particular study, the goal was to develop
new signal processing methods and transfer them from signal processing research to
applied biomedical engineering. Once again, beside the significant amount of math-
ematical and computational developments required to implement accurate methods for
AF classification, the real long-term goal of the project is the development of monitoring
and automatized diagnostic tools. The encouraging results presented in this dissertation
demonstrate that the selected approach can be fruitful. Finally, it should be mentioned
that this work required extensive collaboration with cardiologists, and for this reason the
clinical component of the Lausanne Heart Group was essential for the success of this
study.
In the sections below, a summary of achievements as well as potential future works
suggested by the results are listed. When looking globally at the outcomes of this work,
it becomes clear that the leitmotiv of this thesis was to adopt a practical approach when
developing therapeutic strategies, as engineers do by nature. Each time a method was
explored and tested, it was systematically attempted to translate it into concrete schemes
and propose practical implementations potentially leading to realistic solutions. Only
this kind of approach will help merging together the resources and needs of fundamental
research, private industry and clinical centers, and thereby taking healthcare systems to
the next level.
8.1 Summary of Achievements
The major achievements of this dissertation are summarized below.
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A Dynamical Study of AF Spontaneous Termination Processes
AF spontaneous termination is difficult to observe in real situations due to its tran-
sient and unpredictable nature. Using our biophysical model, it was possible to conduct
a detailed analysis of several AF dynamical parameters during the seconds preceding
this termination process. First, a database of simulations of AF spontaneous termina-
tion was created, taking into account models of AF dynamics with different complexity
levels (paroxysmal AF vs. recent chronic AF). Different termination processes between
models could be described and compared with the existing literature. For the model of
paroxysmal AF, spatial and temporal AF patterns prior to termination could be described
in detail, and critical value of basic dynamical properties such as AFCL were proposed
as potential triggers for termination occurrence.
A better understanding of AF spontaneous termination processes may be of value for
the field of AF therapy research. Indeed, understanding a natural phenomenon can be
the first step of therapeutic developments aiming at reproducing this particular natural
process. Such biomimetic solutions may represent the future of AF therapies.
Rapid Pacing of AF: Optimization of Parameters and Effects of Atrial Substrate
Overdrive pacing has been shown to entrain successfully the electrical activity of
basic ATs, leading to termination of the underlying arrhythmias. However, its efficacy
cannot be clearly demonstrated in the case of AF, although this protocol might be promis-
ing. Using our biophysical model, a systematic study was designed in order to under-
stand the importance of pacing cycle length, pacing location and atrial tissue properties
on the ability to capture AF by rapid pacing. In addition to the massive amount of simu-
lations needed for the statistical description of this study, a complete analysis framework
designed for the assessment of AF capture by rapid pacing had to be conceptualized.
First, an automatic system to assess the local capture of a portion of atrial tissue was de-
veloped in the biophysical model. Once capture could be reliably detected, quantitative
measures of its quality were developed to assess both temporal and spatial aspects of AF
capture by pacing. Based on these tools, pacing parameters such pacing cycle length or
pacing location could be explored in a systematic manner, and optimal combinations for
AF capture could de determined. The ability to capture AF was also shown to depend
on the atrial substrate as characterized by an estimate of its wavelength, a better capture
being achieved at shorter wavelengths.
These results have several implications. First, they show that patients may respond
differently to pacing therapies according to their intrinsic atrial tissue properties. How-
ever, simple measures of tissue wavelength can provide valuable information about the
future response of a specific patient to rapid pacing sequences. Moreover, the results
emphasized some limitations of current rapid pacing protocols, and suggested pacing
sites and cycle lengths that would be optimal for AF capture. Considered together, these
observations are of crucial importance for future developments in AF therapy by low-
energy stimulation.
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A Multi-Stage Pacing Scheme for Automatic AF Termination
Based on the results of the systematic analysis of AF rapid pacing, a multi-stage pac-
ing scheme for AF termination was designed and implemented in the biophysical model.
The atrial septal area was selected as a strategic pacing location, and an abrupt transition
between rapid and slow pacing phases was introduced in the protocol to increase AF ex-
tinction probability. Pacing cycle lengths of both phases were optimized and termination
rates were computed for several configurations to derive statistical performance evalu-
ation. The obtained termination success rates were promising, and potential decreases
in performance when applying the protocol in real experimental settings could be com-
pensated by the high repeatability of the procedure. Moreover, the concepts of capture
pattern during rapid pacing as well as wavelength lengthening were introduced as crucial
elements for AF termination efficacy and as possible directions for future optimization.
The proposed pacing scheme was compared to current pacing protocols such as rapid
pacing, and showed great promise as a potential therapeutic solution for the treatment of
AF in patients with implantable pacemakers.
A multivariate Analysis Framework for AF Organization Assessment
In this study, a database of real surface ECG signals was used to assess the differ-
ences in AF complexity between persistent and permanent AF. Measures of organization
based on multivariate spectral analysis were developed to evaluate the spatiotemporal or-
ganization of AF based on the spectral information of multiple surface ECG electrodes.
In particular, the spectral envelope method was used for the first time in the field of car-
diac arrhythmia, demonstrating interesting abilities to extract oscillatory information of
interest from combined ECG electrodes. The organization measures provided accurate
classification of persistent and permanent AF, and optimal selected features showed that
changes in LA dynamical properties were determinant during late stage AF chronifica-
tion, agreeing with recent clinical and experimental findings. These developments may
be the basis for the conception of automatic diagnostic tools assisting clinicians during
the management of patients with AF.
8.2 Perspectives
The results presented in this dissertation must be considered in the continuation of a
series of projects conducted within the Lausanne Heart Group. As such, this work also
suggests numerous lines of research for future investigations perpetuating the activity of
the group.
From Simple to Complex Models
When used as a first approach, a biophysical model should be made as simple as
possible to provide clear explanations with a minimum number of arbitrary parameters,
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but still with a sufficient level of complexity to capture the essential features needed to
understand the phenomena under investigation. This trade-off was carefully considered
during this dissertation, as the models used were designed in such a way that realistic
AF could be simulated with a relatively small number of parameters and in a reasonable
time. Thanks to this simplicity, the models made it possible to run systematic analyzes
involving a very large number of simulations, and provided precise descriptions of the
basic mechanisms in action.
In order to improve and extend these initial findings, a next step would be to make
models more complex to include more details about the mechanisms already described.
Indeed, with the increasing computational power of today’s computers, it will be feasible
to simulate the protocols developed in the previous chapters on more complex models
that would approximate reality even more closely. Possible refinements of the models
include:
• Tissue thickness: adding a third dimension to the atrial tissue would make AF
wavelet dynamics slightly more complex, as fibrillating spirals would be allowed
to evolve in the thickness of the tissue, creating vortex-like patterns. Whether
this small additional dimension can really change the overall AF dynamics is still
a matter of debate, because the thickness of atrial walls is known to be small
compared to ventricles. Nevertheless, comparing these supplementary simulations
to the results obtained in the present dissertation would be an interesting starting
point for discussions.
• Additional anatomical structures: a clear limitation of the presented models is
the absence of some influencing anatomical structures such as Bachmann’s bun-
dle, pectinate muscles, or crista terminalis. Adding these essential structures could
give rise to new interactions between AF wavefronts, particularly for interatrial
conduction.
• Fibers anisotropy: the models of atrial tissue used in our studies had homo-
geneous properties and did not include anisotropy. Changing these properties
and adding fibers anisotropy would alterate wavefronts propagation patterns, and
could for instance modify the reactions of the modeled atrial tissue to electrical
stimulation.
• Structural remodeling: atrial tissue alterations reflected by structural remodeling
were not considered in this dissertation. In order to simulate long-lasting chronic
AF, it would be crucial to add structural heterogeneities such as fibrosis, hetero-
geneities in specific ionic concentrations or gradients in APD.
These modifications were already implemented in our biophysical model in past
studies [40, 69], and could be added incrementally to assess the specific effect of each
additional element. This step-by-step approach will hopefully lead to a more and more
realistic description of AF as observed by our biophysical model.
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From Simulations to Reality
One of the strengths of a fruitful modeling approach is to formulate innovative hy-
potheses that could be tested experimentally. The model-based studies performed in
chapters 4 to 6 provided several suggestions for experimental validations. During the
study of AF spontaneous termination of chapter 4, the following proposals for further
investigations were made:
• Optimizing the design of clinical studies: the first hypothesis to validate is that
AF spontaneous termination mechanisms may be very different depending on the
stage of the arrhythmia. To test that proposition, clinical studies should be run
with special care when selecting patient populations to compare. Indeed, patients
with paroxysmal AF should be distinguished from patients with chronic AF. Such
procedure may help uncovering termination mechanisms specific to each AF type.
• High-density mapping studies: in order to assess the presence of a lateraliza-
tion process of fibrillating activity prior to termination, it would be interesting to
perform bi-atrial mapping studies with high spatial resolution and analyze these
recordings by means of advanced signal processing methods such as phase sin-
gularity tracking. Doing so, the trajectories of AF reentries could be described
over time and spatial patterns prior to spontaneous termination could be assessed
precisely, in order to confirm or reject the observations made in our model.
• Analysis of population dynamics: it was suggested in section 4.4.4 that consid-
ering portions of excited and non-excited atrial tissue as interacting populations
of predators and preys may help uncovering unknown processes of AF dynamics
related to spontaneous termination. In particular, such analyses could point out
whether parameters such as AFCL or #WF could act as predictors of AF termina-
tion.
The investigations of chapter 5 and 6 on low-energy pacing of AF also led to the follow-
ing testable concepts:
• Measures of AF capture ability: experimental measurements could be performed
either on animals or humans, in order to test the hypothesis that an approximation
of the atrial tissue wavelength may give information about the subsequent ability
to capture AF by rapid pacing (chapter 5). Simple S1-S2 protocols would easily
provide values of APD and CV, and approximated wavelength measures could be
derived, and tested as potential predictors of AF capture ability by rapid pacing.
Ideally, populations of patients with either large or short tissue wavelengths should
be compared during rapid pacing of AF and quantitative capture assessment.
• Validation of the septum pacing protocol: the septal pacing scheme for AF ter-
mination proposed in chapter 6 is now the object of preclinical studies on animals,
with the collaboration of our industrial partner. During these tests, the different
pacing parameters optimized in the model will be adapted to experimental set-
tings, and AF termination abilities will be assessed. Ideally, a cross-talk between
electrophysiologists and modeling engineers will be established in order to better
understand potential issues raised during experiments with the help of additional
simulations, and to eventually tune the current algorithm for its realistic imple-
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mentation. Overall, the goal of this study is to assess the feasibility of a concrete
solution that could be integrated in human patients with implantable pacemakers.
From Signal Processing to Monitoring and Diagnostic Tools
The measures of AF organization presented in chapter 7 certainly represent potential
methods for discriminating between different types of AF, and thereby helping clinicians
in their daily activity. However, further improvements and investigations will be required
to finally develop a robust and automatic diagnostic tool. First, it will be necessary to test
the methods on a larger database of patients with permanent and persistent AF, in order
to verify that the accuracy of the measures remains high and robust against occasionally
large inter-patient variability. Furthermore, ECG leads combinations providing the opti-
mal features for the considered classification task must be determined more precisely in
order to select them and avoid the extensive exploration of parameters performed in this
study. So far, the results obtained clearly suggest that electrodes reflecting the activity of
the LA should be favoured, but further tests on larger datasets will be needed to verify
this hypothesis.
The proposed multivariate organization measures could also be used for other pur-
poses related to AF analysis. The same classifier could be applied to other discrimination
tasks, such as the differentiation between acute and chronic AF, the prediction of electri-
cal or pharmacological cardioversion outcomes, or the prediction of AF recurrence. All
these functionalities could be concentrated in a polyvalent and automatic ECG-based
system that would provide significant support to clinicians during their diagnosis and
decision making.
Another application of the organization measures would consist in a monitoring tool
for AF ablation procedure. Surface ECG leads as well as intracardiac signals could
be processed by the algorithm continuously, which in turn would provide a real-time
assessment of atrial organization. In this context, a sudden increase in the estimated
organization could indicate successful extinction of fibrillating activity, and decisions
whether to stop or continue the ablation procedure could be optimized based on this
quantitative measure. Clearly, the analysis framework proposed in chapter 7 cannot be
restricted to the presented classification task, and future studies will hopefully reveal the
full potential of the methods and their potential contributions to the clinical world.
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